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Abstract
CALCIUM DYSHOMEOSTASIS IN NEURODEGENERATION
Nicholas Emanuel Karagas
Advisory Professor: Kartik Venkatachalam, Ph.D.

Neurodegenerative diseases, despite constituting a major and growing
cause of mortality globally, have few effective treatments. In order to develop
novel therapeutics to combat neurodegeneration, a better understanding of the
molecular mechanisms underlying these diseases is needed. Neurons rely on
Ca2+ to mediate many of their unique functions, and aberrant Ca2+ signaling has
been broadly implicated in neurodegeneration. The goal of this dissertation is to
delineate specific examples of Ca2+ dyshomeostasis that I have uncovered in
Drosophila models of neurodegeneration.
I first define the role a neurodegeneration-associated mutation plays in
perturbing presynaptic [Ca2+], which is an important determinant of proper
morphological development of the Drosophila neuromuscular junction (NMJ).
While previous reports have shown how low [Ca2+] contributes to morphological
defects in synaptic boutons by destabilizing microtubules, this project elaborates
on this story by demonstrating that high [Ca2+] can also cause a similar
phenotype. Deviations in typical presynaptic [Ca2+] that result in improper NMJ
morphology are mediated by a pair of counteracting Ca2+-sensitive enzymes, a
phosphatase and a kinase, which act on the same microtubule-stabilizing
substrate.
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I next describe how depolarization of the plasma membrane potentiates
Phospholipase Cβ (PLCβ) activity, which led to greater inositol trisphosphate
receptor (IP3R)-mediated Ca2+ release. Depolarization-induced augmentation of
PLCβ-IP3R signaling increased mitochondrial [Ca2+] and ATP production,
suggesting that activity of this mechanism constitutes a homeostatic response
that compensates for the intensive bioenergetic needs of the neuron.
Furthermore, in Drosophila models of neurodegeneration that decouple
depolarization from this putative homeostatic response, misappropriation of this
signaling axis induced increased endolysosomal Ca2+ loading, and a reduction in
longevity. Interventions that decreased PLCβ-IP3R signaling or attenuated
endolysosomal Ca2+ overload prevented shortening of lifespan in flies expressing
neurodegenerative transgenes.
This dissertation endeavors to expand the body of knowledge describing
mechanisms of Ca2+ dyshomeostasis that are relevant to neurodegeneration. I
hope that, in the future, what is outlined here will contribute to the development of
therapeutics needed to combat neurodegenerative diseases.
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Chapter 1: Introduction
This chapter is partially based on the following publication: Karagas, N. E., and
K. Venkatachalam. 2019. Roles for the Endoplasmic Reticulum in Regulation of
Neuronal Calcium Homeostasis. Cells 8: 1232. Note: Cells allows use of
published materials without permission.
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1.1 The Growing Burden of Neurodegeneration
Neurodegeneration is one of the major challenges facing biomedical
research and modern medicine (1). Age-related neurodegenerative diseases –
including Alzheimer’s disease (AD), Parkinson’s disease (PD), Lewy body
dementia (LBD), frontotemporal dementia (FTD), and amyotrophic lateral
sclerosis (ALS) – are becoming increasingly common as populations age.
Unfortunately, there is a conspicuous lack of disease-modifying therapies for
nearly all of these afflictions, which threatens to compound the growing social
and financial toll that neurodegeneration imposes upon individuals, families, and
larger communities.
Dementia caused by AD, which leads to progressive cognitive impairment,
loss of independence, and ultimately death, is the most prevalent
neurodegenerative disease with over 5 million individuals in the United States
(US) currently living with the condition (2, 3). This number is expected increase
dramatically to over 13 million by 2050, assuming no curative therapies are
developed (2). The likelihood of developing AD doubles every 5 years after the
age of 65, with over 30% of those over the age of 85 showing signs of dementia
(4). PD, which is caused by degeneration of dopaminergic neurons in the
substantia nigra and is predominantly characterized by motor symptoms,
including resting tremor and bradykinesia, is the second most common
neurodegenerative disease with nearly 1 million affected individuals in the US (5,
6). Patients with LBD, a pathology that overlaps with both AD and PD,
experience cognitive decline, repeated visual hallucinations, rapid eye movement
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sleep behavior disorder, and eventually parkinsonism (7). Given that this disease
shares features of both AD and PD, the exact prevalence of LBD has been
difficult to quantify, although some estimates suggest that LBD makes up ~15%
of all dementia (7). FTD and ALS, two seemingly distinct conditions, are now
thought to exist as a spectrum of disease, as there is substantial overlap in
clinical, pathological, and genetic features in ALS/FTD (8, 9). FTD, which is
second to only AD as a cause of dementia in patients under the age of 65 (10), is
characterized by selective atrophy of the frontal and temporal lobes, which can
manifest with cognitive impairments and personality alterations (8). On the other
end of the continuum, ALS generally spares cognitive faculties but causes a
rapidly progressive decline in voluntary motor function, with 50% of individuals
succumbing to the disease only 3-5 years after symptom onset (11). Compared
to the aforementioned age-related neurodegenerative disease, ALS is relatively
less prevalent, with an incidence of 5.2 per 100,000, which amounts to ~16,500
individuals in the US with the disease (12).
That there are no effective curative therapies available for age-related
neurodegeneration is a testament to the challenge of treating these diseases.
Current treatment options merely manage symptoms or, at best, slow the
progression of the disease (13). The enormous, and so-far unsuccessful, effort
over the past several decades to develop therapeutically beneficial agents
capable of clearing β-amyloid – the protein comprising extracellular plaques
found in the brains of individuals suffering from AD – is the most glaring example
of this difficulty (14). These failures have led many to question the validity of the
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amyloid hypothesis (15). To date, every AD clinical trial, irrespective of target,
has failed to conclusively provide disease-modifying therapy, and new
pharmaceuticals have not been approved since 2003 (16). A similar state of
affairs exists for the other prevalent dementias, including LBD and FTD (17–20).
The standard of care for all three of these dementias is the management of
cognitive and neuropsychiatric symptoms. For AD and LBD, acetylcholinesterase
inhibitors and N-methyl-D-aspartate receptor (NMDAR) antagonists mitigate
cognitive symptoms. However, these agents are either ineffective or detrimental
in FTD, a disease with no approved therapies (19–22). The behavioral
component of FTD, which includes impulsivity, apathy, and lack of empathy, is
managed with off-label use of serotonergic antidepressants and typical
antipsychotics (19, 20). Individuals with PD, though still lacking treatments that
reverse or stall the progressive nature of the disease, can often be more
effectively managed relative to those with other age-related neurodegenerative
diseases (13, 23). Such outcomes are achieved by administration of drugs that
compensate for the decline of dopaminergic neurons in the substantia nigra and,
more recently, deep brain stimulation targeting the subthalamic nucleus or globus
pallidus (23).
As mentioned previously, the prevalence of age-related
neurodegeneration will continue to increase as life expectancy is extended
worldwide. Additionally, as relative mortality rates for other leading causes of
death, such as cardiovascular disease and cancer, fall due to successful
preventative measures and therapeutic advances, neurodegenerative disease
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will only become more common (24–26). Indeed, by 2040, neurodegenerative
diseases are expected to eclipse cancer in mortality ranking, second to only
cardiovascular disease (13, 27). As lifespans lengthen, every effort should be
made to also extend healthspans. Given the seemingly intractable nature of
these diseases and lack of curative therapy to date, age-related
neurodegeneration is perhaps the greatest challenge in the way of achieving this
goal.

1.2 Neuronal Cell Biology
Ever since Ramón y Cajal – the father of modern neuroscience – first
revealed the microanatomy of neural tissue, neurons have proven to be
especially unique cells in both form and function (28). Neurons, easily identifiable
by their elaborate dendritic arborizations and ramifying axonic projections, are
specialized cells evolved to receive, integrate, and transmit information through
electrochemical signaling (29, 30). The underlying biology that enables these
capabilities is necessary to understand the processes that become dysregulated
during neurodegeneration. Here, I will review various concepts that are important
to the findings present in later chapters.
1.2.1 Resting Membrane Potential and Action Potentials
A fundamental feature of neurons is their excitability, a property that
allows for information transfer in the form of action potentials. Excitability is the
ability of a cell to generate all-or-nothing, rapidly conducted action potentials after
a threshold perturbation of its resting membrane potential (RMP) is evoked (31).
Neurons typically maintain a RMP between -60 mV and -70 mV (32), and will
5

generally spike if the membrane potential is depolarized past a certain threshold.
The RMP is ultimately set by the Na+/K+ ATPase, which pumps Na+ out of and K+
into the cell in a 3:2 ratio, respectively (33–35). While the mismatch in
segregation of these cations itself marginally contributes to the neuronal RMP
(35), the vast majority of the RMP is attributable to the selective permeability of
the membrane to K+ (36, 37). Thus, the Na+/K+ ATPase indirectly contributes to
setting the neuronal RMP by continually pumping K+ inside the cell, which allows
for the RMP-setting K+ leak to occur without dissipation of the K+ concentration
gradient.
Neurons express a range of voltage-gated ion channels that are
selectively permeable to specific ions and are activated at different voltages (38).
Excitatory chemical signals are received from presynaptic neurons that, in
chemical synapses, activate ligand-gated channels, which allow the influx of
cations and the spread of positive charge in the postsynaptic neuron (39). Such
local excitatory signals are summated, depolarizing the membrane potential and
increasing the chance of reaching spike threshold (40, 41). Whether or not an
action potential is initiated depends on if the membrane potential is sufficiently
depolarized to overcome the threshold potential (36, 42, 43). If so, in most
neurons, voltage-gated Na+ channels (VGSCs) open, allowing for additional
positive charge to enter the neuron. This culminates in a positive feedback loop
that causes a large depolarization, driving the membrane potential well into the
positive mV range. The influx of Na+ is self-extinguishing, as VGSCs possess
cytosolic domains that render themselves impermeable after a short period (38,

6

44). Additionally, voltage-gated K+ channels become activated when the
membrane potential becomes excessively depolarized, leading to an efflux of K+
that repolarizes the neuronal membrane (36, 42, 43). This process selfpropagates along the axon of a neuron, eventually resulting in synaptic
transmission. (39).
While this conventional description involving only two voltage-dependent
conductances, which was first discovered by Hodgkin and Huxley in the squid
giant fiber (42), serves as a useful conception of the rapid propagation of an
action potential through an axon, the reality of information integration and
transmission in neurons is more complex (43). For example, central neurons in
the mammalian brain display evidence of a remarkable number of conductance
components. By one account, this includes 2-3 Na+ currents, 4-5 voltagedependent Ca2+ currents, 4-5 K+ currents, and 2-3 Ca2+-activated K+ currents to
name only a partial list (43). Many of these voltage-dependent conductances are
likely employed in the neuronal soma and dendrites, where postsynaptic
potentials serve, not to transmit, but to encode information.
1.2.2 Neuronal Bioenergetics
Neurons are especially energy-intensive cells (45–47). Indeed, the human
brain consumes ~20% of body oxygen at rest despite only comprising ~2% of
body mass (47, 48). This disproportionate energy use is necessary to power the
maintenance of ionic gradients required for generating successive action
potentials and the corresponding processes involved with synaptic transmission
(47). Specifically, 20% and 22% of neuronal ATP is allocated for the extrusion of
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Na+ to sustain the RMP and to reset ionic gradients post action potential,
respectively, whereas 50% is needed to reverse postsynaptic receptor ion fluxes.
While a portion of the energy required to restore ionic gradients is allocated
towards actively pumping other ions, most notably Ca2+ via the plasma
membrane Ca2+ ATPase (PMCA) and sarco/endoplasmic reticulum Ca2+ ATPase
(SERCA), a greater quantity of ATP is needed to power the Na+/K+ ATPase (47,
49, 50). Furthermore, with respect to Ca2+ extrusion, the Na+ gradient set by the
Na+/K+ ATPase enables the Na+/Ca2+ exchanger (NCX) to maintain low cytosolic
[Ca2+] (51). Thus, it is unsurprising that, by some accounts, the Na+/K+ ATPase
consumes the majority of neuronal ATP (50).
Neurons, which do not store large quantities of energy-bearing molecules
or perform high rates of β-oxidation (52, 53), manage their steep metabolic
requirements by employing a number of unique strategies. For instance, on the
intercellular level, neurons are thought to cooperate with glial cells, chiefly
astrocytes, to provide the energy needed for neuronal function (54). Astrocytes,
which are highly glycolytic, supplement neurons metabolically via the astrocyteneuron lactate shuttle (ANLS) and are considered by many to be the essential
intermediaries of neuroenergetics, including in Drosophila (55, 56). However,
some reports have disputed the prominence of the ANLS, suggesting that during
periods of stimulation, neurons rely on upregulation of their own metabolic
pathways irrespective of astrocytes (57, 58). Indeed, the fact that neurons –
perhaps more so than any other cell type – switch between periods of
quiescence and acute elevations in energy usage indicates these cells likely
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possess overlapping metabolic strategies that allow them to maintain
bioenergetic homeostasis during alternating states of activity.
Regardless of the origin of the fueling metabolites or the preferred
bioenergetic pathways utilized in different activity states, neurons produce ATP
through both glycolysis and oxidative phosphorylation (OXPHOS) (59), the latter
of which is particularly pertinent to this dissertation. An important, but somewhat
underappreciated, aspect of mitochondrial ATP generation is the multifaceted
role that Ca2+ plays in this process (Figure 1). OXPHOS relies upon reducing
equivalents, namely NADH and FADH2, which are produced in the tricarboxylic
acid (TCA) cycle and are responsible for delivering electrons to the electron
transport chain (ETC) (60). Three TCA cycle dehydrogenases - pyruvate
dehydrogenase, α-ketoglutarate dehydrogenase, and isocitrate dehydrogenase –
require >20 μM [Ca2+] to be activated, necessitating an acute elevation of Ca2+
within the mitochondrial matrix, which has a resting [Ca2+] ~500 nM, for increased
ATP synthesis (61–64). Additionally, ATP synthase itself is thought to be
activated by a Ca2+-dependent mechanism (65, 66). Given the low Ca2+ affinity
(20-30 μM) of the mitochondrial calcium uniporter (MCU), locally heightened
[Ca2+] proximal to the MCU must be achieved for entry into the mitochondrial
matrix (67). To avoid the cytotoxicity that would occur during sustained global
elevations of cytosolic [Ca2+], a fraction of endoplasmic reticulum (ER) is closely
juxtaposed with mitochondria in specialized contact structures called
mitochondrial-associated membranes (MAMs) (64, 68–70). This configuration
serves many functions, including as a conduit for interorganellar Ca2+ transfer
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from the ER to the mitochondria via inositol trisphosphate receptor (IP3R), an ERresident Ca2+ channel (71–76). The IP3R is paired and tethered to the outer
mitochondrial membrane-resident protein, Porin1, by the intermediary linker,
glucose-regulated protein 75 (GRP75) (71). Thus, when Ca2+ is released by the
IP3R, this arrangement facilitates elevation of perimitochondrial [Ca2+], MCUmediated Ca2+ uptake, and ultimately, increased activity of enzymes critical for
OXPHOS (74) (Figure 1).
In addition to activating various enzymes that are important for
mitochondrial ATP production, the elevation of mitochondrial [Ca2+] ensures
progression of the ETC via a more fundamental, biophysical mechanism (59).
Mitochondrial Ca2+ uptake causes depolarization (i.e., diminution) of the
mitochondrial membrane potential (∆Ψm), which is necessary for efficient
consumption of NADH and O2 and progression of electron transport (59). Thus,
Ca2+ is an essential modulator of OXPHOS, which makes the cation relevant to
our understanding of the strategies neurons employ to maintain bioenergetic
homeostasis.
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Figure 1 – ER Ca2+ stimulates oxidative phosphorylation. Inositol
triphosphate receptors (IP3R) are found within mitochondrial-associated
membranes (MAMs) and partner with the outer mitochondrial membrane (OMM)
protein, Porin 1. This interaction is facilitated by the linker protein, glucoseregulated protein 75 (GRP75). In this configuration, IP3-mediated Ca2+ release
results in elevated perimitochondrial [Ca2+], which allows the low-affinity
mitochondrial Ca2+ uniporter (MCU) to be overcome. Thus, Ca2+ enters the matrix
and stimulates the tricarboxylic acid (TCA) cycle by activating pyruvatedehydrogenase (PD), isocitrate-dehydrogenase (ID), and α-ketoglutaratedehydrogenase (α-KD). The TCA cycle produces the reducing equivalents
(NADH and FADH2) that power the electron transport chain (ETC), which
ultimately culminates in ATP production by ATP synthase.

11

Indeed, given that neurons are metabolically intensive aerobic cells, they
are highly dependent on the availability of energy and quickly become
compromised when OXPHOS is disrupted. This is well understood, for example,
in the case of stroke, in which the oxygen-carrying blood supply to the brain is
interrupted, resulting in neuronal apoptosis within 5-10 minutes (77). While much
remains to be elucidated, less severe – but chronically sustained – insults that
impair ATP production, perhaps via mechanisms related to Ca2+ dyshomeostasis,
may be important to the pathogenesis of neurodegeneration. Indeed,
mitochondrial dysfunction is a hallmark of neurodegeneration and has been
implicated in a number of age-related neurodegenerative diseases (78–80).
1.2.3 Neuronal Ca2+ Signaling
Through a diverse array of signaling modalities, Ca2+ controls an
impressive number of cellular processes (51, 81). Relative to other
physiologically relevant ions, resting cytosolic [Ca2+] is very low, typically ~100
nM. However, in the ER, [Ca2+] approaches 1 mM, which is four orders of
magnitude higher than the resting cytosolic [Ca2+] and comparable to the
extracellular [Ca2+] (82). In addition to the ER, the lysosome is now recognized as
a smaller, but still functionally important, intracellular Ca2+ store (82). This
segregation into specific compartments allows Ca2+ to serve as a signaling
molecule when transiently released into the cytosol. While sustained increases in
cytosolic [Ca2+] can be toxic, limited cytosolic Ca2+ influx from either intracellular
stores or the extracellular milieu is important for many specialized (e.g., muscular
contraction, synaptic transmission, egg fertilization) and general (e.g., gene
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expression) cellular functions (51, 81). Here, we will focus on Ca2+-dependent
processes intrinsic to the neuron, which are of particular relevance to this
dissertation.
Ca2+ is an important signaling molecule in all cells, but the cation performs
a number of unique roles in neurons (51, 83, 84). Indeed, Ca2+ is instrumental in
all major neuronal operations – taking part in the reception, propagation, and
transmission of information. The role Ca2+ plays in the postsynaptic compartment
begins in dendritic features called spines. These entities, which pair with axonal
termini to form synapses, are bulbous protrusions that, although contiguous with
their parent dendrites via thin necks, are somewhat biochemically and electrically
segregated from the remainder of the neuron (85). NMDAR, an ionotropic
receptor in the excitatory glutamatergic synapse, is embedded in the spine
plasma membrane (PM) and becomes permeable to Na+, K+, and Ca2+ upon
glutamate binding during concomitant depolarization. This depolarization
removes obstructive Mg2+ from the intracellular domain of the channel pore,
allowing both Na+ and Ca2+ to enter and cause further depolarization (81). While
Na+ primarily induces dendritic depolarizations that contribute to overcoming the
threshold necessary for impulse generation, Ca2+ mainly functions as a signaling
molecule that influences multiple processes within the spine, including those
important for learning and memory (81, 85). For example, short-lived, spinelocalized Ca2+ transients are transformed into more durable biochemical changes
by the Ca2+-sensitive protein, calmodulin (CaM), which activates CaM-dependent
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protein kinase II (CaMKII), a kinase whose activity is essential for long term
potentiation (LTP) (85, 86).
Once postsynaptic excitatory potentials summate and reach a certain
threshold, neurons generate action potentials. Although the flow of Na+ and K+
contribute the most to the formation of neuronal spikes, Ca2+ can also be an
important component of these impulses. Whereas the opening of VGSCs
contributes to the rising phase of action potentials, the same cannot be said for
voltage-gated Ca2+ channels (VGCCs), which have slower activation kinetics and
become permeable around the apex of the spike (43). In fact, although
substantial inflows of Ca2+ occur during action potentials, this conductance
usually contributes to the falling phase of the spike. This counterintuitive
phenomenon is explained by the activation of large conductance Ca2+-activated
K+ channels, which are a major component of repolarization. Thus, because this
Ca2+ influx is coupled to – as well as overshadowed by – an even greater K+
efflux, VGCCs steepen the falling phase of the action potential (43).
Perhaps the most distinct function of Ca2+ in neurons is synaptic
transmission, which has been extensively characterized over the past several
decades and is the most well-understood form of cellular secretion (81, 87).
Synaptic transmission is initiated when a propagating action potential depolarizes
presynaptic termini. The increase in membrane potential causes resident VGCCs
– primarily those in the Cav2 subfamily that generate N-, P/Q-, and R-type
currents – to become permeable (88). Ca2+ influx commences and binds to the
Ca2+-dependent exocytosis machinery that powers the release of
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neurotransmitter into the synaptic cleft. Specifically, the protein synaptotagmin is
activated by elevated presynaptic [Ca2+], and drives synaptic vesicle (SV) fusion
via interaction with the core membranes of the SNARE protein complex,
including synaptobrevin, syntaxin, and synaptosomal-associated protein 25
(SNAP-25) (81, 89). Within presynaptic termini, there are functionally
differentiated pools of SVs, with some vesicles releasing rapidly and others
slowly. In addition to heterogeneity in the Ca2+ sensitivity of individual SVs
contributing to this varying release probability, those vesicles most proximate to
VGCCs may be primed for immediate release (87). Indeed, the molecular
composition and organization of active zones, the subsynaptic structures where
exocytosis occurs, is such that highly concentrated arrays of VGCCs are coupled
with membrane-docked SVs via a scaffolding protein complex, which facilitates
synchronous release upon arrival of an action potential (90).

1.3 ER Ca2+ Signaling
ER Ca2+ signaling, and particularly the inositol 1,4,5-trisphosphate (IP3)
pathway, is especially pertinent to this dissertation. Of note, the previous section
describing the role of Ca2+ in OXPHOS included a specific function of IP3R in the
context of MAMs. Below, I will more generally review the IP3 pathway and several
other related aspects of ER Ca2+ signaling.
1.3.1 The IP3 Pathway and Related Concepts
The IP3 pathway, which is present in a wide range of cell types and
controls a diverse set of functions, results in an efflux of Ca2+ from the ER (91)
(Figure 2). Phospholipase C (PLC) enzymes – primarily represented by PLCβ,
15

PLCγ, and PLCδ – hydrolyze phosphatidylinositol 4,5-bisphosphate (PIP2), to
generate IP3, which diffuses into the cytosol, and diacylglycerol (DAG), which
remains embedded in the PM (91). While all PLCs cleave PIP2 to produce IP3,
the various subtypes are activated in disparate ways and possess unique kinetic
profiles that affect their respective downstream signaling dynamics (64, 92–94).
For example, PLCβ is stimulated by G-protein coupled receptors (GPCRs)
whereas PLCγ is activated by receptor tyrosine kinases (RTKs) (91). In either
case, the second messenger IP3 mobilizes Ca2+ after binding to the IP3 receptor
(IP3R), an ER-resident Ca2+ channel, enabling the cation to flow down its
concentration gradient and affect downstream Ca2+-dependent processes
located in the cytoplasm or within other organelles (Figure 2). The magnitude of
the IP3 signal may be modulated by either the addition or subtraction of a
phosphate group, which renders the inositol inert with respect to IP3R activation
(91).
The efflux of Ca2+ from the ER may be amplified through a process called
Ca2+-induced Ca2+ release (CICR). Both the IP3R and the ryanodine receptor
(RyR) – an additional ER-resident Ca2+ channel that is activated by the second
messenger cyclic ADP-ribose (cADPR) (95) – exhibit biphasic regulation by the
cytosolic [Ca2+] (96, 97) (Figure 2). Therefore, these channels are further
stimulated by limited increases in cytosolic [Ca2+] before becoming inhibited by
excessive elevation (~300 nM) in cytosolic [Ca2+] (98, 99). Thus, CICR acts as a
positive feedback loop until the signal self-extinguishes. Given that cells do not
tolerate sustained elevation of cytosolic [Ca2+], the cation must be actively
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extruded to the extracellular space or sequestered into the ER by the PMCA and
SERCA, respectively (51) (Figure 2).
Finally, an additional component of ER Ca2+ signaling involves the
mechanism by which Ca2+ reenters the ER upon depletion of the cation from the
organelle – a process termed store-operated Ca2+ entry (SOCE) (51). SOCE is
mediated by stromal interaction molecule 1 (STIM1), which senses luminal Ca2+
and become activated when ER [Ca2+] falls below a certain threshold (100).
Upon activation, STIM1 translocates to ER-PM contact sites, where it pairs with
and activates the PM Ca2+ channel, Orai (51). The subsequent influx of
extracellular Ca2+ is used to fill ER Ca2+ stores.
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Figure 2 – Overview of ER Ca2+ channel activation. Agonist stimulation of Gprotein coupled receptors (GPCRs) leads to dissociation of heterotrimeric Gq
protein. Gqα activates phospholipase Cβ (PLCβ), which produces inositol
trisphosphate (IP3) from phosphatidylinositol 4,5-bisphosphate (PIP2). IP3
activates IP3R, evoking ER Ca2+ mobilization. The ryanodine receptor (RyR) is
activated by cyclic ADP ribose (cADPR), which is synthesized from NAD+ by
cyclic ADP ribose hydrolase (CD38). IP3R and RyR are activated by Ca2+ and
can stimulate each other via Ca2+-induced Ca2+ release (CICR). Cytosolic Ca2+ is
removed by plasma membrane Ca2+ ATPase (PMCA) and sarco/endoplasmic
reticulum Ca2+-ATPase (SERCA).
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1.4 Mechanisms of Ca2+ Dyshomeostasis
As described in preceding sections, Ca2+ is an essential signaling
molecule that performs a number of unique functions in neurons. Given the
participation of this cation in so many neuronal processes, it is unsurprising that
the dysregulation of Ca2+ has been implicated in a wide range of
neurodegenerative diseases (81). A central theme of this work is that
mechanisms of Ca2+ dyshomeostasis are crucial to the pathogenicity of
neurodegeneration. Here, I will survey some of what is known in this domain,
focusing on certain aspects (e.g., mechanisms related to ER Ca2+ release or
MAMs) of particular relevance to this dissertation.
1.4.1 Ca2+ Dyshomeostasis in Age-Related Neurodegeneration
Age-related neurodegenerative disease, including AD, PD, and ALS, all
exhibit features of Ca2+ dyshomeostasis (64, 81). In AD, a theory dubbed the
“calcium hypothesis” has been put forth to explain the delay between amyloid-β
accumulation and cognitive impairment (101). The model is predicated on the
finding that resting cytosolic [Ca2+] is increased in various animal models of AD
(102, 103). While these findings are acknowledged by many, the source of this
Ca2+ dysregulation is controversial. Some argue that amyloid-β oligomers
increase the entry of extracellular Ca2+ through a variety of mechanisms (104–
106), while others suggest that release from intracellular Ca2+ stores is
responsible. With respect to the latter group, mutations in presenilins – which
cause a large fraction of familial AD – are thought to underlie increased Ca2+
release from the ER (81, 107). Again, the mode of this release is debated, with
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some reports claiming that presenilins directly mediate ER Ca2+ release (108).
However, others propose an accessory role with release promoted by either
upregulation of the expression or the enhancement of the sensitivity of IP3Rs or
RyRs (109–112). Furthermore, mutated presenilins may also disrupt SERCA
activity and SOCE (107, 113, 114), which are both important for Ca2+
homeostasis. Adding to this complexity, low concentrations of amyloid-β have
been reported to increase the number of MAMs, which leads to elevated
mitochondrial [Ca2+] (115, 116).
While the literature concerning aberrant Ca2+ signaling in PD is also
mixed, one aspect of the disease that is widely acknowledged is the occurrence
of mitochondrial dysfunction (117, 118). Interestingly, a component of this
dysfunction is thought to involve MAMs, which were disrupted in primary neurons
derived from human patients with multiple copies of the gene that encodes αsynuclein (119). Given the importance of MAMs to mitochondrial ATP production,
and the high energetic demands of dopaminergic pacemaker neurons in the
substantia nigra, this mechanism may contribute to the demise of these cells in
PD (120). However, other reports, which find an increase in ER-mitochondrial
contacts, are conflicting with this study (121, 122), highlighting the need for
further research.
The pathogenic role of Ca2+ in ALS has been attributed to several
mechanisms, including overactivation of glutamate receptors, decreased
expression of Ca2+-buffering proteins, and mishandling of ER-mitochondrial Ca2+
transfer (81). The latter category, which again refers to the disruption of MAMs
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and the associated bioenergetic consequences, is of special interest to this work.
The disruption of a MAM tethering complex composed of an ER protein, vesicleassociated membrane protein-associated protein B (VAPB), and an outer
mitochondrial membrane protein, protein tyrosine phosphatase interacting protein
51 (PTPIP51), has been implicated in no fewer than three forms of familial ALS
(123–125) and may have relevance to the more common sporadic form of ALS
(126). Of the familial forms of ALS thought to involve the VAPB-PTPIP51
interaction, one (ALS8) is caused by a mutation in VAPB (VAPBP56S). A fly model
of ALS8, which is described in more detail in a following section, is used
throughout the body of this dissertation. Furthermore, the potential implications of
MAM disruption in this context will also be further explored and discussed.
Finally, mutations in sigma receptor-1 and the hexanucleotide repeat expansion
associated with the gene C9orf72 are thought to mediate ER Ca2+
dyshomeostasis in ALS via elevated IP3R activity and reduced Ca2+ store uptake
(64, 127, 128).

1.5 Drosophila as a Model Organism
For over a century, Drosophila melanogaster, the fruit fly, has served as
an extremely useful model organism, yielding an incredible amount of biological
knowledge (129). From the early insights made by Thomas Hunt Morgan into the
fundamental nature of genetics to the ubiquitous use of Drosophila today in
biomedical research, the humble fruit fly has proved its worth as an instrument of
scientific inquiry (130, 131). Given the widespread use of Drosophila in this
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dissertation, I will review both basic concepts related to fly research and provide
information regarding specific models used.
1.5.1 The Basics of Drosophila Research and the UAS/GAL4 System
Much of the value in using flies to study biology derives from the practical
advantages they offer. Research with Drosophila is both expeditious and
inexpensive relative to vertebrate models. Drosophila has a rapid life cycle on the
order of 10-12 days, with hundreds of progeny generated from the typical cross
(132, 133). Large numbers of many fly strains can be efficiently housed, easily
manipulated and studied under CO2 anesthesia, and conveniently euthanized
when no longer needed. Additionally, the vast array of genetic tools now
available in fly, which is unmatched when compared to other metazoan model
organisms, enables versatile experimentation (129). These resources include
balancer chromosomes, thousands of mutant and transgenic fly lines, multiple
exhaustive RNAi collections, and the bipartite UAS/GAL4 expression system that
allows precise spatiotemporal control over genetic expression (133, 134).
The UAS/GAL4 system is extensively used in this dissertation, and
therefore deserves a more thorough description. The desired ectopic expression
is achieved by breeding a GAL4-driver strain with a strain possessing a UAS
element upstream of a particular transgenic sequence (135) (Figure 3). One
parental driver strain has the GAL4 gene – a transcription factor native to yeast –
downstream of an endogenous Drosophila promoter that dictates the tissue
specificity of GAL4 expression. The other parental stain contains the desired
transgenic element downstream of the UAS element. When these two parental
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lines are mated, the resulting progeny possess both the GAL4 and UAS
elements, which drives transgenic expression in a pattern designated by GAL4
expression (135). In the following chapters, I employ two established GAL4-driver
lines, ok371-GAL4 and d42-GAL4, to drive expression in Drosophila motor
neurons. Specifically, ok371-GAL4 and d42-GAL4 are associated with the
endogenous promoters of the vesicular glutamate transporter (VGlut) gene and
the Toll-6 gene, respectively (136, 137).
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Figure 3 – Schematic depicting the UAS/GAL4 system. In one parental line, a
tissue-specific promoter drives expression of GAL4 protein. In the other parental
line, the transgene of interest lies downstream of a dormant UAS element. Upon
mating of the parental lines, progeny arise that express tissue-specific GAL4
(green circles), which bind to and activate UAS elements that drive expression of
the transgene of interest (blue circles).
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1.5.2 Using Drosophila to Model Human Disease
Despite the obvious differences between flies and humans, over 75% of
human genes linked to specific diseases have a homologue in Drosophila, which
bolsters the rationale of using the fly for translational biomedical research (129,
138). Another genetic advantage that may be leveraged when using Drosophila
to study human disease involves the lack of paralogous genes in the fly genome,
which contains ~14,000 vs. ~22,000 protein-coding genes in humans (133, 139,
140). Due to the relative simplicity of interpreting manipulations of genes with
only a single representative homologue in Drosophila, the complexity that
compensating paralogues would otherwise confer can be avoided (133).
While flies have been utilized to study many aspects of human biology and
disease, they have been particularly fruitful in the context of neuroscience and,
more specifically, neurodegeneration (131, 133, 141). The adult Drosophila brain
is comprised of ~100,000 cells, 85-90% of which are neurons (142). While many
parallels between fly and vertebrate brains cannot be established due to the
structural complexity that large brains afford, surprising similarities do exist. For
instance, the circuitry underlying vision is organized in both systems in a manner
that reveals a striking resemblance in structure and function – an observation
made by Ramón y Cajal himself in the early days of neuroscience (133, 143).
More generally, as in vertebrates, Drosophila brains contain specialized neuronal
and glial cell types as well as a blood-brain barrier (BBB) (133, 144, 145). Of
note, the Drosophila BBB influences ionic homeostasis in a way that is
particularly relevant to many of the experiments in chapter 3, which involve
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depolarization of fly neurons via application of solutions containing high [K+].
Peripherally, the [K+] in fly hemolymph is much higher than what is found in
mammalian blood (146), which would disrupt normal neuronal function. However,
the Drosophila BBB corrects for this imbalance, and maintains a ~5 mM [K+] in
the brain fluid, which is conducive for proper neuronal function (147)
1.5.3 Specific Drosophila Models and Methods
Given the previously outlined similarities, and combined with the other
advantages flies offer, Drosophila is an excellent model for the study of
neurodegeneration. Indeed, flies have been used extensively to probe the
mechanisms underlying AD (148, 149). For example, the UAS/GAL4 system has
been used to overexpress variants of mutant or wild-type MAPT, the human gene
that encodes the protein Tau, which has been implicated in AD and a number of
other neurodegenerative diseases (149–151). Mirroring the pathogenic effects
observed in humans with AD, these flies exhibit brain vacuolization, Tau
hyperphosphorylation, abnormal Tau conformation, and increased mortality
(149). In addition to facilitating the study of prevalent diseases like AD, the ease
with which disease models are created in Drosophila enables research into more
rare forms of neurodegenerative disease (132). For example, a collection of fly
lines has been produced to study a rare form of familial ALS (ALS8), which is
caused by an autosomal dominant mutation in VAPB (152–154). Expression of
the analogous mutation in the Drosophila homologue of VAPB (i.e., vap33,
hereafter referred to as vapb) recapitulates several features of the disease
including synaptic defects, locomotor impairment, and shortened lifespan (155).
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Both of the aforementioned fly models (i.e., those expressing MAPT and mutant
vapb) are used throughout this dissertation to explore the role of Ca2+
dyshomeostasis in neurodegeneration.
There are certain aspects of fly neuroanatomy that have been especially
useful to biological research and are pertinent to this work. The Drosophila larval
neuromuscular junction (NMJ) is a prime example. The neuromuscular system in
larvae is relatively simple, being composed of 32 motor neurons per abdominal
hemisegment that interface with muscles in a stereotyped manner (156). Fly
motor neuron synapses are glutamatergic and resemble those in the vertebrate
brain. Postsynaptically, Drosophila NMJs possess ionotropic glutamate receptors
orthologous to α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
receptors in the mammalian nervous system, making them surprisingly useful
models with respect to human biology (156). Furthermore, additional aspects of
the larval neuromuscular system make it an attractive experimental platform. For
example, individual NMJs can be specifically identified and may be conveniently
stained and visualized by filleting larvae (157). When combined with the wealth of
genetic tools existing in Drosophila, the larval NMJ is one of the most powerful
systems available to study synaptic biology. Of particular relevance to this work
is the influence [Ca2+] has over the development of NMJ morphology. A previous
study from our own lab uncovered a role for ER Ca2+ in promoting the proper
formation of NMJ architecture (158). Interestingly, the fly model of AL8
mentioned above, which expresses mutant vapb, exhibits an altered NMJ
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phenotype, although the underlying mechanism remains incompletely understood
(155).

1.6 Conclusions and Hypotheses
The increasing burden of neurodegeneration is an alarming trend
confronting modern medicine and biomedical science (1). Worse still, there is a
critical lack of effective therapies available to combat this growing threat (13).
Thus, the need for novel approaches to understand the biochemical
underpinnings of neurodegenerative diseases is paramount.
Here, we have reviewed several fundamental aspects of neuronal cell
biology including excitability and depolarization, the unique metabolic demands
of neurons, and the multifaceted role Ca2+ plays in neuronal function. A driving
motivation of my research has been to consider the interconnectedness of these
seemingly disparate features of neurobiology. Furthermore, I believe that novel
methods to mitigate or, eventually, cure neurodegenerative disease will be found
once a comprehensive understanding of the relationship between these subjects
is defined. To this end, the overarching hypothesis of this dissertation is that the
interplay between neuronal excitability, neuroenergetics, and Ca2+ signaling are
crucial drivers of the pathogenicity of neurodegeneration, which is ultimately
mediated by Ca2+ dyshomeostasis.
In the following two chapters, I will explore two instances of this concept in
Drosophila models of neurodegeneration. Each chapter has a sub hypothesis
pertinent to the specifics of the respective study. In Chapter 2, we elaborate on a
mechanism previously explored in our own lab that implicated low cytosolic [Ca2+]
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in the disruption of normal NMJ morphology. We hypothesized that a similar
phenotype, observed in neurons expressing mutant vapb, was also mediated by
low cytosolic [Ca2+]. Intriguingly, our results refuted this initial hypothesis and led
to a more comprehensive understanding of the role of [Ca2+] in NMJ formation. In
Chapter 3, we consider how neurons manage their unique bioenergetic
demands. In doing so, we hypothesize the existence of a bioenergetic pathway
responsive to PM depolarization that does not depend on large influxes of
extracellular Ca2+. Furthermore, we find that PLCβ-IP3R signaling fulfills this role,
but that misappropriation of this pathway in fly models of neurodegeneration can
promote toxic endolysosomal Ca2+ overload. In both Chapter 2 and Chapter 3,
mechanisms of Ca2+ dyshomeostasis are found to mediate the
neurodegenerative phenotypes in question, supporting the overarching
hypothesis.
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Chapter 2: Attenuation of Endoplasmic Reticulum Ca2+
Channel Signaling Rescues Neuromuscular Junction
Defects in an ALS Fly Model
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2.1 Introduction
Neurons are morphologically unique cells with complex architecture (28).
The intricate structures that comprise neurons are supported by cytoskeletal
components that serve to ensure proper form and function (159). In Drosophila,
the NMJ provides an excellent system to study the dynamics that govern
synaptic morphology as well as human disease-relevant perturbations that may
disrupt such processes (156).
The role that Ca2+ plays in synaptic transmission is well characterized
(88). The rapid increase in presynaptic [Ca2+], which is triggered by the opening
of VGCCs following the arrival of a depolarizing action potential, causes the
exocytosis of neurotransmitter-laden SVs within the chemical synapse. Given
that the actuators of synaptic transmission have a relatively low affinity for Ca2+,
high [Ca2+] is necessary to power their activity (87). However, these action
potential-induced events occur only briefly, allowing Ca2+ to function in other
ways – which are less well understood than the mechanisms underlying synaptic
transmission – during the intervening periods. Thus, in addition to influencing the
dynamics of synaptic transmission when spikes do occur, moderate changes in
[Ca2+] over longer durations are important for a wide range of cellular activity that
is more sensitive to Ca2+ than the machinery involved in SV exocytosis.
For example, the concentration of presynaptic resting Ca2+ contributes to
the proper formation of synaptic structure. As the major intracellular reservoir of
Ca2+ (82), the ER plays a substantial role sculpting the dynamics that influence
this process. Previously, our own lab demonstrated that certain ER Ca2+
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channels are important regulators of presynaptic resting [Ca2+] and synapse
development (158). Specifically, decreased expression or loss-of-function
mutations of RyR, IP3R, and the Drosophila transient receptor potential vanilloid
(TRPV) channel, Inactive (Iav), all caused a decrease in bouton number
accompanied by an increase in bouton size within the Drosophila larval NMJ.
These changes in NMJ morphology were found to be dependent upon a
reduction of presynaptic resting [Ca2+], leading to decreased activation of the
microtubule-stabilizing phosphatase, calcineurin (158). These findings
underscore the important regulatory function of Ca2+ in ensuring appropriate
development of synaptic morphology.
Prior studies have demonstrated that the Drosophila gene, vapb, also
influences synaptic morphology (160, 161). Deletion of vapb was found to
severely decrease the number of synaptic boutons while simultaneously
increasing their size, a phenotype that resembles diminished function of the
aforementioned ER Ca2+ channels (160). Likewise, expression of vapbP58S – a
Drosophila allele of the gene homologous to an ALS-causing mutation in humans
(154, 161, 162) – resulted in the same phenotype. The vapbP58S mutation is
thought to function via a dominant-negative mechanism, dimerizing with wild-type
protein and sequestering it within cytosolic aggregates (155, 161). Taking these
facts into account, we wondered how vapbP58S perturbs NMJ morphology. We
hypothesized that vapbP58S would reduce presynaptic resting [Ca2+] and disrupt
NMJ morphology in a calcineurin-dependent manner. Surprisingly, our results
indicate that vapbP58S actually raises cytosolic [Ca2+], but disturbs NMJ
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morphology through an alternative mechanism. More broadly, we define how a
nearly identical synaptic phenotype arises through two distinct Ca2+-dependent
mechanisms. These findings suggest that the presynaptic [Ca2+] regulates NMJ
morphology in a bifunctional manner.

2.2 Results
2.2.1 Expression of vapbP58S Induces Morphological Synaptic Defects and
Impairs Ca2+ Extrusion
Using the UAS/GAL4 system (134), we expressed vapbP58S in motor
neurons and observed results consistent with previous work (161). Compared to
control, expression of vapbP58S led to a reduction in synaptic bouton number
(Figure 4A-C) and a corresponding increase in bouton area (Figure 4A,D).
Overexpression of wild-type vapb (hereafter referred to as vapbWT) did not cause
an appreciable change in NMJ bouton number (Figure 4A,C), suggesting only
the ALS-causing allele influences synaptic development.
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Figure 4 – Expression of vapbP58S induces morphological defects at the
NMJ. (A) Representative confocal images of larval NMJs dissected from animals
of the indicated genotypes stained with antibodies against horseradish
peroxidase (HRP – green) and discs-large (DLG – magenta). Scale bar shown in
the panel on the top left applies to all panels. (B-C) Quantification of the larval
NMJ bouton numbers in animals of the indicated genotypes. (D) Quantification of
relative bouton area at larval NMJs in animals of the indicated genotypes.
Statistical tests employed were pairwise t-tests; **, P<0.01; ****, P<0.0001; n.s.,
not significant. Contribution Note: Data collected by Ching-On Wong
(permission granted to use).
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Given the similarity in phenotype between vapbP58S-expressing neurons
and neurons with reduced expression or function of Iav, RyR, and IP3R, we
wondered if any relationship existed between vapb and these ER Ca2+ channels.
We first evaluated a number of synaptic functional readouts to determine whether
expression of vapbP58S resulted in effects similar to those observed in flies with
compromised ER Ca2+ channel function. In NMJs from mutant larvae expressing
a hypomorphic allele of Iav (iav1), evoked excitatory junctional potentials (EJPs) –
a measure of synaptic transmission – were ~50% diminished and presynaptic
resting [Ca2+] was decreased (158). Additionally, there was an elevation in
paired-pulse facilitation (PPF), which is defined as an increase in the ratio
between a second stimulation and the first evoked EJP. Together, these findings
suggest that SV release probability is decreased during the first pulse in iav1
mutants as indicated by the relative abundance of unreleased SVs at the time of
a second EJP-causing stimulation.
Conversely, there was no difference in the amplitude of the initial EJPs
measured between larvae expressing vapbP58S and vapbWT, suggesting no
decrease in SV release probability (Figure 5A-B). While vapbP58S-expressing
neurons did exhibit an increase in PPF compared to vapbWT control, this should
not be interpreted as it was in the iav1 mutants (Figure 5C). Given that the initial
EJPs between vapbP58S and vapbWT were indistinguishable, this suggests a
problem with cytosolic Ca2+ retention post-stimulus rather than a mechanism
dependent upon ER Ca2+ release affecting presynaptic resting [Ca2+]. Thus,
although iav1 and vapbP58S induce similar disruptions of NMJ morphology, these
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data suggest that while the former causes a decrease in resting [Ca2+], the latter
does not and may instead result in cytosolic [Ca2+] elevation.
To directly measure the ability of vapbP58S-expressing neurons to extrude
cytosolic Ca2+, we isolated primary glutamatergic neurons from larvae
coexpressing the cytosolic [Ca2+] sensor, GCaMP5G–tdTomato (163) and
released ER Ca2+ stores with the SERCA inhibitor, thapsigargin (164).
Interestingly, the thapsigargin-evoked cytosolic Ca2+ transient in vapbP58Sexpressing neurons decayed at slower rate (i.e., possessed a longer half-life)
compared to neurons expressing vapbWT (Figure 5D-E). These data corroborate
our PPF results and demonstrate that cytosolic Ca2+ extrusion is compromised in
vapbP58S-expressing neurons.
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Figure 5 – Expression of vapbP58S impairs Ca2+ extrusion. (A) Representative
paired-pulse EJP traces recorded from larval NMJs isolated in animals
expressing vapbWT (blue trace) or vapbP58S (magenta trace) in motor neurons. (B)
Quantification of the EJP amplitude of the 1st peak of the data shown in (A). (C)
Quantification of the paired-pulse ratio (fractional change in the amplitude of the
second EJP to that of the first EJP when the two stimulatory pulses were applied
50 ms apart) of the data shown in (A). (D) Representative traces showing the
rate of cytosolic Ca2+ extrusion from the peak of the thapsigargin-evoked
response to baseline in indicated genotypes. Respective half-lives are indicated.
(E) Quantification of the half-lives of the data depicted in (D). Statistical tests
employed were pairwise t-tests (B-C) and Mann-Whitney test (E); *, P<0.05; n.s.,
not significant. Contribution Note: Electrophysiological experiments were by
conducted by Kai Li Tan (permission granted to use).
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2.2.2 Morphological Synaptic Defects Induced by vapbP58S are Ameliorated
upon Loss of ER Ca2+ Channels
Intrigued by the data suggesting that vapbP58S induces disruptions in NMJ
morphology through a seemingly paradoxical process involving an increase –
rather than a decrease – in cytosolic [Ca2+], we wondered if a genetic interaction
existed between this intervention and the loss of ER Ca2+ channels (Figure 6A).
To this end, we expressed vapbP58S in an iav1 mutant background and assessed
the effect on NMJ morphology. Remarkably, NMJs from these animals were not
significantly different from controls, possessing boutons of comparable number
and size (Figure 6B-D). However, expression of vapbWT in the iav1 mutant
background did not rescue NMJ morphology, as these animals had fewer
boutons, suggesting only the ALS-causing variant is capable of restoring normal
phenotype (Figure 6B,E). Thus, rather than exacerbating the NMJ phenotype
seen with vapbP58S or iav1 alone, the combination of these elements appear to
counteract each other, bolstering the concept that they act via opposing
mechanisms.
We next pondered whether ER Ca2+ channels other than Iav were also
capable of restoring synaptic morphology in the presence of vapbP58S. Indeed,
knockdown of IP3R using a validated RNAi line (itprRNAi), which previously was
shown to induce fewer boutons when done in isolation (158), restored synaptic
morphology in vapbP58S-expressing neurons (Figure 6F). Similarly, the absence
of one copy of RyR (RyR16) rescued the disrupted NMJ phenotype while RyR16
controls expectedly had reduced bouton number. (Figure 6F). Overall, these
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data provide further support that decreased function or expression of ER Ca2+
channels mitigate vapbP58S-induced defects in NMJ morphology.
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Figure 6 – A genetic interaction exists between vapbP58S and loss of ER
Ca2+ channels. (A) Both VAPBP58S and loss of ER Ca2+ channels lead to an
altered NMJ phenotype in motor neurons (MNs) characterized by fewer and
larger boutons. The combination of both of these respective interventions reveals
a genetic interaction. (B) Representative confocal images of larval NMJs
dissected from animals of the indicated genotypes stained with antibodies
against HRP (green) and DLG (magenta). Scale bar shown in the panel on the
top left applies to all panels. (C, E, F) Quantification of the larval NMJ bouton
numbers in animals of the indicated genotypes. (D) Quantification of relative
bouton area at larval NMJs in animals of the indicated genotypes. Statistical tests
employed were ANOVA and pairwise t-tests; **, P<0.01; ***, P<0.001; ****,
P<0.0001; n.s., not significant. Contribution Note: Data collected in conjunction
with Ching-On Wong (permission granted to use).
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2.2.3 CaMKII Overactivation Mediates Morphological Synaptic Defects
Induced by vapbP58S
The protein Futsch, the Drosophila orthologue of microtubule-associated
protein-1b, associates with microtubules and, ultimately, is important for proper
formation of synaptic architecture (165). When phosphorylated, Futsch
destabilizes microtubules, which was previously shown to underlie the altered
NMJ phenotype in iav1 mutants (158). Specifically, the decrease in presynaptic
resting [Ca2+] diminished the activity of the Ca2+/calmodulin (CaM)-dependent
phosphatase, calcineurin, resulting in greater Futsch phosphorylation and
microtubule destabilization (Figure 7).
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Figure 7 – Schematic depicting the role of Inactive (Iav) in the formation of
proper NMJ morphology. Within the Drosophila NMJ, proper organization of
presynaptic boutons depends upon stabilized microtubules. When Futsch is
phosphorylated, it does not bind to microtubules, which leaves them destabilized.
The Ca2+/CaM-dependent phosphatase, calcineurin, is stimulated by Ca2+
released from the ER by Iav and dephosphorylates Futsch, which leads to
microtubule stabilization. Note on use of published materials: This figure is
taken from a first author review in Cells (64), which allows use of published
materials without permission.
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To assess the effect of vapbP58S on Futsch-dependent bouton morphology,
we examined the quantity of characteristic Futsch loops present in respective
NMJs. As observed in iav1 NMJs (158), vapbP58S-expressing neurons also
contained significantly fewer Futsch loops compared to control (Figure 8A-B).
Since our data consistently suggest a mechanism implicating higher, rather than
lower, presynaptic [Ca2+], we hypothesized that overactivation of Ca2+/CaMdependent protein kinase II (CaMKII), which is known to destabilize microtubules
(166), may mediate vapbP58S-induced synaptic defects. Indeed, coexpression of
CaMKIIala – which encodes the autoinhibitory domain of CaMKII and therefore
limits endogenous kinase activity – in vapbP58S-expressing neurons led to full
restoration in the quantity of Futsch loops and bouton number within the NMJ
(167) (Figure 8A-C). Likewise, CaMKIIala expression rescued the reduction in
bouton number observed in neurons overexpressing iav (Figure 8D). However,
in iav1 mutants, expression of CaMKIIala did not restore bouton number (Figure
8D). Taken in aggregate, these data suggest that perturbations, such as
overexpressing vapbP58S or iav, that promote presynaptic [Ca2+] elevation
mediate NMJ morphological defects via CaMKII.
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Figure 8 – Inhibition of CaMKII rescues NMJ defects in neurons with
elevated presynaptic [Ca2+]. (A) Representative images of NMJs expressing
vapbP58S with or without CaMKIIala (CKIIala) as indicated. Samples were stained
with antibodies against HRP (green) and Futsch (magenta). Arrowheads point to
individual boutons and highlight recovery of Futsch loops in neurons expressing
both vapbP58S and CKIIala. Scale bar applies to all panels. (B) Quantification of
the number of Futsch loops in larval NMJs of the indicated genotypes. (C-D)
Quantification of the bouton numbers at larval NMJs in animals of the indicated
genotypes. All bar graphs represent mean ±SEM. Statistical tests employed were
ANOVA and pairwise t-tests; **, P<0.01; n.s., not significant. Contribution Note:
Data collected in conjunction with Ching-On Wong (permission granted to use).
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2.2.4 Inhibition of CaMKII Fails to Rescue vapbP58S-Induced Reduction in Fly
Lifespan
Flies expressing vapbP58S in their glutamatergic neurons have an
abbreviated lifespan compared to the relevant UAS/GAL4 controls (Figure 9).
While flies expressing vapbWT in glutamatergic neurons have a slightly reduced
lifespan compared to UAS/GAL4 controls, these animals live significantly longer
than those expressing vapbP58S (not shown). Given that inhibition of CaMKII
restored larval NMJ morphology disrupted by vapbP58S, we wondered if
coexpression of CaMKIIala would rescue the this increase in mortality. However,
the lifespans of adult flies coexpressing CaMKIIala and mutant vapbP58S were
nearly indistinguishable, indicating that the toxicity associated with increased
mortality is independent of CaMKII activity (Figure 9). Thus, these data indicate
that the process driving reduced longevity in vapbP58S-expressing flies is different
than the mechanism observed at the larval NMJ.
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Figure 9 – Flies expressing vapbP58S are not rescued by inhibition of
CaMKII. Lifespan of flies of the indicated genotypes. Dashed grey line marks
median survival. Statistical tests employed were log-rank test with Bonferroni
correction; ****, P<0.0001, n.s., not significant.
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2.3 Discussion
Here, we elucidate a mechanism underlying the disruption of NMJ
morphology induced by vapbP58S expression. Despite resembling the phenotype
observed in neurons with reduced ER Ca2+ channel expression or function, we
find that morphological defects in vapbP58S-expressing NMJs are not subject to
the same sequence of signaling events. Additionally, while we delineate a distinct
Ca2+-dependent mechanism mediated by CaMKII activity in the larval stage, this
pathway is not responsible for shortening the adult lifespan of vapbP58Sexpressing flies.
Several lines of evidence, including electrophysiological measurements
and live-cell Ca2+ recordings, indicated that vapbP58S-expressing neurons are
characterized by impaired cytosolic Ca2+ extrusion (Figure 5), a finding
inconsistent with the mechanism known to disrupt NMJ morphology in larvae
lacking adequate ER Ca2+ channel expression or function. Curiously, the
simultaneous presence of both interventions (e.g., vapbP58S expression in an iav1
background) restored wild-type NMJ morphology (Figure 6), which both
demonstrates that these respective interventions neutralize each other and
supports the hypothesis that vapbP58S-induced phenotype is mediated by
elevated cytosolic [Ca2+]. The rescue conferred by inhibition of CaMKII revealed
the pathway that Ca2+ stimulates to disrupt microtubule-stabilization (Figure 8).
Taken together, these results indicate that proper NMJ morphology relies
upon an appropriate range of cytosolic [Ca2+] (Figure 10). As previously
described, microtubule stabilization requires Futsch dephosphorylation by
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calcineurin, a process diminished by low cytosolic [Ca2+]. Thus, it stands to
reason that the activation of a Ca2+-sensitive kinase, such as CaMKII, would
drive the same phenotypic results by promoting phosphorylation of Futsch.
Ultimately, these dynamics are dictated by the differential sensitivity of CaMKII
and calcineurin to Ca2+/CaM (168). Specifically, CaMKII (i.e., CaMKIIδ, the
mammalian isoform most homologous to the single orthologue in Drosophila) has
a Kd = ~33.5 nM for binding of Ca2+/CaM, which indicates a relatively high
threshold for Ca2+-dependent activation (169). In contrast, the Kd for calcineurin
is ~28 pM (170). Obviously, when [Ca2+] is abnormally elevated, as in vapbP58Sexpressing neurons, both calcineurin and CaMKII are activated, but our results
suggest that the kinase overwhelms the phosphatase. Thus, under this signaling
regime, only when cytosolic [Ca2+] is in a moderate range is Futsch
dephosphorylation and proper NMJ morphology unequivocally promoted (Figure
10).
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Figure 10 – Overview of the role presynaptic [Ca2+] plays in regulation of
NMJ morphology. Model showing the relationship between ER Ca2+ release and
NMJ bouton development. Elevated Ca2+ release at synapses expressing
vapbP58S or ER channels results in persistent activation of CaMKII, which induces
disruption of Futsch-positive presynaptic microtubules leading to the appearance
of fewer but larger boutons. Decreased expression of ER Ca2+ channels results
in lower presynaptic resting [Ca2+] and diminished calcineurin activity (163).
Expression of vapbP58S in neurons characterized by decreased ER channel
activity restores Ca2+ release and mitigates persistent activation of CaMKII.
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Our observations indicate that Ca2+ extrusion in vapbP58S-expressing
neurons is compromised (51). Typically, in a resting cell, cytosolic [Ca2+] is
maintained ~100 nM by the Na+/Ca2+ exchanger and PMCA. Upon elevation of
cytosolic [Ca2+], additional Ca2+ removing mechanisms are mobilized, including
SERCA and MCU (51). Given that both PMCA and SERCA rely on active
transport, the depletion of ATP can impair the activity of these pumps. Thus, our
experiment measuring Ca2+ extrusion in vapbP58S-expressing neurons upon
thapsigargin treatment may be explained by a metabolic lesion that prevents
PMCA from operating at full capacity. Importantly, in the context of our
experiment, we can only speculate about PMCA activity since thapsigargin
inhibits the other main Ca2+ pump, SERCA.
In support of this hypothesis, there is evidence that VAPB plays an indirect
role in supporting mitochondrial ATP production. Indeed, through an interaction
with the outer mitochondrial membrane protein, PTPIP51, VAPB forms a
tethering complex that stabilizes MAMs (171), which are points of contact
between the ER and mitochondria that enable OXPHOS-promoting Ca2+ to be
delivered into the matrix (68–70, 74). In models of other forms of familial ALS
(e.g., those caused by mutations in FUS and TDP-43), the VAPB-PTPIP51
association is disrupted, resulting in a decrease in IP3-mediated Ca2+ transfer to
the mitochondrial matrix and a decline in ATP production (123, 124) (Figure 11).
Given that, in Drosophila, VAPBP58S is purported to bind to and render wild type
VAPB nonfunctional via a dominant-negative mechanism (161), we suspect ATP
generation may be compromised by a similar mechanism in our model. If so, the
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ATP powered Ca2+ pumps responsible for removing the cation from the cytosol,
such as PMCA, would be impaired. Future studies that ascertain MAM integrity
and the bioenergetic status in vapbP58S-expressing neurons are required to test
this hypothesis.
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Figure 11 – Mechanisms of MAM breakdown in ALS. Various ALS-associated
mutations compromise the integrity of MAMs by weakening supportive molecular
tethers. Mutated VAPB, FUS, and TDP-43 disrupt the VAPB-PTPIP51
interaction, diminishing Ca2+ transfer to the mitochondria from the ER. Decreased
[Ca2+] in the mitochondrial matrix results in diminished OXPHOS and reduced
ATP production. Note on use of published materials: This figure is taken from
a first author review in Cells (64), which allows use of published materials without
permission.

54

2.4 Materials and Methods
2.4.1 Fly Husbandry and Lifespan Analysis
Flies were reared at 21°C on standard fly food (1 L of food contained: 95 g
agar, 275 g brewer’s yeast, 520 g of cornmeal, 110 g of sugar, 45 g of propionic
acid, and 36 g of tegosept). The following fly lines were obtained from
Bloomington Drosophila Stock Center: ok371-GAL4 and d42-GAL4, RyR16, UASCKII-I.Ala (UAS-CKIIala), UAS-itpr (UAS-Itp-r83A.V), UAS-itprRNAi
(TRiP.JF01957). Other strains used in the study were: UAS-vapbWT and UASvapbP58S (gifts from Dr. Hugo J. Bellen), UAS-tdTomato-2A-GCaMP5G, Canton-S,
Oregon-R, w1118, iav1 (iavhypoB-1), UAS-iav. For detailed methods on fly lifespan
analysis please see section 3.4.7.
2.4.2 NMJ Immunohistochemistry and Confocal Microscopy
Dissection and immunostaining of NMJ was performed as described previously
(163). Briefly, wandering 3rd instar larvae were filleted in ice-cold PBS to remove
all visceral organs except the brain and nerves. The fillets were fixed in 4%
paraformaldehyde in PBS for 30 minutes. The fixed fillets were washed with
0.1% Triton X-100 in PBS before incubation with primary antibodies overnight at
4oC. Primary antibody dilutions were 1:100 mouse anti-DLG and 1:50 mouse
anti-Futsch. The monoclonal antibodies against DLG and Futsch were obtained
from the Developmental Studies Hybridoma Bank developed under the auspices
of the NICHD and maintained by The University of Iowa, Department of Biology,
Iowa City, IA 52242. The samples were then washed and probed with 1:200
FITC-conjugated anti-HRP (Jackson ImmunoResearch) and Alexa Fluor 568-
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conjugated anti-mouse secondary antibodies (ThermoFisher) at room
temperature for 1.5 hours, and then mounted on glass slides with Vectashield
(Vector Labs). Confocal images were obtained using a Nikon A1 Confocal Laser
Microscope System (Nikon). For NMJ bouton counting, a 60x oil objective was
used to focus on the NMJs on abdominal segment 3. An n > 10 NMJs was
completed per genotype.
2.4.3 NMJ Electrophysiology
Wandering 3rd instar larvae were dissected in ice-cold HL-3 (70 mM NaCl, 5 mM
KCl, 20 mM MgCl2.6H2O, 10 mM NaHCO3, 115 mM sucrose, 5 mM trehalose,
and 5 mM HEPES; pH 7.2) and rinsed with HL-3 containing 0.5 mM Ca2+.
Recordings were made from body-wall muscle 6 (abdominal segment 3) with
sharp electrodes filled with a 2:1 mixture of 2 M potassium acetate and 2 M
potassium chloride. Data were collected from samples with resting membrane
potential below −60 mV. EJPs were evoked by directly stimulating the A3
hemisegmental nerve through a glass capillary electrode (internal diameter, ~10
μm) at 0.2 Hz. Stimulus pulses were generated by pClamp 10 software (Axon
Instruments Inc). The applied currents were 6 μA ± 3 with fixed stimulus duration
at 0.3 ms. Twenty to thirty evoked EJPs were recorded for each muscle for
analysis. EJPs were amplified with an Axoclamp 900A amplifier (Axon
Instruments, Foster City, CA) under bridge mode, filtered at 10 kHz, and digitized
at 10 kHz (EJPs) with pClamp 10. Experiments were performed at 21 °C. EJPs
and paired-pulse stimulation were analyzed with pClamp 8.0 software (Axon
Instruments). The EJPs paired-pulse amplitudes were corrected by nonlinear
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summation (172). Paired-pulse ratio was calculated as the ratio of 2nd to 1st peak.
An n > 8 NMJs was completed per genotype.
2.4.4 Live-Cell Imaging in Fly Primary Neurons
Supplemented Schneider’s medium used for maintaining cells (please see
section 3.4.3 for detailed methods on fly primary neuron culture) was replaced
with HL-3. GCaMP5G and tdTomato were sequentially excited at 488 nm and
561 nm respectively by an A1 laser confocal microscope with a 40x objective
(Nikon) (163). Emission signals at 525 nm and 595 nm were recorded.
Backgrounds were measured from a cell-free ROI. Baselines were established
for 1 minute before store-depletion with the SERCA inhibitor, thapsigargin (5 μM)
as described (163). The resulting GCaMP5G-tdTomato signals, representative of
cytosolic [Ca2+] were recorded for ~2 minutes. The half-lives of the thapsigarginevoked transients were calculated for each responding cell by fitting to one
phase decay preceded by a plateau in Prism 8 (GraphPad). An n > 40 cells from
a minimum of 3 independently conducted experiments was completed per
condition.
2.4.5 Statistical Analyses
We used either a parametric or a nonparametric test of statistical significance on
the basis of whether the data were normally distributed. Multiple comparisons
were made by one-way ANOVA followed by t-tests with Bonferroni correction.
Excel (Microsoft) and Prism 8 (GraphPad) were used for statistical analyses.
Statistical significance was defined as a P < 0.05. P-values were shown on the
figures as asterisks: *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.
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Lifespan (Kaplan-Meier) curves were generated using Prism 8. We used the logrank (Mantel-Cox) test to determine these P-values.

58

Chapter 3: Chronic Depolarization of the Plasma
Membrane Activates PLCβ-IP3R Signaling and Drives
Neurodegeneration
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3.1 Introduction
The brain is a metabolically intensive organ due to the unique demands of
neuronal physiology, including the maintenance of ionic gradients and recycling
of synaptic vesicles (45–47, 173). In order to preserve energy homeostasis,
neurons have evolved specialized processes that tightly couple steep energy
requirements and ATP generation (52, 173–175). Given that neurons are
morphologically elaborate cells that perform a variety of location-specific
functions (e.g., axonal terminals release chemical signals, dendrites receive and
compute incoming signals) (28, 87, 176), it stands to reason that spatially distinct
regions may exhibit different metabolic strategies.
Ca2+ signals, which may originate from either the extracellular milieu or the
internal stores, are an important component of neuroenergetic homeostasis (52,
81). For instance, in nerve terminals, the influx of Ca2+ resulting from activation of
VGCCs both triggers synaptic transmission via binding to exocytosis machinery
and energizes mitochondria by overcoming the low affinity MCU (52, 87, 175).
Thus, Ca2+ performs a dual function in the axonal compartment – the
energetically expensive, Ca2+-dependent operation of synaptic recycling is
compensated for by the simultaneous uptake of Ca2+ into the mitochondria matrix
where it activates several TCA cycle dehydrogenases (47, 61, 175). Whereas
this efficient process is optimal in nerve terminals, the somatodendritic regions of
the neuron, which do not specialize in SV release, do not require the same
degree of cytosolic [Ca2+] elevation. Moreover, given this difference in function
between disparate neuronal compartments, it follows that somatodendritic
60

regions would avoid global elevations in cytosolic [Ca2+] for the sole purpose of
energy production. Indeed, mitochondrial Ca2+ uptake was found to be
dependent upon ER Ca2+ release in the dendrites of mammalian cortical
pyramidal neurons after synaptic stimulation (177). The transfer of Ca2+ from ER
to mitochondria is facilitated by points of contact between the two organelles,
where Ca2+ release from IP3R creates local, but highly concentrated,
microdomains of Ca2+ (68–70). Whether this mode of mitochondrial Ca2+ uptake
and ATP production (62, 74), which may be preferred in the somatodendritic
compartment, is regulated by neuronal excitability remains unknown.
In addition to synaptic transmission, the bioenergetic cost of maintaining
ionic gradients – a prerequisite for establishing excitability and firing successive
action potentials – is a primary reason neurons consume such a substantial
quantity of ATP (46, 47). The engine that ultimately prevents the dissipation of
these ionic gradients is Na+/K+ ATPase (34, 35). In agreement with the vital
importance of Na+/K+ ATPase, a computational study has suggested that a mere
15% decrease in neuronal ATP is sufficient to irreversibly depolarize the PM and
cause progressive neuronal decline (178). Given that such a large fraction of
neuronal ATP – as high as 75-90% according to some estimates – is allocated to
this crucial pump (50), it stands to reason that feedback mechanisms coupling
Na+/K+ ATPase activity to bioenergetic upregulation might exist. Additionally,
such a mechanism would avoid the potentially toxic consequences of
indiscriminate cytosolic [Ca2+] elevation, as it would not require VGCC activity to
energize mitochondria as is observed in nerve terminals (52). Thus, we
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hypothesize the existence of a bioenergetic pathway responsive to PM
depolarization that does not depend on large influxes of extracellular Ca2+.
Here, we describe a novel mechanism by which depolarization of the PM
augments PLCβ-IP3R signaling and Ca2+-dependent elevation of OXPHOS in
neurons. We also explore the misappropriation of this signaling axis in the
context of neurodegeneration. Our findings indicate that perturbations associated
with neurodegeneration that prevent compensatory PLCβ-IP3R signaling from
reestablishing PM polarization result in intracellular Ca2+ dyshomeostasis.
Specifically, we implicate elevated IP3-mediated Ca2+ loading into the
endolysosomal compartment as the underlying toxic mechanism responsible for
early death in our models.

3.2 Results
3.2.1 Depolarization of the Plasma Membrane Elevates Cytosolic ATP
Levels and Mitochondrial [Ca2+] via Potentiation of the PLCβ-IP3R Pathway
To test the idea that PM depolarization can influence neuronal
bioenergetics, we expressed the genetically encoded fluorescent biosensor,
PercevalHR, which senses the cytosolic ATP:ADP ratio, in Drosophila
glutamatergic neurons (179). In primary neuronal cultures generated from larvae
expressing PercevalHR, depolarization with high extracellular [K+] led to
negligible changes in the somatic ATP:ADP ratio (Figure 12A). Subsequent
application of muscarine — an agonist of the PLCβ-coupled metabotropic
acetylcholine receptors (mAChRs) expressed in fly glutamatergic neurons (180,
181) – elicited a significant (~5%) and sustained elevation in the ATP:ADP ratio
(Figure 12A-B). However, muscarine did not increase the ATP:ADP ratio in
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polarized neurons (Figure 12A-B). Oligomycin A, an inhibitor of ATP synthase
(182), abolished the differences in depolarization- and muscarine-induced ATP
production, indicating the involvement of mitochondrial OXPHOS (Figure 12C).
Together, these data suggest that the coincidence of PLCβ-IP3R signaling and
PM depolarization are necessary to mount a mitochondrial bioenergetic
response.
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Figure 12 – Mitochondrial ATP production is augmented by coincidence of
depolarization and PLCβ-coupled receptor activation in fly neurons. (A)
Representative traces showing normalized PercevalHR ratio in depolarized
(blue) and polarized (pink) Drosophila glutamatergic neurons. Arrows indicate
respective treatments. (B) Boxplots quantifying muscarine-induced changes in
PercevalHR ratio. Black ****, P<0.0001, Mann-Whitney test; red ****, P<0.0001,
one sample t-test for a hypothetical mean of 0. (C) Normalized PercevalHR ratio
after oligomycin A treatment in depolarized (blue) and polarized (pink) Drosophila
glutamatergic neurons. Values represent mean ± SEM. *, P<0.05, t-test. Except
for the 1st time point, none of the other time-points showed significant differences
in PercevalHR ratio between depolarized and polarized cells. Contribution
Note: Data collected in conjunction with Ching-On Wong (permission granted to
use).
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The stimulation of PLCβ-IP3R signaling culminates in release of Ca2+ from
the ER. To directly demonstrate that depolarization augments PLCβ-IP3R
signaling, we expressed the cytosolic [Ca2+] sensor, GCaMP5G–tdTomato, in fly
glutamatergic neurons (158). Whereas somatic [Ca2+] elevations induced by
either depolarization or muscarine alone were negligible (Figure 13A), the
coincidence of both was significant with respect to the fraction of responding cells
and the magnitude of individual responses (Figure 13A-B). Importantly, the
amplitudes of transients evoked by thapsigargin-mediated ER Ca2+ store
depletion were indistinguishable in cells exposed to 5 mM or 50 mM [K+],
suggesting that the changes observed upon muscarine application are not due to
differences in ER [Ca2+] (Figure 13C).
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Figure 13 – Depolarization potentiates PLCβ-IP3R signaling in fly neurons.
(A) Representative traces showing normalized GCaMP5G/tdTomato ratio in
depolarized (blue) and polarized (pink) Drosophila glutamatergic neurons. Arrows
indicate respective treatments. (B) Traces showing cumulative distribution of
muscarine-induced fold-change of GCaMP5G/tdTomato ratio from baseline
values in depolarized (blue) and polarized (pink) fly neurons. **, P < 0.01,
Kolmogorov-Smirnov test. (C) Bar graph showing maximum amplitude of
changes in GCaMP5G/tdTomato ratio induced by thapsigargin (5 μM) in
depolarized (blue) and polarized (pink) fly neurons in the absence of bath Ca2+.
Since thapsigargin depletes ER Ca2+ by blocking SERCA, an increase in
cytosolic [Ca2+] (i.e. GCaMP5G/tdTomato ratio) reveals total ER Ca2+ content.
n.s., not significant, Mann-Whitney test. Data represent median and 95%
confidence intervals. Contribution Note: Data collected in conjunction with
Ching-On Wong (permission granted to use).
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IP3R-mediated Ca2+ release can be delivered to cellular compartments
other than the cytosol, including the mitochondria, where it plays a role in
activating several TCA cycle dehydrogenases (61–63). Given our results
indicating that PLCβ-IP3R signaling and PM depolarization conspire to boost
OXPHOS and enhance cytosolic [Ca2+] responses (Figure 12-13), we sought to
test whether the mitochondrial matrix [Ca2+] also is elevated. Indeed, in fly
glutamatergic neurons expressing mito-TNXXL – a genetically encoded
ratiometric Ca2+ biosensor that is targeted to the mitochondrial matrix (183) –
application of muscarine induced a significantly greater [Ca2+] response in
depolarized neurons compared to polarized neurons (Figure 14A-B). These data
demonstrate that concurrent PLCβ-IP3R activity and PM depolarization elevate
mitochondrial matrix [Ca2+], which is known to stimulate production of the
reducing equivalents utilized in OXPHOS and is consistent with our observation
that the ATP:ADP ratio is increased under the same conditions (74).

69

Figure 14 – Mitochondrial [Ca2+] is elevated by coincidence of
depolarization and activation of PLCβ-IP3R signaling in fly neurons. (A)
Representative traces showing mito-TNXXL ratio in depolarized (blue) and
polarized (pink) neurons. Arrow indicates point of muscarine addition. (B)
Cumulative distribution of muscarine-induced change in mito-TNXXL ratio in
depolarized (blue) and polarized (pink) fly neurons. **, P = 0.0024, KolmogorovSmirnov test. Contribution Note: Data collected in conjunction with Ching-On
Wong (permission granted to use).
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3.2.2 Depolarization Potentiates PLCβ-IP3R Signaling and Promotes PIP2PLCβ Association in Mammalian Cells
To ensure our results were indeed due to ER Ca2+ release, we attempted
to isolate intracellular Ca2+ stores by removing extracellular Ca2+ from the bath
before stimulation of PLCβ-IP3R signaling. However, we did not observe
appreciable PLCβ-IP3R signaling in the absence of extracellular Ca2+ in
Drosophila glutamatergic neurons (not shown). Using an alternative approach,
we turned to N2a cells – an excitable murine cell line (184, 185) – to determine
whether depolarization-induced PLCβ-IP3R signaling augmentation was
preserved without the addition of extracellular Ca2+. Upon depolarization with
high [K+] or ouabain, an inhibitor of the Na+/K+ ATPase (186), in Ca2+-free
solution, significantly larger cytosolic Ca2+ transients were elicited by histamine,
an activator of IP3-mediated Ca2+ release in N2a cells (Figure 15A-B). These
data suggest that increases in cytosolic [Ca2+] observed upon stimulation of
PLCβ are indeed due to IP3-medatied Ca2+ release from the ER.
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Figure 15 – Depolarization augments PLCβ–IP3R signaling in mammalian
cells. (A) Representative traces showing Fura-2 ratio in N2a cells depolarized
with 100 mM [K+] (left) or ouabain (right). Arrows indicate treatments. Line
indicates Ca2+-free bath. (B) Bar graphs quantifying normalized amplitudes of
Ca2+ transients shown in (A). Values represent mean ± SEM. *, P<0.05, ****,
P<0.0001, Mann-Whitney tests. Contribution Note: Data collected in
conjunction with Ching-On Wong (permission granted to use).
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We next sought to understand how changes in membrane potential could
affect PLCβ-IP3R signaling, as the proteins involved in this pathway are not
thought to be intrinsically voltage-dependent. Although activation of IP3R is
unlikely to be directly influenced by PM depolarization, the circumstances are
different for PLCβ – an enzyme localized to the PM that acts on PIP2, a
phospholipid substrate (91). Indeed, previous work has demonstrated that
depolarization increases the propensity of PIP2 to self-associate (187). In these
studies, fluorescence lifetime imaging-FRET (FLIM-FRET) was used to measure
this phenomenon in cells coexpressing RFP- and GFP-tagged variants of the
PIP2-sensor, PH-PLCδ (hereafter RFP-PH and GFP-PH) (Figure 16A).
Consistent with these findings, which were conducted by inducing depolarization
via high extracellular [K+], we found that ouabain treatment also led to an
increase in PIP2 self-association in N2a cells coexpressing RFP-PH and GFPPH, which manifests as a decrease in GFP-lifetime (Figure 16B-C).
While depolarization-induced PIP2 self-association was certainly relevant
to our inquiry, the more pertinent question with respect to augmentation of PLCβIP3R signaling was whether changes in membrane potential could increase
association of the phosphoinositide with its enzyme, PLCβ. To test this question,
we used a similar approach as described above, but substituted GFP-PH with a
GFP-tagged PLCβ1 (PLCβ1-GFP) (Figure 16D). Compared to N2a cells solely
expressing PLCβ1-GFP, cells coexpressing PLCβ1-GFP and RFP-PH had a
decreased GFP-lifetime, indicating a degree of constitutive PIP2-PLCβ1
association (Figure 16E). Upon treatment with ouabain, GFP-lifetime was
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reduced further, suggesting enhancement of PIP2-PLCβ1 association (Figure
16E). These data provide a potential mechanism by which depolarization of the
PM can augment PLCβ activity, induce IP3-mediated increases in cytosolic and
mitochondrial [Ca2+], and boost OXPHOS.
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Figure 16 – Depolarization enhances PIP2 self-association and PIP2-PLCβ1
association in mammalian cells. (A) Top, PIP2 molecules are bound by GFPPH or RFP-PH. Plasma membrane depolarization causes clustering of PIP2 and
probes. Bottom, FLIM-FRET is based on the principle that energy transfer of
proximal fluorophores, due to formation of nanoclusters, leads to decreased
lifetime of the donor (GFP) fluorescence. (B) Representative heat maps showing
GFP lifetime in N2a cells expressing the indicated fluorophores under control or
ouabain-treated conditions. (C) Boxplots showing quantification of relative GFP
lifetime in control (pink) and ouabain-treated (blue) cells. Values are normalized
to the mean of GFP-PH-only datasets. ****, P<0.0001, t-test. (D) PIP2-PLCβ1
interactions in depolarized cells are reflected by proximity of PLCβ1-GFP and
RFP-PH. (E) Boxplots quantifying GFP-lifetime in depolarized or polarized N2a
cells expressing the indicated probes. ****, P<0.0001, t-tests with Bonferroni
correction. Contribution Note: Data collected in conjunction with Yong Zhou
(permission granted to use).
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3.2.3 Chronic Depolarization of Glutamatergic Neurons Shortens Adult Fly
Lifespan via Overactivation of PLCβ-IP3R Signaling
Having uncovered a putative link between PM depolarization and
bioenergetic stimulation in neurons, we sought to further test these concepts and
explore the potential ramifications of unchecked PLCβ-IP3R signaling at the level
of the organism (Figure 17A). To this end, we endeavored to genetically inhibit
Na+/K+ ATPase in fly glutamatergic neurons, which include motor neurons in
Drosophila, and evaluate any effect on lifespan. Given that the RMP is
maintained by Na+/K+ ATPase (34, 35), inhibition of the pump would render the
neuron incapable of reestablishing polarization irrespective of any ATP
generation elicited by increased PLCβ-IP3R signaling.
We first expressed an RNAi targeting Na+/K+ ATPase, which proved
excessively toxic and induced embryonic lethality (not shown). To produce a
milder phenotype, we expressed a dominant-negative α-subunit of Na+/K+
ATPase (ATPαDN) that has been shown to depolarize RMP (188), which lead to a
moderate, yet significant, reduction in lifespan compared to controls (Figure
17B). To test whether PLCβ-IP3R signaling was involved in mediating this
phenotype, we made multiple interventions in this pathway and assessed their
effect on lifespan. Intriguingly, either simultaneous knockdown of the fly IP3R
orthologue, itpr, or expression of ATPαDN in animals null for Drosophila PLCβ
(norpAP54) restored longevity (Figure 17B). This rescue was not attributable to
nonspecific life-extension, as expression of itprRNAi had no affect on lifespan
(Figure 17C-D). Further supporting the rigor of our approach, we did not observe
expression dilution upon expression of multiple UAS transgenes (Figure 17E).
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Having found that PLCβ-IP3R signaling is necessary to induce lifespanshortening toxicity in glutamatergic neurons handicapped by Na+/K+ ATPase
inhibition, we wondered if the pathway was also sufficient to increase mortality.
Indeed, overexpression of itpr alone led to an abbreviated lifespan compared to
controls (Figure 17F). Unsurprisingly, coexpression with itprRNAi mitigated the
lifespan-shortening effect of itpr overexpression, which also points to the
specificity of this RNAi line (Figure 17F). Taken together, these data implicate
neuronal hyperexcitability as a driver of toxic PLCβ-IP3R signaling and suggest
that this pathway is both necessary and sufficient to reduce longevity in fly
glutamatergic neurons.
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Figure 17 – Chronic depolarization of neurons shortens fly lifespan in a
PLCβ/IP3R-dependent manner. (A) Stimulation of Gq-coupled receptor (GPCR)
activates PLCβ1, which hydrolyzes PIP2 to generate DAG and IP3. IP3 binds to
IP3R in the ER leading to Ca2+ release. (B-D, F) Lifespan of flies of the indicated
genotypes. Dashed grey line marks median survival. ****, P<0.0001, n.s., not
significant, log-rank test with Bonferroni correction. (E) Top, representative
Western blot staining for GFP and tubulin in flies expressing UAS-mCD8::GFP
with or without UAS-itprRNAi using d42-GAL4. Bottom, bar graph depicting
quantification of [GFP]/[tubulin] from indicated genotypes. Protein samples were
obtained from fly head extracts. Bar graphs represent mean ±SEM. n.s., not
significant, t-test.
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3.2.4 Fly Glutamatergic Neurons Expressing Neurodegenerative
Transgenes are Chronically Depolarized
To determine whether the relationship between PM depolarization,
augmented PLCβ–IP3R signaling, and decreased lifespan are potentially relevant
to neurodegeneration, we chose models based on their capacity to induce cellautonomous hyperexcitability or destabilization of MAMs, which are points of
ER–mitochondria juxtaposition necessary for Ca2+-stimulated ATP production.
We selected human MAPT (i.e., the 0N3R isoform, hereafter referred to as tau)
because of the hyperexcitability – a manifestation of chronic depolarization –
present in AD and other tauopathies (189–192), and the previously mentioned
ALS-causing variant, vapbP58S, which is thought to destabilize MAMs by
disrupting the tethering between the ER and mitochondria (123–125, 161).
Conducting whole-cell patch clamp on isolated glutamatergic neurons
identified by mCD8::GFP expression, we measured the RMP of cells
coexpressing the aforementioned neurodegenerative transgenes (Figure 18A).
Interestingly, compared to the RMP of neurons expressing mCD8::GFP alone (~
-75 mV), tau-expressing neurons were markedly depolarized (~ -25 mV) (Figure
18B), which is consistent with previous reports (193). Similarly, neurons
expressing vapbP58S had a more depolarized RMP (~ -45mV) than vapbWTexpressing neurons (~ -80 mV), the latter of which was not significantly different
than mCD8::GFP alone (Figure 18B). These data demonstrate that tau- and
vapbP58S-expressing primary glutamatergic neurons are chronically depolarized,
and thus, are relevant neurodegenerative models to probe the nexus of PM
potential, overactive PLCβ–IP3R signaling, and organismal longevity.
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Figure 18 – Expression of neurodegenerative transgenes depolarizes the
resting membrane potential of fly neurons. (A) Work-flow for isolation of GFPtagged glutamatergic neurons (GNs) from fly larvae. Inset, confocal image of
dissociated glutamatergic neuron expressing GFP. (B) Bar graph quantifying
resting membrane potential in dissociated fly glutamatergic neurons expressing
the indicated transgenes. Values represent mean ± SEM. **, P<0.005, ANOVA
followed by t-tests with Bonferroni correction. Contribution Note: Data collected
in conjunction with Qiaochu Wang (permission granted to use).
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3.2.5 Flies Expressing Neurodegenerative Transgenes in Glutamatergic
Neurons have Abbreviated Lifespans and are Rescued by Attenuation of
PLCβ-IP3R Signaling
Given that tau and vapbP58S depolarize glutamatergic neurons, we
wondered whether these transgenes would induce early mortality when
expressed in the same subset of neurons, as was observed in animals
expressing ATPαDN (Figure 17B). Indeed, either the expression of vapbP58S or
tau led to premature demise compared to the appropriate UAS/GAL4 controls
(Figure 19A-B). While expression of vapbWT in glutamatergic neurons did result
in a slight, yet significant, reduction in lifespan compared to the relevant controls,
the lifespan of the mutant variant was far shorter than the wild-type variant
(Figure 19C).
Knowing that attenuation of PLCβ–IP3R signaling rescued flies expressing
ATPαDN, we questioned if similar interventions made in the context of
neurodegenerative transgene expression would offer any benefit. Remarkably,
coexpression of itprRNAi with either tau or vapbP58S fully rescued longevity back to
control levels (Figure 19A-B). In addition, locomotor activity in 30-day-old
vapbP58S-expressing flies was drastically reduced compared to control, a
phenotype that was completely reversed upon coexpression of itprRNAi (Figure
19D). Pointing to the specificity of itprRNAi, concurrent overexpression of itpr with
tau or vapbP58S expression counteracted the beneficial effects of knockdown
(Figure 19E-F). Furthermore, the shortening of lifespan induced by vapbP58S and
tau coexpression was also mitigated by itpr knockdown (Figure 19F). Targeting
the GPCR coupled to fly PLCβ (mAChR-A) (194, 195) – an intervention that
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should attenuate the upstream signal required for PLCβ–IP3R activation – also
provided benefit. Indeed, knockdown of mAChR-A with two different RNAi lines
(mAChRRNAi-1 and mAChRRNAi-2) led to a robust restoration in lifespan in either
vapbP58S- or tau-expressing flies (Figure 19A-B,G). As with itpr knockdown,
mAChR knockdown conferred no general extension of lifespan when expressed
alone in glutamatergic neurons (Figure 19G). Finally, expression of tau or
vapbP58S in a PLCβ null (norpAP54) background significantly lengthened lifespan
compared to expression of either transgene alone (Figure 19H). Importantly,
while less impressive than either itpr or mAChR-A knockdown, this rescue was
statistically indistinguishable from norpAP54 without neurodegenerative transgene
expression, which inherently has an abbreviated lifespan relative to UAS/GAL4
controls (Figure 19I).

83

Figure 19 – Neuronal expression of neurodegenerative transgenes
shortens fly lifespan in a PLCβ/IP3R-dependent manner. (A-C, E-I) Lifespan
of flies of the indicated genotypes. ****, P<0.0001, log-rank tests with Bonferroni
correction. (D) Bar graph showing daily locomotion exhibited by adult flies of the
indicated genotypes and age. Values represent mean ±SEM of beam-crossing
counts. **, P<0.01, ANOVA followed by t-tests with Bonferroni correction. n.s.,
not significant.
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In addition to IP3R, other ER-resident Ca2+ channels, such as RyR (95),
could be contributing to the toxicity observed in neurodegenerative transgeneexpressing flies. To determine whether these effects are specific to IP3R, we
expressed either vapbP58S or tau in flies heterozygous for RyR (RyR16/+) (196),
which conferred no protective benefit compared to the relevant controls (Figure
20A-B). Furthermore, in flies expressing an extra copy of RyR (RyR24D03/+)
(197), no increase in mortality was observed, suggesting that, in contrast to IP3R,
overexpression of RyR alone is insufficient to induce toxicity (Figure 20C). Taken
together, these data indicate that PLCβ–IP3R signaling specifically mediates the
lifespan-shortening toxicity induced by expression of depolarizing
neurodegenerative transgenes in glutamatergic neurons.
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Figure 20 – RyR does not rescue lifespan of flies expressing
neurodegenerative transgenes. (A-C) Lifespan of flies of the indicated
genotypes. RyR16 and RyR24D03 are null and genomic duplication alleles,
respectively. Dashed grey line marks median survival. n.s., not significant, logrank test.
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3.2.6 Mitochondrial Ca2+ Overload does not Cause Increased Mortality in
Flies Expressing Neurodegenerative Transgenes in Glutamatergic Neurons
Given that PLCβ–IP3R signaling is necessary to shorten lifespan in flies
expressing tau and vapbP58S, we sought to understand what process, which
ultimately is responsible for the increased lethality, lies downstream of this
pathway. One destination of IP3-mediated Ca2+ release is the mitochondrial
matrix (67), where the cation upregulates the activity of TCA cycle
dehydrogenases (61–63). While this bioenergetic function is important, an
overabundance of Ca2+ delivery to the mitochondria can result in necro-apoptotic
signaling cascades that cause cell death (198). We hypothesized that, due to
overactive PLCβ–IP3R signaling, tau- and vapbP58S-expressing neurons would
exhibit increased levels of mitochondrial [Ca2+] compared to controls upon
administration of muscarine. As before, we used mito-TNXXL to measure matrix
[Ca2+] (183). Interestingly, while itpr overexpression led to elevated mitochondrial
Ca2+ uptake upon stimulation of PLCβ–IP3R signaling, both tau and vapbP58S
exhibited diminished levels of matrix [Ca2+] compared to control (Figure 21A).
These data demonstrate that despite the observation that itpr, vapbP58S, and tau
all shorten lifespan through a common downstream pathway, only the former
elevates mitochondrial [Ca2+] (Figure 21B). Thus, tau- and vapbP58S-induced
toxicity does not correlate with mitochondrial matrix [Ca2+].
To support these results with an orthogonal approach, we evaluated the
effect on lifespan of MCU knockdown in tau- and vapbP58S-expressing flies. Given
that Ca2+ gains entry into the mitochondrial matrix via the MCU (67), it would
stand to reason that knockdown of MCU would be protective in the context of
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mitochondrial Ca2+ overload. In contrast to attenuation of PLCβ–IP3R signaling,
coexpression of MCURNAi did not alter the lifespan of tau- expressing flies and
actually exacerbated the phenotype in vapbP58S-expressing animals (Figure 21CD). Consistent with the implications of our mitochondrial [Ca2+] measurements,
MCU knockdown is not protective to tau- and vapbP58S-expressing flies. In
addition to invalidating our initial hypothesis, these data suggest an alternative
IP3R-dependent process underlying lifespan-reducing toxicity.
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Figure 21 – Mitochondrial Ca2+ overload does not occur in flies expressing
neurodegenerative transgenes. (A) Cumulative distribution of muscarineinduced change in mito-TNXXL ratio in fly neurons of the indicated genotypes. **,
P<0.01, ***, P<0.001, ****, P<0.0001, Kolmogorov-Smirnov test. (B) Ca2+
released via IP3Rs is not sequestered into mitochondria in fly neurons expressing
vapbP58S/tau. (C-D) Lifespan of flies of the indicated genotypes. Dashed grey line
marks median survival. ****, P<0.0001, n.s., not significant, log-rank test with
Bonferroni correction. Contribution Note: Data collected in conjunction with
Ching-On Wong (permission granted to use).
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3.2.7 Endolysosomal Ca2+ Content is Elevated in Glutamatergic Neurons
Expressing Neurodegenerative Transgenes
IP3-mediated Ca2+ mobilization may also be delivered into endolysosomes
(199, 200). Eliminating mitochondrial Ca2+ overload as the underlying source of
lifespan-limiting toxicity, we sought to evaluate whether any of our models
affected endolysosomal Ca2+ content. To infer endolysosomal content, we
treated isolated glutamatergic neurons with glycyl-L-phenylalanine-2naphthylamide (GPN), an agent that ruptures endolysosomal membranes (201,
202), while monitoring cytosolic [Ca2+] with GCaMP5G–tdTomato. In
glutamatergic neurons expressing vapbP58S, GPN revealed greater
endolysosomal Ca2+ content than in vapbWT-expressing neurons (Figure 22A-B).
Upon coexpression of itprRNAi, this increase was entirely prevented. Likewise, in
tau-expressing glutamatergic neurons, larger GPN-induced endolysosomal Ca2+
release was fully reversed with itprRNAi coexpression (Figure 22C-D). Thus, in
contrast to our result measuring mitochondrial [Ca2+], endolysosomal Ca2+
content is elevated in both tau- and vapbP58S-expressing glutamatergic neurons.
Arguing against the notion that ER Ca2+ may contribute to GPN-induced Ca2+
signals (203), we found that thapsigargin-evoked store release following GPN
pretreatment was undiminished (Figure 22E). Additionally, the fact that
depolarization does not affect ER Ca2+ stores also supports this conclusion
(Figure 22E). Taken together, these data indicate that increased endolysosomal
content in tau- and vapbP58S-expressing glutamatergic neurons relies upon an
IP3R-dependent mechanism.
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Figure 22 – Expression of neurodegenerative transgenes causes
endolysosomal Ca2+ overload in an IP3R-dependent manner in fly neurons.
(A, C) Representative traces showing GCaMP5G/tdTomato ratio in dissociated
fly glutamatergic neurons expressing the indicated transgenes. Arrow indicates
point of GPN application. (B, D) Bar graphs quantifying GPN-induced changes in
GCaMP5G/tdTomato ratio in dissociated fly glutamatergic neurons expressing
the indicated transgenes. Data represent median and 95% confidence intervals.
***, P<0.001, ****, P<0.0001, n.s., not significant, Mann-Whitney tests with
Bonferroni corrections. (E) Bar graph showing maximum amplitude of
thapsigargin-induced changes in GCaMP5G/tdTomato ratio in depolarized (blue)
and polarized (pink and maroon) fly neurons in the absence of bath Ca2+. In the
GPN-pretreatment group, GPN (500 μM) was applied for 3.5 minutes prior to
thapsigargin. Since thapsigargin depletes ER Ca2+ by blocking SERCA, increase
in cytosolic [Ca2+] (i.e. GCaMP5G/tdTomato ratio) reveals total ER Ca2+ content.
n.s., not significant, Kruskal-Wallis test. Contribution Note: Data collected in
conjunction with Ching-On Wong (permission granted to use).
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3.2.8 Elevated Endolysosomal Ca2+ Content in IP3R-Overexpressing
Glutamatergic Neurons is Rescued by TRPML Knockdown
In agreement with previous reports (199, 200), we found that
glutamatergic neurons overexpressing itpr produced larger GPN-evoked Ca2+
release compared to control (Figure 23A). To test whether limiting
endolysosomal Ca2+ release would exacerbate this phenotype, we sought to
reduce expression of trpml, the Drosophila gene encoding the endolysosomal
cation channel, transient receptor potential mucolipin (TRPML) (204, 205).
Surprisingly, simultaneous knockdown of trpml rescued the endolysosomal Ca2+
overload seen with itpr overexpression alone (Figure 23A) – a result observed
using two different RNAi lines (trpmlRNAi-1 and trpmlRNAi-2). Furthermore, unlike
trpml knockdown, expression of a neutral transgene (luciferase) did not diminish
the GPN response in itpr-overexpressing glutamatergic neurons, arguing against
the possibility that our results are attributable to GAL4 dilution (Figure 23B). In
addition, knockdown of trpml alone did not alter the magnitude of GPN-induced
Ca2+ signals, suggesting that the presence of heightened IP3-mediated Ca2+
release is required for TRPML to increase endolysosomal Ca2+ content (Figure
23C). These data indicate that TRPML is involved in an IP3R-dependent
mechanism that results in endolysosomal Ca2+ overload.
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Figure 23 – IP3R-dependent endolysosomal Ca2+ overload is rescued by
TRPML knockdown. (A-C) Bar graphs quantifying GPN-induced changes in
GCaMP5G/tdTomato ratio in dissociated fly glutamatergic neurons expressing
the indicated transgenes. Data represent median and 95% confidence intervals.
****, P<0.0001, n.s., not significant, Mann-Whitney test. Contribution Note: Data
collected in conjunction with Ching-On Wong (permission granted to use).
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3.2.9 TRPML Knockdown Rescues Shortened Lifespan and Endolysosomal
Ca2+ Overload in Flies with Overactive PLCβ-IP3R Signaling in
Glutamatergic Neurons
Consistent with endolysosomal Ca2+ overload contributing to the
pathologic process underlying increased mortality, the shortened lifespan of flies
overexpressing itpr was completely restored compared to UAS/GAL4 controls
upon knockdown of trpml (Figure 24A). Likewise, in flies expressing either tau or
vapbP58S in their glutamatergic neurons, trpml knockdown led to either a complete
or partial restoration in lifespan, respectively (Figure 24B-C). Furthermore,
mirroring our results in itpr-overexpressing glutamatergic neurons, coexpression
of trpmlRNAi-1 reversed the endolysosomal Ca2+ overload observed with tau
expression (Figure 24D). While coexpression of trpmlRNAi-1 in vapbP58Sexpressing glutamatergic neurons appeared to reduce the magnitude of GPNinduced Ca2+ release, this trend did not meet the threshold of significance
(Figure 24E). Overall, these data suggest that endolysosomal Ca2+ overload,
enabled by both IP3R and TRPML, is the operative process underlying lifespanlimiting toxicity in flies expressing itpr, tau, or vapbP58S.
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Figure 24 – TRPML knockdown mitigates lifespan and endolysosomal Ca2+
phenotypes associated with enhanced PLCβ–IP3R signaling. (A-C) Lifespan
of flies of the indicated genotypes. ****, P<0.0001, n.s., not significant, log-rank
tests with Bonferroni correction. (D-E) Bar graphs quantifying GPN-induced
changes in GCaMP5G/tdTomato ratio in dissociated fly glutamatergic neurons
expressing the indicated transgenes. Data represent median and 95%
confidence intervals. ****, P<0.0001, ***, P<0.001, Mann-Whitney test.
Contribution Note: Data collected in conjunction with Ching-On Wong
(permission granted to use).
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3.2.10 Elevated Endolysosomal Ca2+ Content and Shortened Lifespan is
Caused by Overexpression of TRPML in Glutamatergic Neurons
Given our results implicating TRPML in the mechanism driving toxicity in
various models, we wondered whether the endolysosomal cation channel was
sufficient to induce these phenotypes independently. Indeed, compared to
control, overexpression of trpml in glutamatergic neurons led to greater release
of endolysosomal Ca2+content upon administration of GPN (Figure 25A). In
agreement with these data, flies overexpressing trpml in their glutamatergic
neurons exhibited abbreviated lifespans, which, unsurprisingly, was reversed
upon coexpression of either trpmlRNAi-1 or trpmlRNAi-2 (Figure 25B). Finally, in
contrast to the previously mentioned inverse experiment, knockdown of itpr does
not rescue the lethality induced by trpml overexpression, suggesting that TRPML
acts downstream of IP3R (Figure 25C).
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Figure 25 – TRPML operates downstream of IP3R to promote
endolysosomal Ca2+ overload and shortening of lifespan. (A) Bar graphs
quantifying GPN-induced changes in GCaMP5G/tdTomato ratio in dissociated fly
glutamatergic neurons expressing the indicated transgenes. Data represent
median and 95% confidence intervals. *, P<0.05, Mann-Whitney test. (B-C)
Lifespan of flies of the indicated genotypes. ****, P<0.0001, n.s., not significant,
log-rank tests with Bonferroni correction. Contribution Note: Data collected in
conjunction with Ching-On Wong (permission granted to use).
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3.3 Discussion
Here, we describe an unconventional augmentation of PLCβ–IP3R
signaling driven by PM depolarization using a combination of approaches in
Drosophila and mammalian cells. The broad implications of these results –
relevant in both the context of normal physiology and disease – are twofold. First,
depolarization-induced upregulation of this pathway may represent a strategy
neurons employ to maintain bioenergetic homeostasis. Second, in the context of
neurodegeneration, overactivation of PLCβ–IP3R signaling contributes to the
toxicity that ultimately culminates in death via endolysosomal Ca2+ overload
(Figure 26).
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Figure 26 – Overview of toxic cascade. Model depicting the sequence of
events that relate depolarization of glutamatergic neurons with endolysosomal
[Ca2+] overload and regulation of lifespan.
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Neurons are energy intensive cells that must match the rapid onset of ATP
consumption that accompanies stimulation with timely energy generation. This
need implies the existence of robust systems that couple correlates of neuronal
activity with bioenergetic pathways. Our data support the claim that activation of
PLCβ–IP3R signaling via depolarization of the PM constitutes one method by
which neurons compensate for increased activity-driven ATP consumption.
Specifically, we demonstrate that the coincidence of PM depolarization and
activation of PLCβ–IP3R signaling elevates both mitochondrial [Ca2+] and ATP
production (Figure 12-13). Moreover, the depolarization-induced increase in
PIP2-PLCβ association suggests IP3 production is promoted via a voltagedependent mechanism that brings substrate and enzyme into proximity (Figure
16). While this specific concept is novel, the idea that the RMP can influence
intracellular signaling in ways other than dictating excitability for the purpose of
firing action potentials has been established. For example, the RMP has been
shown to influence circadian rhythm, smooth muscle cell contractility, secretion of
insulin from β-cells, cell migration, and cell proliferation (206). In the case of
proliferation, the promotion of cell division is thought to be mediated by
nanoscale reconfiguration of phosphatidylserine (PS) upon depolarization, which
ultimately upregulates mitogenic signaling pathways (187). While most cell
functions influenced by RMP manifest though changes in ionic conductance, the
ability of changes in voltage across the PM to reorganize constituents of the lipid
bilayer itself (i.e., certain anionic phospholipids) represents a different category of
effect. The depolarization-promoting associations we describe involving PIP2 are
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best classified within this category. However, while our observations are entirely
consistent with the aforementioned study (187), the manner in which the
downstream signaling consequences are actualized is distinct. Whereas PS selfassociation serves to promote the assembly of signaling competent nanoclusters
important for proliferation (187, 207), the PIP2-PLCβ association we describe
promotes the rate of an enzymatic reaction. Given that PLCβ obeys first-orderkinetics (208), which dictates that the availability of substrate is the rate-limiting
step of a reaction, depolarization-induced PIP2-PLCβ association might prime the
enzyme for enhanced IP3 production.
We propose that augmented PLCβ–IP3R signaling in the setting of PM
depolarization represents a bioenergetic strategy neurons employ to counter the
metabolic demands imposed by repetitive firing of action potentials. Such
compensatory mechanisms that operate in the axonal compartment have been
described (47, 52, 174). For instance, upon stimulation, neurons upregulate
glycolysis and increase glucose uptake by mobilizing glucose transporter type 4
(GLUT4) via an AMP-kinase (AMPK)-dependent mechanism in nerve terminals
(173, 174). While this example constitutes a feedback loop, Ca2+-dependent
feedforward mechanisms that elevate OXPHOS in presynaptic mitochondria
have also been defined. In one report, a regulator of the MCU, MICU3, which is
exclusively expressed in brain, was shown to lower the threshold for
mitochondrial Ca2+ uptake and allow for compensatory ATP production upon
VGCC-mediated Ca2+ influx (52). While this mechanism would appear to render
obsolete the need for IP3R-mediated mitochondrial Ca2+ uptake, our data are

102

compatible with these results. As mentioned by the authors of the study revealing
the specialized role of MICU3 in the brain, different neuronal compartments may
rely on ER-mediated Ca2+ transfer to the mitochondria to a greater extent than is
observed in axonal terminals (52). Indeed, in stimulated dendrites, mitochondrial
Ca2+ uptake was abolished after pharmacological inhibition of PLCβ–IP3R
signaling (177). In agreement with this result, our experiments measuring
mitochondrial matrix [Ca2+] and the ATP:ADP ratio (Figure 12-13), which only
captured signals in the somatodendritic compartment, are consistent with IP3Rmediated Ca2+ delivery to the mitochondria predominating in these regions of the
neuron. Future studies, conducted in both invertebrate and mammalian models,
are needed to further elucidate the spatiotemporally differentiated metabolic
strategies neurons utilize to meet their unique energy demands.
In addition to uncovering that depolarization-induced PLCβ–IP3R signaling
has relevance to neuronal bioenergetic homeostasis, we found that inappropriate
elevation of this signaling axis proved maladaptive in Drosophila models of
neurodegeneration. Chronically depolarizing perturbations that either prevented
compensatory Ca2+-mediated ATP generation or rendered the affected neurons
unresponsive to such bioenergetic upregulation led to unchecked PLCβ–IP3R
signaling and early demise on the organismal level (Figure 17,19). Furthermore,
our data suggest that the downstream toxicity-inducing destination of increased
IP3-mediated Ca2+ release is the endolysosomal compartment, which involves
the participation of the cation channel, TRPML (Figure 23-25).
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While our results support the notion of a common, overactivated pathway
(i.e., PLCβ–IP3R-TRPML) acting in our depolarization-promoting models (i.e.,
ATPαDN, tau, and vapbP58S), the exact nature of the mechanism underlying each
individual model remains to be fully elucidated. However, our data and previous
literature suggest several interesting possibilities, which are illustrated in Figure
27 and described in detail below. Inhibition of Na+/K+ ATPase via expression of
ATPαDN is the most straightforward model, as this intervention directly hampers
the RMP-maintaining pump, rendering afflicted neurons impotent regardless of
any compensatory elevation in ATP production. Validating the notion that this
perturbation truly induces depolarization, a previous study demonstrated that fly
motor neurons expressing ATPαDN exhibited a less negative RMP compared to
control (188). Due to several differences in experimental protocol, we cannot
directly compare ATPαDN-induced depolarization to the recordings we conducted
in tau- and vapbP58S-expressing neurons. However, we can infer that expression
of the Na+/K+ ATPase dominant-negative likely induces a relatively mild
depolarization given that the RMP in ATPαDN-expressing motor neurons is only
around 5 mV more depolarized compared to a GAL4 control (188). Extrapolating
to tau and vapbP58S, a presumptive trend emerges correlating the degree of
depolarization with the severity of shortened lifespan. Although additional data
would be required to confirm this connection, a greater extent of PM
depolarization would be expected to progressively augment lifespan-limiting
PLCβ–IP3R signaling.

104

Figure 27 – Overview of putative mechanisms underlying
neurodegeneration in respective models. The IP3 pathway is upregulated by
plasma membrane (PM) depolarization, which enhances hydrolysis of PIP2 into
IP3 and DAG by phospholipase Cβ (PLCβ). Augmented Ca2+ release from
inositol trisphosphate receptor (IP3R) results in lifespan shortening
endolysosomal (Lyso) Ca2+ overload, which is potentiated by trpml. IP3-mediated
Ca2+ delivery into the mitochondria (Mito) may be disrupted by vapbP58S, which
lowers activity of the Na+/K+ ATPase, further depolarizing the PM. Resting
membrane potential (RMP)-setting K+ leak channels (Ch) may be downregulated
by tau, which would lead to PM depolarization.
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Unlike with Na+/K+ ATPase inhibition, the mechanism underlying vapbP58Sinduced depolarization is incompletely defined. One interesting hypothesis
revolves around the function of VAPB as a tethering protein that contributes to
MAM stabilization. If contacts between the ER and mitochondria were to be
disrupted, the privileged position of IP3R would be compromised, reducing the
capacity of a neuron to elevate OXPHOS via increased Ca2+ delivery to the
mitochondrial matrix. In turn, the resulting scarcity of ATP would reduce activity
of the Na+/K+ ATPase, causing depolarization (178). Indeed, our measurements
revealing diminished muscarine-evoked mitochondrial Ca2+ elevations in
vapbP58S-expressing glutamatergic neurons suggest this might be the case
(Figure 21). However, while this mechanism may contribute to vapbP58S-induced
depolarization in vivo, the altered RMP detected in our patch-clamp experiments
cannot be attributed to this mechanism. Given that cytosolic [K+] in whole-cell
patch clamp measurements is clamped by the pipette solution, the influence of
Na+/K+ ATPase over the RMP is minimal. Thus, expression of vapbP58S must be
inducing depolarization though an alternative mechanism that may involve the
perturbation of RMP-setting ion channels (209). While future studies are needed
to ascertain the nature of this mechanism, reports of wild-type VAPB interacting
with and affecting the function of certain K+ channels (i.e., Kv2) that contribute to
neuronal excitability add plausibility to this idea (210, 211).
Expression of tau in glutamatergic neurons led to both the most severe
depolarization and the greatest reduction in lifespan. While subsequent studies
are required to confirm in our particular model, Tau is thought to mediate
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hyperexcitability by altering the function or expression of particular K+ channels
that determine excitability, including in Drosophila (189, 191, 193). Intriguingly, as
in vapbP58S, tau-expressing neurons exhibited reduced mitochondrial Ca2+
transients upon activation of PLCβ–IP3R signaling (Figure 21). This observation
may indicate an additional, ATP-limiting component to the mechanism underlying
depolarization in tau. Whereas vapbP58S may induce this effect though a
disruption restricted to the MAM, expression of human tau has been shown to
alter the global distribution and fusion-fission dynamics of neuronal mitochondria
(212). Given that a decline in the ATP:ADP ratio is a consequence of these
perturbations (212), the disruption of ER-mediated Ca2+ import into the
mitochondria may play a role in this process.
Our inquires into the destination of Ca2+ downstream of IP3R, which
centered on mitochondria and endolysosomes, led to some unexpected but
intriguing findings. Given the literature stating that mitochondrial Ca2+ overload
can trigger cell death (198), we wondered if the Ca2+ mobilized by enhanced
PLCβ–IP3R signaling exerted toxicity by accumulating in this organelle.
Unsurprisingly, overexpression of itpr, which presumably increases the
abundance of IP3R in MAMs, led to greater muscarine-induced Ca2+ transients
and supported this notion (Figure 21). However, the opposite effect was
observed in tau- and vapbP58S-expressing neurons, suggesting either a
divergence in mechanism underlying the different models or the existence of an
alternative cellular compartment responsible for Ca2+-induced toxicity. Resolving
this quandary, all three of the aforementioned models exhibited an IP3R-
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dependent increase in endolysosomal Ca2+ levels (Figure 22-23). Unexpectedly,
abundance of TRPML was correlated with lower endolysosomal Ca2+ content
and trpml knockdown rescued abbreviated lifespans in all models evaluated
(Figure 24). The complete restoration of lifespan demonstrated in flies
overexpressing itpr is of particular note (Figure 24), given that this suggests no
contribution of toxicity due to mitochondrial Ca2+ overload in this model.
The surprising and somewhat counterintuitive findings conferred by trpml
knockdown and trpml overexpression is the most perplexing, yet intriguing,
aspect of this study. Given that TRPML is a cation release channel, the
unexpected results we obtained assessing endolysosomal Ca2+ content are likely
due to the secondary or tertiary consequences of altering trpml expression. For
instance, in mammalian cells, TRPML1-mediated Ca2+ release has been shown
to upregulate transcription factor EB (TFEB)-dependent lysosomal biogenesis by
activating calcineurin (213). Thus, perhaps the increase in endolysosomal Ca2+
capacity afforded by generation of more such vesicles outweighs the amount of
Ca2+ lost via TRPML. Lending credence to the possibility that such a mechanism
has relevance to neurodegeneration, studies have indicated that, in Presenilin-1
knockout cells, either TRPML1 activity is increased (214) or genes implicated in
lysosomal biogenesis are upregulated (215). However, these same reports
explicitly contradict each other in important ways, making the interpretation of the
details uncertain. In any case, future studies are required to unravel the
mechanistic details associated with TRPML-dependent endolysosomal Ca2+
overload.
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3.4 Materials and Methods
3.4.1 Fly Husbandry
Flies were reared at 21°C on standard fly food (1 L of food contained: 95 g agar,
275 g brewer’s yeast, 520 g of cornmeal, 110 g of sugar, 45 g of propionic acid,
and 36 g of tegosept). The following fly lines were obtained from Bloomington
Drosophila Stock Center: vglutok371-GAL4 (ok371-GAL4), d42-GAL4, RyR16,
UAS-tau (UAS-MAPT.A; htau0N3R), UAS-itpr (UAS-Itp-r83A.V), UAS-itprRNAi
(TRiP.JF01957), UAS-trpmlRNAi-1 (TRiP.JF01466), UAS-trpmlRNAi-2
(TRiP.JF01239), UAS-mAChR-ARNAi-1 (TRiP.HMC02343), UAS-mAChR-ARNAi-2
(TRiP.JF02725), UAS-MCURNAi (TRiP.HMS05618), UAS-luc (UAS-lucVALIUM10), and UAS-mCD8::GFP. Other strains used in the study were: UAStrpml, UAS-PercevalHR, UAS-mito-TNXXL (UAS-2mt8TNXXL; gift from Dr.
Gregory Macleod), UAS-tdTomato-2A-GCaMP5G, UAS-vapbWT and UASvapbP58S (gifts from Dr. Hugo J. Bellen), canton S, Oregon R, w1118, norpAP33 and
norpAP54, UAS-ATPαD369N (gift from Dr. Leslie C. Griffith), and RyR24D03.
3.4.2 Construction of UAS-PercevalHR
PercevalHR was PCR amplified from Addgene construct #49082
(https://www.addgene.org/49082/) and cloned into pUAST-C5 via an intermediate
pC5-Kan shuttle vector using Not I and Xho I restriction sites. The insert was fully
sequenced before submission to Bestgene for random P-element-based
integration.
3.4.3 Cell Culture
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Neuro-2a (N2a) cells were cultured in DMEM (D5796; Sigma-Aldrich)
supplemented with 10% fetal bovine serum (FBS) and maintained at 5% CO2
and 37°C. For primary glutamatergic neurons isolated from Drosophila,
wandering 3rd instar larvae were first submerged in ethanol, and then washed
with sterilized H2O before dissection in filtered Schneider’s medium (S0146;
Sigma-Aldrich) containing 10% FBS. Brains dissected from these larvae were
washed in separate wells containing filtered Schneider’s medium before being
transferred to a filtered HL-3 solution (70 mM NaCl, 5 mM KCl, 1 mM CaCl2, 20
mM MgCl2, 10 mM NaHCO3, 115 mM sucrose, 5 mM trehalose, and 5 mM
HEPES) supplemented with 0.423 mM L-cysteine (Calbiochem) and 5 U/mL
papain (Worthington) (Note: After L-cysteine addition but before papain addition,
the pH of the solution was recalibrated to 7.4). The brains were then
enzymatically digested in the papain solution for 15 minutes before transfer to a
1.5 mL tube containing 1 mL of filtered Schneider’s medium. Centrifugation at
100G for 1 minute was employed prior to decantation of Schneider’s medium and
replacement with 1 mL of fresh filtered Schneider’s medium. This process was
repeated twice before neurons were dissociated by pipetting repeatedly until
solution was homogeneous. Solution with dissociated neurons was then placed
on 35 mm glass bottom dishes (D35-10-0-N; Cellvis) that had been coated with
concanavalin A (C2010; Sigma-Aldrich). Cells were cultured in Schneider’s
medium supplemented with 10% FBS, antibiotic/antimycotic solution (A5955;
Sigma-Aldrich), and 50 μg/mL of insulin (I6634; Sigma-Aldrich) at room
temperature in a humidified container. After one day of culture, cells were
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washed twice with PBS to remove any debris remaining from dissociation. After
this step, the dissociated neurons were left in supplemented Schneider’s medium
for ~4-days to develop before experimentation.
3.4.4 Live-Cell Imaging in Fly Primary Neurons
Mito-TNXXL: Media of dissociated fly glutamatergic neurons was replaced with
HL-3 (70 mM NaCl, 5 mM KCl, 1 mM CaCl2, 20 mM MgCl2, 10 mM NaHCO3, 115
mM sucrose, 5 mM trehalose, and 5 mM HEPES; pH 7.2, room temperature).
Mito-TNXXL signals, which represent free mitochondrial matrix [Ca2+], were
recorded by measuring CFP and cpCitrine emissions (183). Briefly, emissions at
482 nm and 532.5 nm were monitored after excitation at 445 nm using an A1R
laser confocal microscope with a 40x objective (Nikon). Background emission
signals, which were subtracted from all captured images, were measured from a
cell-free region of interest (ROI). For experiments requiring neurons with fully
polarized membrane potential, the baseline mitochondrial [Ca2+] was established
by recording cells for 1 minute before addition of muscarine (1 mM). To
depolarize the neurons, the bath was replaced with high-K+ HL-3 (23.3 mM NaCl,
51.7 mM KCl, 1 mM CaCl2, 20 mM MgCl2, 10 mM NaHCO3, 115 mM sucrose, 5
mM trehalose, and 5 mM HEPES; pH 7.2). Muscarine (1 mM) was then added 2
minutes after depolarization, and mito-TNXXL signals were recorded for 3
minutes. The amplitude of the cpCitrine/CFP ratio represented free [Ca2+] in
mitochondrial matrix. For quantification of responses, magnitudes of responses
from baseline were calculated by dividing the maximum value measured
following muscarine stimulation by the average of the five baseline values
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immediately preceding muscarine addition. An n > 50 cells from a minimum of 4
independently conducted experiments was completed per genotype/condition.

PercevalHR: Supplemented Schneider’s medium used for maintaining cells was
replaced with room temperature HL-3 (70 mM NaCl, 5 mM KCl, 1 mM CaCl2, 20
mM MgCl2, 10 mM NaHCO3, 115 mM sucrose, 5 mM trehalose, and 5 mM
HEPES; pH 7.2). PercevalHR signals, which represent the cytosolic ATP/ADP
ratio, were recorded by measuring the ratio of fluorescence emissions at 525 nm
sequentially excited at 487.5 nm and 407.8 nm (179). An A1R laser confocal
microscope with 40x objective (Nikon) was used for measurement. Background
emission signals were measured from a cell-free ROI. Baselines were
established for 1 minute before addition of muscarine (1 mM). For cells subjected
to depolarization, the bath was replaced with high [K+] HL-3. Muscarine (1 mM)
was then added 2 minutes after depolarization, and PercevalHR signals were
recorded for 3 minutes. Oligomycin A (10 μM) was then added, and signals were
recorded for an additional 3 minutes. Amplitudes of the emission ratio
represented cytosolic [ATP]/[ADP] ratio. Data were quantified as change in
muscarine-induced PercevalHR ratio, which was determined as the maximum
change in the ratio following the application of muscarine. An n ≥ 80 cells from a
minimum of 5 independently conducted experiments was completed per
condition.
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GCaMP5G-tdTomato: Supplemented Schneider’s medium used for maintaining
cells was replaced with HL-3. GCaMP5G and tdTomato were sequentially
excited at 488 nm and 561 nm respectively by an A1 laser confocal microscope
with a 40x objective (Nikon) (163). Emission signals at 525 nm and 595 nm were
recorded. Backgrounds were measured from a cell-free ROI. Baselines were
established for 1 minute before addition of muscarine (1 mM). For cells subjected
to depolarization, the bath was replaced with high [K+] HL-3. Muscarine (1 mM)
was then added 2 minutes after depolarization, and GCaMP5G-tdTomato signals
were recorded for 3 minutes. Total ER [Ca2+] was quantified as the change in
cytosolic Ca2+ signals following store-depletion with the SERCA inhibitor,
thapsigargin as described (163). Amplitudes of the GCaMP5G/tdTomato ratio
represents cytosolic free [Ca2+]. Amplitudes were quantified as change in ratio
from baseline, and calculated using custom code generated using R. An n > 50
cells from a minimum of 5 independently conducted experiments was completed
per condition.

GPN-dependent lysosomal Ca2+ release: Supplemented Schneider’s medium
used for maintaining cells was replaced with HL-3. Baseline
GCaMP5G/tdTomato ratios were recorded for 1 minute before the bath was
replaced with Ca2+-free HL-3. The cells were then recorded for an additional 1minute before treatment with GPN (500 μM). Data were quantified as area under
the curve, which was generated using the AUC function in R, for a duration of 2
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minutes following GPN application. An n ≥ 45 cells from a minimum of 3
independently conducted experiments was completed per genotype/condition.
3.4.5 Ca2+ Imaging in N2a Cells
Fura-2 signals, which represent cytosolic free [Ca2+], were recorded by detecting
intensities of emission at 510 nm after excitation at 340 and 380 nm using a
Nikon TiE Wide-Field Fluorescence Imaging System (Nikon). The background
subtracted emission ratio (ΔF340/ΔF380) was measured and calculated by NIS
Elements imaging software (Nikon). Cells were loaded with 10 μM fura-2
(Invitrogen) for 30 minutes in culture medium at 37 ˚C. Cells were then washed
and bathed in a bath solution containing 140 mM NaCl, 5 mM KCl, 2 mM CaCl2,
1 mM MgCl2, 10 mM HEPES, 10 mM glucose, 30 mM sucrose; pH 7.4. Baseline
fura-2 signals were recorded for 1 minute, before replacing the bath with Ca2+free bath solution. To depolarize PM with extracellular K+, we changed the
concentrations of K+ and Na+ in the bath solution from 5 mM KCl/140 mM NaCl to
100 mM KCl/45 mM NaCl (Ca2+-free). To depolarize PM using ouabain, 50 μM
ouabain or 0.2 μL DMSO (vehicle control) was added into the bath 30 seconds
after Ca2+-free bath exchange. Histamine was added 1.5 minutes after
depolarization. The fura-2 signals were recorded for 3 minutes after histamine
application. Amplitude of the ΔF340/ΔF380 signal represented IP3R-dependent ER
Ca2+ release. An n ≥ 80 cells from a minimum of 7 independently conducted
experiments was completed per condition.
3.4.6 Whole-Cell Patch Clamp Recordings
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Approximately 3 hours after plating, GFP-expressing dissociated primary
Drosophila neurons were identified and selected for whole-cell patch clamp.
Before measurement of resting membrane potential, the bath solution was
replaced with room temperature HL-3 (70 mM NaCl, 5 mM KCl, 1 mM CaCl2, 20
mM MgCl2, 10 mM NaHCO3, 115 mM sucrose, 5 mM trehalose, and 5 mM
HEPES; pH 7.2). The pipette solution used contained the following: 109 mM Kgluconate, 10 mM NaCl, 1.7 mM MgCl2, 0.085 mM CaCl2, 0.94 mM EGTA, 2 mM
ATP, 8.5 mM HEPES; pH 7.2. Recording pipettes were pulled from micropipette
glass (Sutter Instruments) to 8-10 MΩ on a PC-10 puller (Narishige). Clamping
was performed with an EPC10 (HEKA Instruments) amplifier. Commands were
made from the PatchMaster program (version 2X90.1; HEKA). GΩ seal was
achieved under voltage-clamping mode with V-membrane holding at -70 mV to
prevent cell excitation after membrane was broken. Cells with resistance higher
than 1 GΩ were used for measuring resting membrane potential. Currents were
clamped at zero, and voltage was continuously recorded at 10 kHz.
3.4.7 Analysis of Fly Lifespan
Newly eclosed adult flies were collected and transferred to vials containing
standard fly food (≤15 flies per vial). Flies were kept at room temperature (~21
˚C) and transferred to new vials twice a week. Dead flies at the bottom of the old
vials were counted after each transfer until all the animals in a cohort died.
3.4.8 Fly Activity Assay
Adult flies were reared at 25 °C in an incubator with a 12-hour light-dark cycle.
Locomotor activity was recorded using a 32-sample Drosophila activity monitor
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(DAM2; TriKinetics). Individual flies were enclosed in a hollow 65-mm glass rod
plugged with food (5% sucrose, 2.5% agar) on one end and cotton on the other.
The vials are bisected by a central infrared beam, which reports the number of
times each fly crosses the infrared beam per minute. Flies were placed in the
monitor at least 2 hours before data acquisition. The recordings lasted for 1.5
days, after which the flies were removed from the vials and maintained on
standard fly food until the next recording.
3.4.9 FLIM-FRET Experiments
N2a cells coexpressing PLCβ1-GFP or GFP-tagged PH-PLCδ with either empty
vector pC1 or RFP-tagged PH-PLCδ were washed with PBS, fixed in 4%
paraformaldehyde, and quenched with 50 mM NH4OH. FRET pairs were
transfected using standardized protocols to optimize for equal expression of
respective proteins. Cells were imaged using an x60 Plan-Apo/1.4NA oil
emersion lens mounted on a wide field Nikon Eclipse microscope. GFP was
sinusoidally excited by a modulating 3-Watt 497nm light-emitting diode (LED) at
40 MHz and fluorescence lifetime measured using a Lambert Instrument (Roden,
Netherlands) FLIM unit mounted on the Nikon Eclipse microscope. At least 60
individual cells were imaged and lifetime (phase) values were pooled and
averaged.
3.4.10 Western Blotting
Five adult heads were harvested and homogenized in 2x Laemmli sample Buffer
(Bio-Rad). Head extracts were then loaded onto 4-20% Tris-glycine gels (BioRad) for SDS-PAGE. After transfer to nitrocellulose membranes, blots were
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blocked in Odyssey blocking buffer (LI-COR Biosciences). Blots were then
incubated with primary and secondary antibodies diluted in Odyssey blocking
buffer. Blots were incubated with primary antibodies overnight at 4°C, and with
secondary antibodies for 2 hours at room temperature. Blots were imaged using
the Odyssey imaging platform (LI-COR Biosciences). Quantification of band
intensities was done using ImageJ (NIH). Primary antibodies used were mouse
anti-α-tubulin (12G10; DSHB) at 1:1000 and rabbit anti-GFP (A-11122;
Invitrogen) at 1:1000. Secondary antibodies used were goat IRDye 680LT antirabbit and goat IRDye 800CW anti-mouse (LI-COR Biosciences) at 1:20000 and
1:15000, respectively.
3.4.11 Statistical Analyses
We used either a parametric or a nonparametric test of statistical significance on
the basis of whether the data were normally distributed. Multiple comparisons
were made by ANOVA followed by t-tests with Bonferroni correction. R, Excel
(Microsoft), and Prism 8 (GraphPad) were used for statistical analyses. Statistical
significance was defined as a P < 0.05. P-values were shown on the figures as
asterisks: *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. Lifespan
(Kaplan-Meier) curves were generated using Prism 8. We used the log-rank
(Mantel-Cox) test to determine these P-values.
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Chapter 4: Discussion
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4.1 Summary
Neurodegenerative diseases, particularly those associated with advanced
age, are a major cause of mortality worldwide (1). Despite demographic trends
that ensure the societal burden of neurodegeneration will increase, there is a
paucity of effective therapies to reverse, or even mitigate, these diseases (13).
Given the lack of progress thus far, a better understanding of the biochemical
underpinning of neurodegeneration is required to make substantive
advancements.
As outlined in Chapter 1, Ca2+ is involved in a large number of processes
integral to neuronal function (51). Given the potential toxic consequences of
inappropriate elevations in [Ca2+], Ca2+ is subject to tight spatiotemporal
regulation. Thus, imbalances in the homeostatic controls that constitute this
regulation, or Ca2+ dyshomeostasis, represent an understudied source of
pathogenicity in neurodegeneration (81). Here, I have described two instances of
neuronal Ca2+ dyshomeostasis using Drosophila models of neurodegeneration.
In Chapter 2, using the ALS fly model, vapbP58S, I defined a mechanism by
which presynaptic [Ca2+] can influence the morphology of the NMJ. This study
complemented prior work done in our own lab in an intriguing and unexpected
manner. Whereas previously, low presynaptic resting [Ca2+] induced by loss of
various ER Ca2+ channels led to NMJs characterized by fewer, yet larger,
synaptic boutons (158), vapbP58S-expressing neurons were found to exhibit a
similar phenotype though the elevation of [Ca2+]. Specifically, we uncovered
evidence that expression of vapbP58S impairs Ca2+ extrusion, which may be the
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result of reduced biogenetic capacity. The NMJ defects induced by vapbP58S were
abolished upon inhibition of CaMKII, a kinase that phosphorylates and
deactivates the microtubule-stabilizing protein, Futsch. Thus, since both
calcineurin, a phosphatase, and CaMKII, a kinase, are stimulated by Ca2+ and
act on Futsch, but the former is more sensitive than the latter, nearly identical
phenotypes can arise from varying concentrations of Ca2+.
In Chapter 3, I described how depolarization of the PM potentiates PLCβIP3R signaling, elevates mitochondrial [Ca2+], and increases ATP production. We
provided evidence that depolarization increases association between PLCβ and
PIP2, bringing enzyme and substrate together, and augmenting IP3-mediated
Ca2+ release. Applying these findings to Drosophila models of neurodegeneration
characterized by chronic depolarization, we found that unchecked PLCβ-IP3R
signaling led to increased mortality in flies expressing tau or vapbP58S in
glutamatergic neurons. Furthermore, endolysosomal Ca2+ overload, which was
surprisingly dependent upon the presence of the cation channel, TRPML,
appeared to be responsible for the shortening of lifespan. Thus, we uncovered a
link between PM depolarization and PLCβ-IP3R signaling with potential
ramifications for neuronal bioenergetics and neurodegeneration.
Here, in Chapter 4, I will endeavor to provide synthesis where necessary,
guidance on the prospect of future directions, and commentary on the
significance and impact of this work. I will outline both the immediate next steps
and the long-term goals of this line of research. Finally, I will also speculate on
the implications of this work if our findings stand the test of time.
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4.2 Future Directions and Commentary
4.2.1 Investigating the Bioenergetic Effects of Neurodegenerative
Transgenes
In both Chapter 2 and Chapter 3, I attribute aspects of the described
mechanisms to the detrimental effect vapbP58S expression is thought to have on
bioenergetic capacity. While, in Chapter 3, I demonstrated that depolarization
leads to increased ATP production and vapbP58S-expressing neurons themselves
are depolarized, we did not explicitly measure ATP in neurons expressing
vapbP58S. However, we do provide evidence that mitochondrial [Ca2+] elevation,
which is a proxy for increased OXPHOS, is reduced in vapbP58S-expressing
neurons upon stimulation of PLCβ-IP3R signaling. Nevertheless, determination of
the bioenergetic status of vapbP58S-expressing neurons is the obvious next
experimental step. Evaluation of such neurons using the PercevalHR biosensor
(179), both at baseline and upon activation of PLCβ-IP3R signaling, would inform
our previous findings.
To gain a more comprehensive understanding of their metabolic status,
we could subject vapbP58S-expressing neurons to high-throughput evaluation of
the O2 consumption and extracellular acidification rates (i.e., Seahorse assay),
which correspond to OXPHOS and glycolysis, respectively (216). These
experiments would not only inform our suspicion that vapbP58S impairs
mitochondrial OXPHOS, but would expand our understanding into the glycolytic
domain, which we cannot rule out as potentially relevant to our inquiry. These
assays would buttress claims made in both Chapter 2 and Chapter 3, which
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implicate metabolic deficiency in impaired Ca2+ extrusion and chronic
depolarization of the PM, respectively.
Additionally, given our model that ATP production is compromised by the
vapbP58S-induced destabilization of MAMs, direct evaluation of these structures
by electron microscopy would be beneficial. Indeed, via this method, knockdown
of either component of the VAPB-PTPIP51 tether has been shown to reduce
points of contact between ER and mitochondria (123). If vapbP58S-expressing
neurons exhibited a diminished quantity of MAMs, this result would corroborate
our mitochondrial [Ca2+] measurements and add mechanistic detail to our model.
While our initial rationale for selecting tau as a neurodegenerative model
in Chapter 3 was not due to its likelihood of reducing bioenergetic capacity in a
vapbP58S-like manner, we cannot ignore the fact that mitochondrial [Ca2+]
elevations are also reduced in tau-expressing neurons upon activation of PLCβIP3R signaling. Unlike VAPB, human Tau is not widely acknowledged to be a
MAM-resident protein, suggesting mitochondrial Ca2+ transfer may be disrupted
by an alternative mechanism in neurons expressing tau. As previously
mentioned, expression of tau in mammalian neurons has been shown to alter
mitochondrial morphology and distribution, as well as reduce cellular ATP levels
(212). To determine whether our tau-expressing neurons exhibit similar
phenotypes, which would corroborate our mitochondrial Ca2+ measurements, we
could (1) conduct the same series of aforementioned metabolic assays
prescribed for vapbP58S and (2) assess mitochondrial quantity, morphology, and
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distribution. These studies would represent the first steps to ascertaining whether
or not a bioenergetic component to tau-induced depolarization exists.
4.2.2 Characterizing the Nature of Depolarization Caused by
Neurodegenerative Transgenes
Our understanding of the depolarization of RMP measured in both
vapbP58S- and tau-expressing neurons remains incomplete. As mentioned in the
previous section, a bioenergetic component that limits activity of the Na+/K+
ATPase may contribute to RMP depolarization in vivo. However, given that the
nature of our patch-clamp recordings in Chapter 3 preclude the influence of ATP
on RMP, these data strongly suggest the perturbation of RMP-setting ion
channels in our neurodegenerative models.
A number K+ channels have been identified in Drosophila that are open at
RMP and are expressed in neural tissue, including Ork1, Sh, and Shaw (217).
Inactivation or decreased expression of any of these channels could contribute to
depolarization of RMP in our models. As a first step to evaluate this possibility in
our models, RT-qPCR targeting these genes could be conducted on RNA
extracted from Drosophila brains expressing vapbP58S and tau. This experiment
would allow us to ascertain whether or not the expression of RMP-setting ion
channels is downregulated. More sophisticated imaging studies performed on
individual primary neurons could provide information on the localization of these
ion channels in vapbP58S- or tau-expressing neurons. Additionally, if these RMPsetting ion channels were the source of the chronic depolarization that initiates
the toxic cascade apparent in our neurodegenerative models, then knockdown of
Ork1, Sh, or Shaw would be expected to recapitulate our observed phenotypes.
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Furthermore, attenuation of PLCβ-IP3R signaling or endolysosomal Ca2+ loading
would rescue these phenotypes.
The literature points to additional possibilities in this domain. As
mentioned in Chapter 3, wild type VAPB has been shown to interact with and
affect the function of the voltage-gated K+ channel, Kv2, which is encoded by the
gene KCNB1, in mammalian neurons (210, 211). Kv2 is not thought to be a
canonical K+ leak channel, but it certainly regulates neuronal excitability and may
contribute to RMP under certain circumstances (218, 219). The fly orthologue of
KCNB1 is Shab, which presents another experimental route to explore (220).
Although there is no current evidence that the fly orthologues of mammalian
VAPB and KCNB1 interact in a conserved fashion – or what effect vapbP58S
would have on such a potential interaction – interrogation of these questions is of
relevance to the nature of vapbP58S-induced chronic depolarization.
There are experimental opportunities related to tau in this context as well.
As mentioned, numerous examples in the literature have demonstrated that tau
induces neuronal hyperexcitability. Expression of the K+ channel, Kv4.2, has
been shown to be downregulated in a Tau-dependent manner in mice (189) and
the fly orthologue of this gene, Shal, was found to be degraded in a Drosophila
AD model (221). While Shal is not thought to be an RMP-setting channel,
investigation of this K+ channel in the context our tau-expressing flies may be
fruitful. Regardless of the K+ channel in question, proper trafficking of these
proteins may be compromised in tau-expressing neurons. Expression of the
particular isoform of human tau used in our model is known to destabilize
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microtubules in Drosophila (151, 222), which has been speculated to disrupt
microtubule-dependent trafficking of K+ channels that regulate excitability and
RMP (193). Thus, imaging of the microtubule network – a technique we are
proficient in as exhibited in Chapter 2 – in tau-expressing neurons would provide
insight into this plausible mechanism.
4.2.3 Exploring the Alternative Manifestations of Ca2+ Dyshomeostasis
While our lifespan studies in Chapter 3 suggest that endolysosomal Ca2+
loading is the primary determinant of increased mortality in neurodegenerative
models, a thorough investigation would include evaluation of other cellular
compartments, such as the cytosol. Indeed, our data suggest that depolarizationinduced augmentation of PLCβ-IP3R signaling can also lead to elevation of
cytosolic [Ca2+]. To complement this finding, analogous experiments in vapbP58Sand tau-expressing neurons would constitute the first step towards exploring this
experimental avenue. Obviously, a vast number of Ca2+-sensitive proteins are
localized to the neuronal cytosol, so experimental discretion would be required to
determine which proteins to investigate. The Ca2+-sensitive components of
MAMs, which IP3R activity undoubtedly influence, would be a logical starting
point (223).
A clear point of relevance to this discussion involves what we uncovered
in Chapter 2 concerning Ca2+ extrusion in vapbP58S-expressing neurons. In the
context of electrical stimulation or pharmacological release of ER Ca2+ stores,
expeditious removal of Ca2+ from the cytosol was compromised. Importantly, a
distinction should be made between these two experiments, which do not imply
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an increase in IP3-mediated Ca2+ release, and the hypothetical elevation in [Ca2+]
that might be seen in vapbP58S- or tau-expressing neurons upon stimulation of
PLCβ-IP3R signaling. Nevertheless, our results in Chapter 2 clearly demonstrate
that altered cytosolic [Ca2+] can produce meaningful and interesting phenotypes
(i.e., CaMKII-mediated disruption of NMJ morphology), even if these effects do
not result in early death.
4.2.4 Defining the Mechanism Underlying Endolysosomal Ca2+ Overload
Several lines of inquiry were opened after we implicated endolysosomal
Ca2+ in the early demise of flies characterized by augmented PLCβ-IP3R
signaling, including (1) the nature of TRPML-dependent Ca2+ uptake and (2) the
mechanism by which endolysosomal Ca2+ overload induces increased mortality.
Our results involving endolysosomal Ca2+ overload are intriguing, but raise just
as many questions as they answer, which will need to be addressed in multiple
future studies.
An appropriate starting point would include a survey of the lysosomal
compartment. As mentioned in Chapter 3, our findings could be partially
explained by the putative TRPML1-TFEB-calcineurin pathway, which upregulates
lysosomal biogenesis (213). An obvious follow-up study to interrogate this
hypothesis in our models would entail assessing the quantity, dimensions, and
distribution of lysosomes by staining for acidic vesicles in isolated neurons.
Furthermore, while the TFEB-dependent signaling axis has not been described in
Drosophila, the fly orthologue of the human TFEB gene, which is named mitf, has
been shown to upregulate lysosomal biogenesis (224). Preliminary studies
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conducted in our lab (not shown) have indicated that overexpression of mitf in
glutamatergic neurons shortens lifespan, but whether this phenotype is
recapitulating phenotypes observed in our models exhibiting augmented PLCβIP3R signaling remains to be verified. Thus, a series of lifespan assays
analogous to those conducted in Chapter 3 would provide another avenue to
evaluate this hypothesis. In addition, a validated mitf overexpression model that
recapitulates the phenotypes in flies characterized by PLCβ-IP3R signaling would
be an excellent model to unravel the pathogenicity of endolysosomal Ca2+
overload.
TRPML could also increase endolysosomal content by a less circuitous
mechanism. Multiple reports have established that IP3R selectively loads Ca2+
into lysosomes (199, 200). Analogous to the configuration of MAMs, IP3mediated Ca2+ delivery from the ER to lysosomes is enabled by contact sites,
which are supported by tethering complexes, between the organelles (200).
Thus, one possibility is that TRPML participates in maintenance of these contact
sites, which facilitate IP3-dependent endolysosomal Ca2+ loading. This role need
not include direct physical binding – a function thought to be mediated via other
proteins – since Ca2+ signals derived from endolysosomes have been shown to
regulate ER-endolysosomal contacts (200, 225). Indeed, in mammalian cells,
activation of two-pore channel (TPC) 1 and TPC 2, which are purported to be
endolysosomal Ca2+/Na+ channels, were found to promote the formation of ER
contacts with late endosomes and lysosomes, respectively (225).
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While intriguing, application of these findings to our future studies is
problematic. One issue revolves around the classification of TPCs as Ca2+
channels, given that direct lysosomal patch-clamp recordings have demonstrated
that TPCs are selective for Na+ and have limited Ca2+ permeability (226).
Furthermore, there are no identified orthologues in Drosophila of the genes
coding for mammalian TPCs. However, the former point may operate in our
favor, since the single trpml gene in flies may perform a similar function if an
analogous mechanism exists in Drosophila. To explore these concepts in
isolated primary neurons, coexpression of fluorescent markers of the ER and
endolysosomes could be employed to visualize changes in association between
these organelles upon pharmacologic inhibition or genetic knockdown of TRPML.
Given the granular nature of ER-endolysosomal contact sites, electron
microscopy may be required to definitively evaluate these structures.
ER-endolysosomal tethering may have further relevance to our findings. In
Chapter 3, we noted that knockdown of trpml did not result in a restoration of
endolysosomal Ca2+ content back to control levels. Interestingly, as in MAMs,
mammalian VAP proteins (VAPA and VAPB) have been shown to mediate
tethering between ER-endolysosomal contact sites (227, 228). As in other
instances, it is not known whether vapb plays a similar tethering role in flies.
Although speculative, perhaps the lack of Ca2+ overload rescue conferred by
trpml knockdown observed in vapbP58S-expressing neurons can be attributed to
this interaction. This seems somewhat unlikely given that lifespan was nearly
completely restored in the same genotype. To reconcile these putative
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discrepancies, the potential involvement of vapbP58S in ER-endolysosomal
contact sites warrants further inquiry.
A related aspect of ER-endolysosomal contact sites – namely, the
bidirectional Ca2+ signaling they facilitate (200, 229, 230) – may also pertain to
our findings and inform future studies. Intriguingly, in mammalian cells, TRPML1
activity has been shown to trigger IP3-mediated ER Ca2+ release in a type of
CICR (200, 230). Thus, in our models, knockdown of trpml may short-circuit this
type of signaling, preventing the accumulation of Ca2+ in the endolysosomal
compartment. Obviously, the complex Ca2+ signaling dynamics that govern this
bidirectional signaling would be laborious to tease apart in future studies, but
understanding the theoretical basis for such a mechanism is necessary before
beginning such an endeavor.
4.2.5 Interrogating the Influence of Depolarization on PM Components
Perhaps the most intriguing aspect of this dissertation is the idea that
changes in PM potential, specifically depolarization, can influence the
organization of anionic phospholipids in a manner that is consequential to cellular
signaling. While our findings both corroborate and elaborate upon previous work
(187), future studies are needed to both reinforce our results and deepen our
understanding of this unique phenomenon.
A straightforward experimental strategy to better characterize
depolarization-induced phospholipid reorganization would evaluate the
magnitude of change in signaling output at varying degrees of depolarization. For
example, by titrating the dose of ouabain or extracellular [K+] while activating
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PLCβ-IP3R signaling with invariant concentration of muscarine/histamine, a
response curve that quantifies the relationship between depolarization and IP3mediated Ca2+ release could be produced. Since our observations in Chapter 3
only addressed PLCβ-IP3R signaling under highly depolarizing conditions, these
experiments would provide insight into questions regarding the behavior of this
pathway in vivo. For instance, it may be the case that relatively small
depolarizations in RMP may still provoke physiologically relevant augmentation
of PLCβ-IP3R signaling.
Experiments to understand depolarization-induced phospholipid
reorganization itself represent a separate challenge. Given that PIP2 and PS, two
anionic phospholipids, are the only known lipids to exhibit this behavior (187),
clues may be found in their specific properties. For example, the particular
molecular arrangement or orientation of fatty acid tails and the accessibility of
head groups to hydrolysis may be of importance. Lipidomic analysis of cells
subjected to depolarization and PLCβ-IP3R signaling constitute an experimental
approach to this question (231). Additionally, the distribution of electric charge in
PIP2 may bestow the lipid with the ability to be manipulated by changes in
electrical potential across the PM. Given the emergent nature of depolarizationinduced phospholipid reorganization, the entire composition of the PM itself may
be of relevance in understanding this phenomenon. For example, what would be
the result of varying the relative abundance of particular species of phospholipid,
including those other than PS and PIP2? Obviously, many compositional
permutations of the PM could be explored in this context. Thus, to truly
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understand this biophysical phenomenon, the application of molecular dynamics
simulations is likely necessary (232).
4.2.6 Probing the Link Between Depolarization and Neuroenergetics
The ability of depolarization to potentiate PLCβ-IP3R signaling has unique
implications for neurons, which undergo frequent and rapid shifts in electrical
potential across their PM (42). We hypothesize that our results in Chapter 3,
which indicate that depolarization augments OXPHOS via PLCβ-IP3R signaling,
are not a quirk of experimental methodology, but instead represent a biologically
relevant neuronal adaptation. As explained in Chapter 1, the maintenance of
ionic gradients represents a major energetic cost in neurons, which is primarily
due to the ATP requirements of powering Na+/K+ ATPase (46, 47, 233).
Evolutionarily, it stands to reason that neurons would develop adaptations that
would allow them to tightly couple their energy demands with energy production.
Given the effect depolarization has on PLCβ-IP3R signaling, and the relevance
this pathway has to bioenergetics (74), we propose our findings represent such
an adaptation. Indeed, from a theoretical standpoint, it would be odd if the
evolutionary process to provide an advantage did not leverage such a
biophysical phenomenon.
Regardless of the merits of this theory, a large effort to contextualize these
results within the broader field of neuroenergetics is needed. That being said,
there is a fascinating diversity of perspectives in the literature with respect to
neuronal metabolism (52, 54, 57, 59, 174, 234). This may partially be a reflection
of the complexity of the strategies neurons must employ to manage the energetic
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requirements of unpredictable changes in activity. In other words, neurons may
preferentially utilize different metabolic pathways (e.g., OXPHOS or glycolysis),
in different subcellular regions (e.g., axonal termini or soma), during different
activity states (e.g., resting or action potential trains). This complexity is further
amplified by the vast diversity of neurons even within the same species. For
example, the metabolic configuration of a meter-long human motor neuron is
likely different than a typical neuron that is orders of magnitude smaller. All this is
to say, our future endeavors in this domain must cater to this complexity.
The results we obtained in fly primary glutamatergic neurons were
measured by recording mitochondrial [Ca2+] elevation and the ATP:ADP ratio in
the soma. An obvious next step would be to determine whether these finding are
conserved in mammalian neurons. To this end, the fact that depolarizationinduced augmentation of PLCβ-IP3R signaling is apparent in N2a cells is
encouraging. The evaluation of additional neuronal regions other than the soma
represents another interesting experimental avenue. We initially hypothesized
that, in the somatic regions, neurons might employ signaling strategies that
elevate levels of OXPHOS-promoting mitochondrial [Ca2+] while avoiding
unnecessary global increases in cytosolic [Ca2+]. Our findings support this
hypothesis, but they do not provide any information about other neuronal regions,
such as energetically intensive axonal termini, which may not require such an
arrangement given that considerable cytosolic [Ca2+] elevations are required for
SV release (52, 183). Although difficult to do in our current preparations of
isolated Drosophila primary neurons, which have minuscule axonal termini, we
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could perform in situ bioenergetic measurements of filleted larval NMJs to
overcome this barrier. Another way to explore this concept, using electron
microscopy, would entail quantifying the relative proportion of MAMs in different
regions of mature primary neurons, which should correlate with regions that
operate via our purported mechanism.
Another area of future interest concerns the relationship of our OXPHOScentric mechanism to glycolysis, which some argue is important not only in
axonal termini (174), but throughout all regions of the neuron (57). Our existing
results may offer insight into this subject. In Chapter 3, we did not observe a
decrease in the ATP:ADP ratio upon depolarization of the PM, which should
induce greater ATP consumption by Na+/K+ ATPase. This implies that the neuron
was able to compensate for the increased energetic demand without activation of
PLCβ-IP3R signaling. One explanation for this observation is that glycolysis is
immediately able to respond to this demand, an idea that has been suggested
previously (234). To be clear, a rapid glycolytic response does not preclude the
coexistence of an additional mechanism that must be transmitted to the
mitochondria via our purported pathway. Indeed, it is possible that overlapping
mechanisms exist that operate over different timescales.

4.3 Significance and Impact
There is a lack of effective therapies to treat neurodegenerative diseases,
which impose a large societal burden and are increasing globally (1, 13). This
dissertation represents a small contribution in the effort to overcome this
problem. The overarching theme of this dissertation is that mechanisms of
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neuronal Ca2+ dyshomeostasis represent a fundamental, and therapeutically
underexploited, aspect of neurodegeneration.
While the body of this work is mostly comprised of basic neurobiology
conducted in invertebrate models, the potential translational impact is farreaching. This is especially true of our findings in Chapter 3, which uncovers a
mechanism that links hyperexcitability and bioenergetic dysfunction – two
features of human neurodegenerative diseases – with pathogenic Ca2+
dyshomeostasis. That the toxic phenotypes observed in these studies could be
reversed by attenuation of certain kinds of Ca2+ signaling raises the exciting
possibility of efficacy in human diseases. Given that curative or diseasemodifying agents have been difficult to develop for neurodegeneration, the
rationale for pursing new therapeutic approaches has never been so clear.
In addition to the potentially actionable therapeutic targets this dissertation
highlights, this work also possesses significance with respect to our
understanding of fundamental neuronal cell biology. This includes a potentially
novel signaling modality mediated by changes in electric potential across the PM
and a new mechanism by which neurons may compensate for increased energy
usage. While the results presented here have outlined some of the features of
these mechanisms, much more remains to be uncovered, as indicated in my
future directions section. It is my hope that others will find this dissertation useful
in their own efforts to understand neurons and combat neurodegeneration.

134

References
1. Abbott, A. 2011. Dementia: A problem for our age. Nature 475.
2. Hebert, L. E., J. Weuve, P. A. Scherr, and D. A. Evans. 2013. Alzheimer
disease in the United States (2010-2050) estimated using the 2010 census.
Neurology 80: 1778–1783.
3. Lane, C. A., J. Hardy, and J. M. Schott. 2018. Alzheimer’s disease. Eur. J.
Neurol. 25: 59–70.
4. Qiu, C., M. Kivipelto, and E. Von Strauss. 2009. Epidemiology of Alzheimer’s
disease: Occurrence, determinants, and strategies toward intervention.
Dialogues Clin. Neurosci. 11: 111–128.
5. Poewe, W., K. Seppi, C. M. Tanner, G. M. Halliday, P. Brundin, J. Volkmann,
A. E. Schrag, and A. E. Lang. 2017. Parkinson disease. Nat. Rev. Dis. Prim. 3:
1–21.
6. Marras, C., J. C. Beck, J. H. Bower, E. Roberts, B. Ritz, G. W. Ross, R. D.
Abbott, R. Savica, S. K. Van Den Eeden, A. W. Willis, and C. Tanner. 2018.
Prevalence of Parkinson’s disease across North America. npj Park. Dis. 4: 21.
7. Arnaoutoglou, N. A., J. T. O’Brien, and B. R. Underwood. 2019. Dementia with
Lewy bodies — from scientific knowledge to clinical insights. Nat. Rev. Neurol.
15: 103–112.
8. Lillo, P., and J. R. Hodges. 2009. Frontotemporal dementia and motor neurone
disease: overlapping clinic-pathological disorders. J. Clin. Neurosci. 16: 1131–5.
9. Renton, A. E., E. Majounie, A. Waite, J. Simón-Sánchez, S. Rollinson, J. R.
Gibbs, J. C. Schymick, H. Laaksovirta, J. C. van Swieten, L. Myllykangas, H.

135

Kalimo, A. Paetau, Y. Abramzon, A. M. Remes, A. Kaganovich, S. W. Scholz, J.
Duckworth, J. Ding, D. W. Harmer, D. G. Hernandez, J. O. Johnson, K. Mok, M.
Ryten, D. Trabzuni, R. J. Guerreiro, R. W. Orrell, J. Neal, A. Murray, J. Pearson,
I. E. Jansen, D. Sondervan, H. Seelaar, D. Blake, K. Young, N. Halliwell, J. B.
Callister, G. Toulson, A. Richardson, A. Gerhard, J. Snowden, D. Mann, D.
Neary, M. A. Nalls, T. Peuralinna, L. Jansson, V. M. Isoviita, A. L. Kaivorinne, M.
Hölttä-Vuori, E. Ikonen, R. Sulkava, M. Benatar, J. Wuu, A. Chiò, G. Restagno,
G. Borghero, M. Sabatelli, D. Heckerman, E. Rogaeva, L. Zinman, J. D.
Rothstein, M. Sendtner, C. Drepper, E. E. Eichler, C. Alkan, Z. Abdullaev, S. D.
Pack, A. Dutra, E. Pak, J. Hardy, A. Singleton, N. M. Williams, P. Heutink, S.
Pickering-Brown, H. R. Morris, P. J. Tienari, and B. J. Traynor. 2011. A
hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome
9p21-linked ALS-FTD. Neuron 72: 257–268.
10. Ratnavalli, E., C. Brayne, K. Dawson, and J. R. Hodges. 2002. The
prevalence of frontotemporal dementia. Neurology 58: 1615–1621.
11. Rowland, L. P., and N. A. Shneider. 2001. Amyotrophic lateral sclerosis. N.
Engl. J. Med. 344: 1688–1700.
12. Mehta, P., W. Kaye, J. Raymond, R. Punjani, T. Larson, J. Cohen, O.
Muravov, and K. Horton. 2018. Prevalence of amyotrophic lateral sclerosis —
United States, 2015. Morb. Mortal. Wkly. Rep. 67: 1285–1289.
13. Durães, F., M. Pinto, and E. Sousa. 2018. Old drugs as new treatments for
neurodegenerative diseases. Pharmaceuticals 11.
14. Mehta, D., R. Jackson, G. Paul, J. Shi, and M. Sabbagh. 2017. Why do trials

136

for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for
2010-2015. Expert Opin. Investig. Drugs 26: 735–739.
15. Makin, S. 2018. The amyloid hypothesis on trial. Nature 559: S4–S7.
16. Cummings, J., G. Lee, A. Ritter, M. Sabbagh, and K. Zhong. 2019.
Alzheimer’s disease drug development pipeline: 2019. Alzheimer’s Dement.
Transl. Res. Clin. Interv. 5: 272–293.
17. Zhang, Q., Y. C. Kim, and N. S. Narayanan. 2015. Disease-modifying
therapeutic directions for lewy-body dementias. Front. Neurosci. 9.
18. Lee, G., J. Cummings, B. Decourt, J. B. Leverenz, and M. N. Sabbagh. 2019.
Clinical drug development for dementia with Lewy bodies: past and present.
Expert Opin. Investig. Drugs 28: 951–965.
19. Logroscino, G., B. P. Imbimbo, M. Lozupone, R. Sardone, R. Capozzo, P.
Battista, C. Zecca, V. Dibello, G. Giannelli, A. Bellomo, A. Greco, A. Daniele, D.
Seripa, and F. Panza. 2019. Promising therapies for the treatment of
frontotemporal dementia clinical phenotypes: from symptomatic to diseasemodifying drugs. Expert Opin. Pharmacother. 20: 1091–1107.
20. Tsai, R. M., and A. L. Boxer. 2016. Therapy and clinical trials in
frontotemporal dementia: past, present, and future. J. Neurochem. 138 Suppl 1:
211–221.
21. Gomperts, S. N. 2016. Lewy body dementias: Dementia with lewy bodies and
Parkinson disease dementia. Contin. Lifelong Learn. Neurol. 22: 435–463.
22. Kumar, A., A. Singh, and Ekavali. 2015. A review on Alzheimer’s disease
pathophysiology and its management: An update. Pharmacol. Reports 67: 195–

137

203.
23. Poewe, W., K. Seppi, C. M. Tanner, G. M. Halliday, P. Brundin, J. Volkmann,
A. E. Schrag, and A. E. Lang. 2017. Parkinson disease. Nat. Rev. Dis. Prim. 3:
1–21.
24. Mensah, G. A., G. S. Wei, P. D. Sorlie, L. J. Fine, Y. Rosenberg, P. G.
Kaufmann, M. E. Mussolino, L. L. Hsu, E. Addou, M. M. Engelgau, and D.
Gordon. 2017. Decline in Cardiovascular Mortality: Possible Causes and
Implications. Circ. Res. 120: 366–380.
25. Taylor, C. A., S. F. Greenlund, L. C. McGuire, H. Lu, and J. B. Croft. 2017.
Deaths from Alzheimer’s disease — United States, 1999-2014. Morb. Mortal.
Wkly. Rep. 66: 521–526.
26. Siegel, R. L., K. D. Miller, and A. Jemal. 2020. Cancer statistics, 2020. CA.
Cancer J. Clin. 70: 7–30.
27. Gammon, K. 2014. Neurodegenerative disease: brain windfall. Nature 515:
299–300.
28. Ramon Y Cajal, S. 1904. Textura del Sistema Nervioso del Hombre y de los
Vertebrados, tomo II, primera parte. Imprenta y Libr. Nicolas Moya, Madrid, Repr.
by Graf. Vidal Leuka, Alicant. 1992 399–402.
29. Garcia-Lopez, P., V. Garcia-Marin, and M. Freire. 2010. The histological
slides and drawings of Cajal. Front. Neuroanat. 4.
30. Koch, C., and I. Segev. 2000. The role of single neurons in information
processing. Nat. Neurosci. 3: 1171–1177.
31. Miura, R. M. 2002. Analysis of excitable cell models. J. Comput. Appl. Math.

138

144: 29–47.
32. Lodish, H., A. Berk, L. Zipursky, P. Matsudaira, D. Baltimore, and J. Darnell.
2000. The Action Potential and Conduction of Electric Impulses. In Molecular Cell
Biology, 4th ed. W. H. Freeman, New York.
33. Skou, J. C. 1957. The influence of some cations on an adenosine
triphosphatase from peripheral nerves. BBA - Biochim. Biophys. Acta 23: 394–
401.
34. Skou, J. C., and M. Esmann. 1992. The Na,K-ATPase. J. Bioenerg.
Biomembr. 24: 249–61.
35. Suhail, M. 2010. Na+, K+-ATPase: Ubiquitous Multifunctional
Transmembrane Protein and its Relevance to Various Pathophysiological
Conditions. J. Clin. Med. Res. 2: 1.
36. Hille, B., and W. A. Catterall. 1999. Electrically Excitable Cells. In Basic
Neurochemistry, 6th ed. G. J. Siegel, B. W. Agranoff, R. W. Albers, S. K. Fisher,
and M. D. Uhler, eds. Lippincott-Raven, Philadelphia.
37. Wright, S. H. 2004. Generation of resting membrane potential. Am. J.
Physiol. - Adv. Physiol. Educ. 28: 139–142.
38. Armstrong, C. M., and B. Hille. 1998. Voltage-gated ion channels and
electrical excitability. Neuron 20: 371–380.
39. Pereda, A. E. 2014. Electrical synapses and their functional interactions with
chemical synapses. Nat. Rev. Neurosci. 15: 250–263.
40. Cash, S., and R. Yuste. 1999. Linear summation of excitatory inputs by CA1
pyramidal neurons. Neuron 22: 383–394.

139

41. Rall, W. 1964. Theoretical significance of dendritic trees for neuronal inputoutput relations. Neural Theory Model. 73–97.
42. Hodgkin, A. L., and A. F. Huxley. 1952. A quantitative description of
membrane current and its application to conduction and excitation in nerve. J.
Physiol. 117: 500–544.
43. Bean, B. P. 2007. The action potential in mammalian central neurons. Nat.
Rev. Neurosci. 8: 451–465.
44. Bezanilla, F., and C. M. Armstrong. 1977. Inactivation of the sodium channel:
I. sodium current experiments. J. Gen. Physiol. 70: 549–566.
45. Shulman, R. G., D. L. Rothman, K. L. Behar, and F. Hyder. 2004. Energetic
basis of brain activity: Implications for neuroimaging. Trends Neurosci. 27: 489–
495.
46. Attwell, D., and S. B. Laughlin. 2001. An energy budget for signaling in the
grey matter of the brain. J. Cereb. Blood Flow Metab. 21: 1133–1145.
47. Harris, J. J., R. Jolivet, and D. Attwell. 2012. Synaptic Energy Use and
Supply. Neuron 75: 762–777.
48. Mink, J. W., R. J. Blumenschine, and D. B. Adams. 1981. Ratio of central
nervous system to body metabolism in vertebrates: Its constancy and functional
basis. Am. J. Physiol. - Regul. Integr. Comp. Physiol. 10: 203–212.
49. Carafoli, E., and M. Brini. 2000. Calcium pumps: Structural basis for and
mechanism of calcium transmembrane transport. Curr. Opin. Chem. Biol. 4: 152–
161.
50. Fergestad, T., B. Bostwick, and B. Ganetzky. 2006. Metabolic disruption in

140

drosophila bang-sensitive seizure mutants. Genetics 173: 1357–1364.
51. Bagur, R., and G. Hajnóczky. 2017. Intracellular Ca2+ Sensing: Its Role in
Calcium Homeostasis and Signaling. Mol. Cell 66: 780–788.
52. Ashrafi, G., J. de Juan-Sanz, R. J. Farrell, and T. A. Ryan. 2020. Molecular
Tuning of the Axonal Mitochondrial Ca2+ Uniporter Ensures Metabolic Flexibility
of Neurotransmission. Neuron 105: 678-687.e5.
53. Schönfeld, P., and G. Reiser. 2013. Why does brain metabolism not favor
burning of fatty acids to provide energy-Reflections on disadvantages of the use
of free fatty acids as fuel for brain. J. Cereb. Blood Flow Metab. 33: 1493–1499.
54. Bélanger, M., I. Allaman, and P. J. Magistretti. 2011. Brain energy
metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 14:
724–38.
55. Pellerin, L., A. K. Bouzier-Sore, A. Aubert, S. Serres, M. Merle, R. Costalat,
and P. J. Magistretti. 2007. Activity-dependent regulation of energy metabolism
by astrocytes: An update. Glia 55: 1251–1262.
56. Volkenhoff, A., A. Weiler, M. Letzel, M. Stehling, C. Klämbt, and S.
Schirmeier. 2015. Glial glycolysis is essential for neuronal survival in drosophila.
Cell Metab. 22: 437–447.
57. Díaz-García, C. M., R. Mongeon, C. Lahmann, D. Koveal, H. Zucker, and G.
Yellen. 2017. Neuronal Stimulation Triggers Neuronal Glycolysis and Not Lactate
Uptake. Cell Metab. 26: 361-374.e4.
58. Hall, C. N., M. C. Klein-Flügge, C. Howarth, and D. Attwell. 2012. Oxidative
phosphorylation, not glycolysis, powers presynaptic and postsynaptic

141

mechanisms underlying brain information processing. J. Neurosci. 32: 8940–
8951.
59. Yellen, G. 2018. Fueling thought: Management of glycolysis and oxidative
phosphorylation in neuronal metabolism. J. Cell Biol. 217: 2235–2246.
60. Breuer, M. E., W. J. Koopman, S. Koene, M. Nooteboom, R. J. Rodenburg,
P. H. Willems, and J. A. M. Smeitink. 2013. The role of mitochondrial OXPHOS
dysfunction in the development of neurologic diseases. Neurobiol. Dis. 51: 27–
34.
61. Denton, R. M. 2009. Regulation of mitochondrial dehydrogenases by calcium
ions. Biochim. Biophys. Acta - Bioenerg. 1787: 1309–1316.
62. McCormack, J. G., and R. M. Denton. 1989. The role of Ca2+ ions in the
regulation of intramitochondrial metabolism and energy production in rat heart.
Mol. Cell. Biochem. 89: 121–125.
63. Duchen, M. R. 1992. Ca2+-dependent changes in the mitochondrial
energetics in single dissociated mouse sensory neurons. Biochem. J. 283: 41–
50.
64. Karagas, N. E., and K. Venkatachalam. 2019. Roles for the Endoplasmic
Reticulum in Regulation of Neuronal Calcium Homeostasis. Cells 8: 1232.
65. Tarasov, A. I., E. J. Griffiths, and G. A. Rutter. 2012. Regulation of ATP
production by mitochondrial Ca2+. Cell Calcium 52: 28–35.
66. Boerries, M., P. Most, J. R. Gledhill, J. E. Walker, H. A. Katus, W. J. Koch, U.
Aebi, and C.-A. Schoenenberger. 2007. Ca2+-Dependent Interaction of S100A1
with F1-ATPase Leads to an Increased ATP Content in Cardiomyocytes. Mol.

142

Cell. Biol. 27: 4365–4373.
67. Marchi, S., and P. Pinton. 2014. The mitochondrial calcium uniporter
complex: Molecular components, structure and physiopathological implications.
J. Physiol. 592: 829–839.
68. Rizzuto, R., P. Pinton, W. Carrington, F. S. Fay, K. E. Fogarty, L. M. Lifshitz,
R. A. Tuft, and T. Pozzan. 1998. Close contacts with the endoplasmic reticulum
as determinants of mitochondrial Ca2+ responses. Science (80-. ). 280: 1763–
1766.
69. Grimm, S. 2012. The ER-mitochondria interface: the social network of cell
death. Biochim. Biophys. Acta 1823: 327–34.
70. Rizzuto, R., M. Brini, M. Murgia, and T. Pozzan. 1993. Microdomains with
high Ca2+ close to IP3-sensitive channels that are sensed by neighboring
mitochondria. Science (80-. ). 262: 744–747.
71. Szabadkai, G., K. Bianchi, P. Várnai, D. De Stefani, M. R. Wieckowski, D.
Cavagna, A. I. Nagy, T. Balla, and R. Rizzuto. 2006. Chaperone-mediated
coupling of endoplasmic reticulum and mitochondrial Ca2+ channels. J. Cell Biol.
175: 901–11.
72. Wu, S., Q. Lu, Q. Wang, Y. Ding, Z. Ma, X. Mao, K. Huang, Z. Xie, and M. H.
Zou. 2017. Binding of FUN14 Domain Containing 1 with Inositol 1,4,5Trisphosphate Receptor in Mitochondria-Associated Endoplasmic Reticulum
Membranes Maintains Mitochondrial Dynamics and Function in Hearts in Vivo.
Circulation 136: 2248–2266.
73. Hayashi, T., and T. P. Su. 2007. Sigma-1 Receptor Chaperones at the ER-

143

Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival. Cell 131:
596–610.
74. Cárdenas, C., R. A. Miller, I. Smith, T. Bui, J. Molgó, M. Müller, H. Vais, K. H.
Cheung, J. Yang, I. Parker, C. B. Thompson, M. J. Birnbaum, K. R. Hallows, and
J. K. Foskett. 2010. Essential Regulation of Cell Bioenergetics by Constitutive
InsP3 Receptor Ca2+ Transfer to Mitochondria. Cell 142: 270–283.
75. Wiel, C., H. Lallet-Daher, D. Gitenay, B. Gras, B. Le Calvé, A. Augert, M.
Ferrand, N. Prevarskaya, H. Simonnet, D. Vindrieux, and D. Bernard. 2014.
Endoplasmic reticulum calcium release through ITPR2 channels leads to
mitochondrial calcium accumulation and senescence. Nat. Commun. 5: 3792.
76. Decuypere, J. P., G. Monaco, G. Bultynck, L. Missiaen, H. De Smedt, and J.
B. Parys. 2011. The IP3 receptor-mitochondria connection in apoptosis and
autophagy. Biochim. Biophys. Acta - Mol. Cell Res. 1813: 1003–1013.
77. Deb, P., S. Sharma, and K. M. Hassan. 2010. Pathophysiologic mechanisms
of acute ischemic stroke: An overview with emphasis on therapeutic significance
beyond thrombolysis. Pathophysiology 17: 197–218.
78. Schon, E. A., and G. Manfredi. 2003. Neuronal degeneration and
mitochondrial dysfunction. J. Clin. Invest. 111: 303–312.
79. Beal, M. F. 1998. Mitochondrial dysfunction in neurodegenerative diseases.
Biochim. Biophys. Acta - Bioenerg. 1366: 211–223.
80. Wang, Y., E. Xu, P. R. Musich, and F. Lin. 2019. Mitochondrial dysfunction in
neurodegenerative diseases and the potential countermeasure. CNS Neurosci.
Ther. 25: 816–824.

144

81. Brini, M., T. Calì, D. Ottolini, and E. Carafoli. 2014. Neuronal calcium
signaling: Function and dysfunction. Cell. Mol. Life Sci. 71: 2787–2814.
82. Raffaello, A., C. Mammucari, G. Gherardi, and R. Rizzuto. 2016. Calcium at
the Center of Cell Signaling: Interplay between Endoplasmic Reticulum,
Mitochondria, and Lysosomes. Trends Biochem. Sci. 41: 1035–1049.
83. Berridge, M. J. 1998. Neuronal calcium signaling. Neuron 21: 13–26.
84. Dominguez, D. C. 2004. Calcium signalling in bacteria. Mol. Microbiol. 54:
291–297.
85. Nishiyama, J., and R. Yasuda. 2015. Biochemical Computation for Spine
Structural Plasticity. Neuron 87: 63–75.
86. Lisman, J., R. Yasuda, and S. Raghavachari. 2012. Mechanisms of CaMKII
action in long-term potentiation. Nat. Rev. Neurosci. 13: 169–182.
87. Neher, E., and T. Sakaba. 2008. Multiple Roles of Calcium Ions in the
Regulation of Neurotransmitter Release. Neuron 59: 861–872.
88. Catterall, W. A. 2000. Structure and Regulation of Voltage-Gated Ca 2+
Channels . Annu. Rev. Cell Dev. Biol. 16: 521–555.
89. Ramakrishnan, N. A., M. J. Drescher, and D. G. Drescher. 2012. The SNARE
complex in neuronal and sensory cells. Mol. Cell. Neurosci. 50: 58–69.
90. Südhof, T. C. 2012. The presynaptic active zone. Neuron 75: 11–25.
91. Berridge, M. J. 2016. The Inositol Trisphosphate/Calcium Signaling Pathway
in Health and Disease. Physiol. Rev. 96: 1261–96.
92. Pawelczyk, T., and A. Matecki. 1998. Localization of phospholipase C δ3 in
the cell and regulation of its activity by phospholipids and calcium. Eur. J.

145

Biochem. 257: 169–177.
93. Litosch, I. 2016. Decoding Gαq signaling. Life Sci. 152: 99–106.
94. Kang, D. S., Y. R. Yang, C. Lee, S. B. Kim, S. H. Ryu, and P. G. Suh. 2016.
Roles of phosphoinositide-specific phospholipase Cγ1 in brain development.
Adv. Biol. Regul. 60: 167–173.
95. Lanner, J. T., D. K. Georgiou, A. D. Joshi, and S. L. Hamilton. 2010.
Ryanodine receptors: structure, expression, molecular details, and function in
calcium release. Cold Spring Harb. Perspect. Biol. 2.
96. Kato, B. M., and E. W. Rubel. 1999. Glutamate Regulates IP 3 -Type and
CICR Stores in the Avian Cochlear Nucleus. J. Neurophysiol. 81: 1587–1596.
97. Keizer, J., and L. Levine. 1996. Ryanodine receptor adaptation and Ca2+()induced Ca2+ release-dependent Ca2+ oscillations. Biophys. J. 71: 3477–3487.
98. Zahradník, I., S. Györke, and A. Zahradníková. 2005. Calcium Activation of
Ryanodine Receptor Channels—Reconciling RyR Gating Models with Tetrameric
Channel Structure. J. Gen. Physiol. 126: 515.
99. Politi, A., L. D. Gaspers, A. P. Thomas, and T. Höfer. 2006. Models of IP3
and Ca2+ oscillations: frequency encoding and identification of underlying
feedbacks. Biophys. J. 90: 3120–33.
100. Hogan, P. G., and A. Rao. 2015. Store-operated calcium entry: Mechanisms
and modulation. Biochem. Biophys. Res. Commun. 460: 40–49.
101. Berridge, M. J. 2010. Calcium hypothesis of Alzheimer’s disease. Pflügers
Arch. - Eur. J. Physiol. 459: 441–449.
102. Lopez, J. R., A. Lyckman, S. Oddo, F. M. LaFerla, H. W. Querfurth, and A.

146

Shtifman. 2008. Increased intraneuronal resting [Ca2+] in adult Alzheimer’s
disease mice. J. Neurochem. 105: 262–271.
103. Kuchibhotla, K. V., S. T. Goldman, C. R. Lattarulo, H. Y. Wu, B. T. Hyman,
and B. J. Bacskai. 2008. Aβ Plaques Lead to Aberrant Regulation of Calcium
Homeostasis In Vivo Resulting in Structural and Functional Disruption of
Neuronal Networks. Neuron 59: 214–225.
104. Mattson, M. P., B. Cheng, D. Davis, K. Bryant, I. Lieberburg, and R. E.
Rydel. 1992. β-Amyloid peptides destabilize calcium homeostasis and render
human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12: 376–389.
105. Kagan, B. L., Y. Hirakura, R. Azimov, R. Azimova, and M. C. Lin. 2002. The
channel hypothesis of Alzheimer’s disease: Current status. Peptides 23: 1311–
1315.
106. Price, S. A., B. Held, and H. A. Pearson. 1998. Amyloid beta protein
increases Ca2+ currents in rat cerebellar granule neurones. Neuroreport 9: 539–
45.
107. LaFerla, F. M. 2002. Calcium dyshomeostasis and intracellular signalling in
alzheimer’s disease. Nat. Rev. Neurosci. 3: 862–872.
108. Tu, H., O. Nelson, A. Bezprozvanny, Z. Wang, S. F. Lee, Y. H. Hao, L.
Serneels, B. De Strooper, G. Yu, and I. Bezprozvanny. 2006. Presenilins Form
ER Ca2+ Leak Channels, a Function Disrupted by Familial Alzheimer’s DiseaseLinked Mutations. Cell 126: 981–993.
109. Chan, S. L., M. Mayne, C. P. Holden, J. D. Geiger, and M. P. Mattson.
2000. Presenilin-1 mutations increase levels of ryanodine receptors and calcium

147

release in PC12 cells and cortical neurons. J. Biol. Chem. 275: 18195–18200.
110. Leissring, M. A., I. Parker, and F. M. LaFerla. 1999. Presenilin-2 mutations
modulate amplitude and kinetics of inositol 1,4,5-trisphosphate-mediated calcium
signals. J. Biol. Chem. 274: 32535–32538.
111. Guo, Q., K. Furukawa, B. L. Sopher, D. G. Pham, J. Xie, N. Robinson, G. M.
Martin, and M. P. Mattson. 1997. Alzheimer’s PS-1 mutation perturbs calcium
homeostasis and sensitizes PC12 cells to death induced by amyloid β-peptide.
Neuroreport 8: 379–383.
112. Lee, S. Y., D. Y. Hwang, Y. K. Kim, J. W. Lee, I. C. Shin, K. W. Oh, M. K.
Lee, J. S. Lim, D. Y. Yoon, S. J. Hwang, and J. T. Hong. 2006. PS2 mutation
increases neuronal cell vulnerability to neurotoxicants through activation of
caspase-3 by enhancing of ryanodine receptor-mediated calcium release.
FASEB J. 20: 151–3.
113. Brunello, L., E. Zampese, C. Florean, T. Pozzan, P. Pizzo, and C. Fasolato.
2009. Presenilin-2 dampens intracellular Ca 2+ stores by increasing Ca 2+
leakage and reducing Ca 2+ uptake. J. Cell. Mol. Med. 13: 3358–3369.
114. Green, K. N., A. Demuro, Y. Akbari, B. D. Hitt, I. F. Smith, I. Parker, and F.
M. LaFerla. 2008. SERCA pump activity is physiologically regulated by presenilin
and regulates amyloid β production. J. Cell Biol. 181: 1107–1116.
115. Zampese, E., C. Fasolato, M. J. Kipanyula, M. Bortolozzi, T. Pozzan, and P.
Pizzo. 2011. Presenilin 2 modulates endoplasmic reticulum (ER)-mitochondria
interactions and Ca2+ cross-talk. Proc. Natl. Acad. Sci. 108: 2777–2782.
116. Hedskog, L., C. M. Pinho, R. Filadi, A. Rönnbäck, L. Hertwig, B. Wiehager,

148

P. Larssen, S. Gellhaar, A. Sandebring, M. Westerlund, C. Graff, B. Winblad, D.
Galter, H. Behbahani, P. Pizzo, E. Glaser, and M. Ankarcrona. 2013. Modulation
of the endoplasmic reticulum-mitochondria interface in Alzheimer’s disease and
related models. Proc. Natl. Acad. Sci. U. S. A. 110: 7916–7921.
117. Beal, M. F. 2005. Mitochondria take center stage in aging and
neurodegeneration. Ann. Neurol. 58: 495–505.
118. Exner, N., A. K. Lutz, C. Haass, and K. F. Winklhofer. 2012. Mitochondrial
dysfunction in Parkinson′s disease: Molecular mechanisms and
pathophysiological consequences. EMBO J. 31: 3038–3062.
119. Paillusson, S., P. Gomez-Suaga, R. Stoica, D. Little, P. Gissen, M. J.
Devine, W. Noble, D. P. Hanger, and C. C. J. Miller. 2017. α-Synuclein binds to
the ER–mitochondria tethering protein VAPB to disrupt Ca2+ homeostasis and
mitochondrial ATP production. Acta Neuropathol. 134: 129–149.
120. Gómez-Suaga, P., J. M. Bravo-San Pedro, R. A. González-Polo, J. M.
Fuentes, and M. Niso-Santano. 2018. ER-mitochondria signaling in Parkinson’s
disease review-article. Cell Death Dis. 9.
121. Ottolini, D., T. Calì, A. Negro, and M. Brini. 2013. The Parkinson diseaserelated protein DJ-1 counteracts mitochondrial impairment induced by the tumour
suppressor protein p53 by enhancing endoplasmic reticulum-mitochondria
tethering. Hum. Mol. Genet. 22: 2152–68.
122. Calì, T., D. Ottolini, A. Negro, and M. Brini. 2012. α-synuclein controls
mitochondrial calcium homeostasis by enhancing endoplasmic reticulummitochondria interactions. J. Biol. Chem. 287: 17914–17929.

149

123. Stoica, R., K. J. De Vos, S. Paillusson, S. Mueller, R. M. Sancho, K. F. Lau,
G. Vizcay-Barrena, W. L. Lin, Y. F. Xu, J. Lewis, D. W. Dickson, L. Petrucelli, J.
C. Mitchell, C. E. Shaw, and C. C. J. Miller. 2014. ER-mitochondria associations
are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTDassociated TDP-43. Nat. Commun. 5: 3996.
124. Stoica, R., S. Paillusson, P. Gomez‐Suaga, J. C. Mitchell, D. H. Lau, E. H.
Gray, R. M. Sancho, G. Vizcay‐Barrena, K. J. De Vos, C. E. Shaw, D. P. Hanger,
W. Noble, and C. C. Miller. 2016. ALS / FTD ‐associated FUS activates GSK ‐3β
to disrupt the VAPB – PTPIP 51 interaction and ER –mitochondria associations .
EMBO Rep. 17: 1326–1342.
125. Smith, E. F., P. J. Shaw, and K. J. De Vos. 2019. The role of mitochondria
in amyotrophic lateral sclerosis. Neurosci. Lett. 710: 132933.
126. Anagnostou, G., M. T. Akbar, P. Paul, C. Angelinetta, T. J. Steiner, and J.
de Belleroche. 2010. Vesicle associated membrane protein B (VAPB) is
decreased in ALS spinal cord. Neurobiol. Aging 31: 969–985.
127. Nguyen, L., B. P. Lucke-Wolds, S. Mookerjee, N. Kaushal, and R. R.
Matsumoto. 2017. Sigma-1 Receptors and Neurodegenerative Diseases:
Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration
and Neuroprotection. Adv. Exp. Med. Biol. 964: 133.
128. Dafinca, R., J. Scaber, N. Ababneh, T. Lalic, G. Weir, H. Christian, J.
Vowles, A. G. L. Douglas, A. Fletcher-Jones, C. Browne, M. Nakanishi, M. R.
Turner, R. Wade-Martins, S. A. Cowley, and K. Talbot. 2016. C9orf72

150

Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum
Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem
Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and
Frontotemporal Demen. Stem Cells 34: 2063–2078.
129. Jennings, B. H. 2011. Drosophila-a versatile model in biology & medicine.
Mater. Today 14: 190–195.
130. Morgan, T. H. 1910. Sex limited inheritance in drosophila. Science (80-. ).
32: 120–122.
131. Bellen, H. J., C. Tong, and H. Tsuda. 2010. 100 years of Drosophila
research and its impact on vertebrate neuroscience: A history lesson for the
future. Nat. Rev. Neurosci. 11: 514–522.
132. Pandey, U. B., and C. D. Nichols. 2011. Human disease models in
drosophila melanogaster and the role of the fly in therapeutic drug discovery.
Pharmacol. Rev. 63: 411–436.
133. McGurk, L., A. Berson, and N. M. Bonini. 2015. Drosophila as an in vivo
model for human neurodegenerative disease. Genetics 201: 377–402.
134. Brand, A. H., and N. Perrimon. 1993. Targeted gene expression as a means
of altering cell fates and generating dominant phenotypes. Development 118:
401–415.
135. Caygill, E. E., and A. H. Brand. 2016. The GAL4 system: A versatile system
for the manipulation and analysis of gene expression. In Methods in Molecular
Biology vol. 1478. Humana Press Inc. 33–52.
136. Mahr, A., and H. Aberle. 2006. The expression pattern of the Drosophila

151

vesicular glutamate transporter: A marker protein for motoneurons and
glutamatergic centers in the brain. Gene Expr. Patterns 6: 299–309.
137. Sanyal, S. 2009. Genomic mapping and expression patterns of C380, OK6
and D42 enhancer trap lines in the larval nervous system of Drosophila. Gene
Expr. Patterns 9: 371–380.
138. Reiter, L. T., L. Potocki, S. Chien, M. Gribskov, and E. Bier. 2001. A
systematic analysis of human disease-associated gene sequences in Drosophila
melanogaster. Genome Res. 11: 1114–1125.
139. Pertea, M., and S. L. Salzberg. 2010. Between a chicken and a grape:
Estimating the number of human genes. Genome Biol. 11: 1–7.
140. Adams, M. D., S. E. Celniker, R. A. Holt, C. A. Evans, J. D. Gocayne, P. G.
Amanatides, S. E. Scherer, P. W. Li, R. A. Hoskins, R. F. Galle, R. A. George, S.
E. Lewis, S. Richards, M. Ashburner, S. N. Henderson, G. G. Sutton, J. R.
Wortman, M. D. Yandell, Q. Zhang, L. X. Chen, R. C. Brandon, Y. H. C. Rogers,
R. G. Blazej, M. Champe, B. D. Pfeiffer, K. H. Wan, C. Doyle, E. G. Baxter, G.
Helt, C. R. Nelson, G. L. Gabor Miklos, J. F. Abril, A. Agbayani, H. J. An, C.
Andrews-Pfannkoch, D. Baldwin, R. M. Ballew, A. Basu, J. Baxendale, L.
Bayraktaroglu, E. M. Beasley, K. Y. Beeson, P. V. Benos, B. P. Berman, D.
Bhandari, S. Bolshakov, D. Borkova, M. R. Botchan, J. Bouck, P. Brokstein, P.
Brottier, K. C. Burtis, D. A. Busam, H. Butler, E. Cadieu, A. Center, I. Chandra, J.
Michael Cherry, S. Cawley, C. Dahlke, L. B. Davenport, P. Davies, B. de Pablos,
A. Delcher, Z. Deng, A. Deslattes Mays, I. Dew, S. M. Dietz, K. Dodson, L. E.
Doup, M. Downes, S. Dugan-Rocha, B. C. Dunkov, P. Dunn, K. J. Durbin, C. C.

152

Evangelista, C. Ferraz, S. Ferriera, W. Fleischmann, C. Fosler, A. E. Gabrielian,
N. S. Garg, W. M. Gelbart, K. Glasser, A. Glodek, F. Gong, J. Harley Gorrell, Z.
Gu, P. Guan, M. Harris, N. L. Harris, D. Harvey, T. J. Heiman, J. R. Hernandez,
J. Houck, D. Hostin, K. A. Houston, T. J. Howland, M. H. Wei, C. Ibegwam, M.
Jalali, F. Kalush, G. H. Karpen, Z. Ke, J. A. Kennison, K. A. Ketchum, B. E.
Kimmel, C. D. Kodira, C. Kraft, S. Kravitz, D. Kulp, Z. Lai, P. Lasko, Y. Lei, A. A.
Levitsky, J. Li, Z. Li, Y. Liang, X. Lin, X. Liu, B. Mattei, T. C. McIntosh, M. P.
McLeod, D. McPherson, G. Merkulov, N. V. Milshina, C. Mobarry, J. Morris, A.
Moshrefi, S. M. Mount, M. Moy, B. Murphy, L. Murphy, D. M. Muzny, D. L.
Nelson, D. R. Nelson, K. A. Nelson, K. Nixon, D. R. Nusskern, J. M. Pacleb, M.
Palazzolo, G. S. Pittman, S. Pan, J. Pollard, V. Puri, M. G. Reese, K. Reinert, K.
Remington, R. D. C. Saunders, F. Scheeler, H. Shen, B. Christopher Shue, I.
Siden-Kiamos, M. Simpson, M. P. Skupski, T. Smith, E. Spier, A. C. Spradling,
M. Stapleton, R. Strong, E. Sun, R. Svirskas, C. Tector, R. Turner, E. Venter, A.
H. Wang, X. Wang, Z. Y. Wang, D. A. Wassarman, G. M. Weinstock, J.
Weissenbach, S. M. Williams, T. Woodage, K. C. Worley, D. Wu, S. Yang, Q.
Alison Yao, J. Ye, R. F. Yeh, J. S. Zaveri, M. Zhan, G. Zhang, Q. Zhao, L. Zheng,
X. H. Zheng, F. N. Zhong, W. Zhong, X. Zhou, S. Zhu, X. Zhu, H. O. Smith, R. A.
Gibbs, E. W. Myers, G. M. Rubin, and J. Craig Venter. 2000. The genome
sequence of Drosophila melanogaster. Science (80-. ). 287: 2185–2195.
141. Hirth, F. 2012. Drosophila melanogaster in the Study of Human
Neurodegeneration. CNS Neurol. Disord. - Drug Targets 9: 504–523.
142. Davie, K., J. Janssens, D. Koldere, M. De Waegeneer, U. Pech, Ł. Kreft, S.

153

Aibar, S. Makhzami, V. Christiaens, C. Bravo González-Blas, S. Poovathingal, G.
Hulselmans, K. I. Spanier, T. Moerman, B. Vanspauwen, S. Geurs, T. Voet, J.
Lammertyn, B. Thienpont, S. Liu, N. Konstantinides, M. Fiers, P. Verstreken, and
S. Aerts. 2018. A Single-Cell Transcriptome Atlas of the Aging Drosophila Brain.
Cell 174: 982-998.e20.
143. Sanes, J. R., and S. L. Zipursky. 2010. Design Principles of Insect and
Vertebrate Visual Systems. Neuron 66: 15–36.
144. Kremer, M. C., C. Jung, S. Batelli, G. M. Rubin, and U. Gaul. 2017. The glia
of the adult Drosophila nervous system. Glia 65: 606–638.
145. Stork, T., D. Engelen, A. Krudewig, M. Silies, R. J. Bainton, and C. Klämbt.
2008. Organization and function of the blood-brain barrier in Drosophila. J.
Neurosci. 28: 587–597.
146. Olsson, T., H. A. MacMillan, N. Nyberg, D. Staerk, A. Malmendal, and J.
Overgaard. 2016. Hemolymph metabolites and osmolality are tightly linked to
cold tolerance of Drosophila species: A comparative study. J. Exp. Biol. 219:
2504–2513.
147. Limmer, S., A. Weiler, A. Volkenhoff, F. Babatz, and C. Klämbt. 2014. The
drosophila blood-brain barrier: Development and function of a glial endothelium.
Front. Neurosci. 8.
148. Jeon, Y., J. H. Lee, B. Choi, S. Y. Won, and K. S. Cho. 2020. Genetic
dissection of Alzheimer’s disease using Drosophila models. Int. J. Mol. Sci. 21.
149. Prüßing, K., A. Voigt, and J. B. Schulz. 2013. Drosophila melanogaster as a
model organism for Alzheimer’s disease. Mol. Neurodegener. 8: 35.

154

150. Sun, M., and L. Chen. 2015. Studying tauopathies in Drosophila: A fruitful
model. Exp. Neurol. 274: 52–57.
151. Gistelinck, M., J.-C. Lambert, P. Callaerts, B. Dermaut, and P. Dourlen.
2012. Drosophila models of tauopathies: what have we learned? Int. J.
Alzheimers. Dis. 2012: 970980.
152. Trilico, M. L. C., P. J. Lorenzoni, C. S. K. Kay, R. D. P. Ducci, O. J. H.
Fustes, L. C. Werneck, and R. H. Scola. 2020. Characterization of the
amyotrophic lateral sclerosis-linked P56S mutation of the VAPB gene in
Southern Brazil. Amyotroph. Lateral Scler. Front. Degener. 1–5.
153. Nishimura, A. L., M. Mitne-Neto, H. C. A. Silva, A. Richieri-Costa, S.
Middleton, D. Cascio, F. Kok, J. R. M. Oliveira, T. Gillingwater, J. Webb, P.
Skehel, and M. Zatz. 2004. A mutation in the vesicle-trafficking protein VAPB
causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am.
J. Hum. Genet. 75: 822–831.
154. Nishimura, A. L., A. Al-Chalabi, and M. Zatz. 2005. A common founder for
amyotrophic lateral sclerosis type 8 (ALS8) in the Brazilian population. Hum.
Genet. 118: 499–500.
155. Chai, A., J. Withers, Y. H. Koh, K. Parry, H. Bao, B. Zhang, V. Budnik, and
G. Pennetta. 2008. hVAPB, the causative gene of a heterogeneous group of
motor neuron diseases in humans, is functionally interchangeable with its
Drosophila homologue DVAP-33A at the neuromuscular junction. Hum. Mol.
Genet. 17: 266–80.
156. Menon, K. P., R. A. Carrillo, and K. Zinn. 2013. Development and plasticity

155

of the Drosophila larval neuromuscular junction. Wiley Interdiscip. Rev. Dev. Biol.
2: 647–670.
157. Brent, J., K. Werner, and B. D. McCabe. 2009. Drosophila larval NMJ
immunohistochemistry. J. Vis. Exp. .
158. Wong, C.-O., K. Chen, Y. Q. Lin, Y. Chao, L. Duraine, Z. Lu, W. H. Yoon, J.
M. Sullivan, G. T. Broadhead, C. J. Sumner, T. E. Lloyd, G. T. Macleod, H. J.
Bellen, and K. Venkatachalam. 2014. A TRPV channel in Drosophila motor
neurons regulates presynaptic resting Ca2+ levels, synapse growth, and synaptic
transmission. Neuron 84: 764–77.
159. Kapitein, L. C., and C. C. Hoogenraad. 2015. Building the Neuronal
Microtubule Cytoskeleton. Neuron 87: 492–506.
160. Pennetta, G., P. R. Hiesinger, R. Fabian-Fine, I. A. Meinertzhagen, and H.
J. Bellen. 2002. Drosophila VAP-33A directs bouton formation at neuromuscular
junctions in a dosage-dependent manner. Neuron 35: 291–306.
161. Ratnaparkhi, A., G. M. Lawless, F. E. Schweizer, P. Golshani, and G. R.
Jackson. 2008. A Drosophila model of ALS: Human ALS-associated mutation in
VAP33A suggests a dominant negative mechanism. PLoS One 3: e2334.
162. Tsuda, H., S. M. Han, Y. Yang, C. Tong, Y. Q. Lin, K. Mohan, C. Haueter, A.
Zoghbi, Y. Harati, J. Kwan, M. A. Miller, and H. J. Bellen. 2008. The Amyotrophic
Lateral Sclerosis 8 Protein VAPB Is Cleaved, Secreted, and Acts as a Ligand for
Eph Receptors. Cell 133: 963–977.
163. Wong, C.-O., K. Chen, Y. Q. Lin, Y. Chao, L. Duraine, Z. Lu, W. H. Yoon, J.
M. Sullivan, G. T. Broadhead, C. J. Sumner, T. E. Lloyd, G. T. Macleod, H. J.

156

Bellen, and K. Venkatachalam. 2014. A TRPV channel in Drosophila motor
neurons regulates presynaptic resting Ca2+ levels, synapse growth, and synaptic
transmission. Neuron 84: 764–77.
164. Lytton, J., M. Westlin, and M. R. Hanley. 1991. Thapsigargin inhibits the
sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. J.
Biol. Chem. 266: 17067–17071.
165. Hummel, T., K. Krukkert, J. Roos, G. Davis, and C. Klämbt. 2000.
Drosophila Futsch/22C10 is a MAP1B-like protein required for dendritic and
axonal development. Neuron 26: 357–370.
166. Mcvicker, D. P., M. M. Millette, and E. W. Dent. 2015. Signaling to the
microtubule cytoskeleton: An unconventional role for CaMKII. Dev. Neurobiol. 75:
423–434.
167. Joiner MlA, and L. C. Griffith. 1997. CaM kinase II and visual input modulate
memory formation in the neuronal circuit controlling courtship conditioning. J.
Neurosci. 17: 9384–91.
168. Saucerman, J. J., and D. M. Bers. 2008. Calmodulin mediates differential
sensitivity of CaMKII and calcineurin to local Ca2+ in cardiac myocytes. Biophys.
J. 95: 4597–4612.
169. Gaertner, T. R., S. J. Kolodziej, D. Wang, R. Kobayashi, J. M. Koomen, J.
K. Stoops, and M. N. Waxham. 2004. Comparative Analyses of the Threedimensional Structures and Enzymatic Properties of α, β, γ, and δ Isoforms of Ca
2+-Calmodulin-dependent Protein Kinase II. J. Biol. Chem. 279: 12484–12494.
170. Quintana, A. R., D. Wang, J. E. Forbes, and M. N. Waxham. 2005. Kinetics

157

of calmodulin binding to calcineurin. Biochem. Biophys. Res. Commun. 334:
674–680.
171. Gomez-Suaga, P., S. Paillusson, R. Stoica, W. Noble, D. P. Hanger, and C.
C. J. Miller. 2017. The ER-Mitochondria Tethering Complex VAPB-PTPIP51
Regulates Autophagy. Curr. Biol. 27: 371–385.
172. Feeney, C. J., S. Karunanithi, J. Pearce, C. K. Govind, and H. L. Atwood.
1998. Motor nerve terminals on abdominal muscles in larval flesh flies,
Sarcophaga bullata: comparisons with Drosophila. J. Comp. Neurol. 402: 197–
209.
173. Rangaraju, V., N. Calloway, and T. A. Ryan. 2014. Activity-driven local ATP
synthesis is required for synaptic function. Cell 156: 825–35.
174. Ashrafi, G., Z. Wu, R. J. Farrell, and T. A. Ryan. 2017. GLUT4 Mobilization
Supports Energetic Demands of Active Synapses. Neuron 93: 606-615.e3.
175. Chouhan, A. K., M. V. Ivannikov, Z. Lu, M. Sugimori, R. R. Llinas, and G. T.
Macleod. 2012. Cytosolic Calcium Coordinates Mitochondrial Energy Metabolism
with Presynaptic Activity. J. Neurosci. 32: 1233–1243.
176. London, M., and M. Häusser. 2005. Dendritic Computation. Annu. Rev.
Neurosci. 28: 503–532.
177. Hirabayashi, Y., S.-K. Kwon, H. Paek, W. M. Pernice, M. A. Paul, J. Lee, P.
Erfani, A. Raczkowski, D. S. Petrey, L. A. Pon, and F. Polleux. 2017. ERmitochondria tethering by PDZD8 regulates Ca2+ dynamics in mammalian
neurons. Science 358: 623–630.
178. Le Masson, G., S. Przedborski, and L. F. Abbott. 2014. A Computational

158

Model of Motor Neuron Degeneration. Neuron 83: 975–988.
179. Tantama, M., J. R. Martínez-François, R. Mongeon, and G. Yellen. 2013.
Imaging energy status in live cells with a fluorescent biosensor of the intracellular
ATP-to-ADP ratio. Nat. Commun. 4.
180. Ren, G. R., J. Folke, F. Hauser, S. Li, and C. J. P. Grimmelikhuijzen. 2015.
The A- and B-type muscarinic acetylcholine receptors from Drosophila
melanogaster couple to different second messenger pathways. Biochem.
Biophys. Res. Commun. 462: 358–364.
181. Collin, C., F. Hauser, E. G. De Valdivia, S. Li, J. Reisenberger, E. M. M.
Carlsen, Z. Khan, N. O. Hansen, F. Puhm, L. Søndergaard, J. Niemiec, M.
Heninger, G. R. Ren, and C. J. P. Grimmelikhuijzen. 2013. Two types of
muscarinic acetylcholine receptors in Drosophila and other arthropods. Cell. Mol.
Life Sci. 70: 3231–3242.
182. Lardy, H. A., D. Johnson, and W. C. McMurray. 1958. Antibiotics as tools for
metabolic studies. I. A survey of toxic antibiotics in respiratory, phosphorylative
and glycolytic systems. Arch. Biochem. Biophys. 78: 587–597.
183. Ivannikov, M. V., and G. T. Macleod. 2013. Mitochondrial free Ca2+ levels
and their effects on energy metabolism in drosophila motor nerve terminals.
Biophys. J. 104: 2353–2361.
184. Lange, K., K. Keller, W. ‐D Ludwig, I. Monden, I. Reinsch, and U. Brandt.
1982. Rapid Cellular Regulation of D‐Glucose Transport in Cultured Neural Cells.
J. Neurochem. 39: 1594–1600.

159

185. Combs, D. J., H. G. Shin, Y. Xu, Y. Ramu, and Z. Lu. 2013. Tuning voltagegated channel activity and cellular excitability with a sphingomyelinase. J. Gen.
Physiol. 142: 367–380.
186. Carpenter, D. O., and B. O. Alving. 1968. A contribution of an electrogenic
Na+ pump to membrane potential in Aplysia neurons. J. Gen. Physiol. 52: 1–21.
187. Zhou, Y., C. O. Wong, K. J. Cho, D. Van Der Hoeven, H. Liang, D. P.
Thakur, J. Luo, M. Babic, K. E. Zinsmaier, M. X. Zhu, H. Hu, K. Venkatachalam,
and J. F. Hancock. 2015. Membrane potential modulates plasma membrane
phospholipid dynamics and K-Ras signaling. Science (80-. ). 349: 873–876.
188. Parisky, K. M., J. Agosto, S. R. Pulver, Y. Shang, E. Kuklin, J. J. L. Hodge,
K. Kang, X. Liu, P. A. Garrity, M. Rosbash, and L. C. Griffith. 2008. PDF Cells
Are a GABA-Responsive Wake-Promoting Component of the Drosophila Sleep
Circuit. Neuron 60: 672–682.
189. Hall, A. M., B. T. Throesch, S. C. Buckingham, S. J. Markwardt, Y. Peng, Q.
Wang, D. A. Hoffman, and E. D. Roberson. 2015. Tau-dependent Kv4.2
depletion and dendritic hyperexcitability in a mouse model of Alzheimer’s
disease. J. Neurosci. 35: 6221–6230.
190. Folwell, J., C. M. Cowan, K. K. Ubhi, H. Shiabh, T. A. Newman, D.
Shepherd, and A. Mudher. 2010. Aβ exacerbates the neuronal dysfunction
caused by human tau expression in a Drosophila model of Alzheimer’s disease.
Exp. Neurol. 223: 401–409.
191. Holth, J. K., V. C. Bomben, J. Graham Reed, T. Inoue, L. Younkin, S. G.
Younkin, R. G. Pautler, J. Botas, and J. L. Noebels. 2013. Tau loss attenuates

160

neuronal network hyperexcitability in mouse and drosophila genetic models of
epilepsy. J. Neurosci. 33: 1651–1659.
192. Crimins, J. L., A. B. Rocher, and J. I. Luebke. 2012. Electrophysiological
changes precede morphological changes to frontal cortical pyramidal neurons in
the rTg4510 mouse model of progressive tauopathy. Acta Neuropathol. 124:
777–795.
193. Buhl, E., J. P. Higham, and J. J. L. Hodge. 2019. Alzheimer’s diseaseassociated tau alters Drosophila circadian activity, sleep and clock neuron
electrophysiology. Neurobiol. Dis. 130: 104507.
194. Ren, G. R., J. Folke, F. Hauser, S. Li, and C. J. P. Grimmelikhuijzen. 2015.
The A- and B-type muscarinic acetylcholine receptors from Drosophila
melanogaster couple to different second messenger pathways. Biochem.
Biophys. Res. Commun. 462: 358–364.
195. Collin, C., F. Hauser, E. G. De Valdivia, S. Li, J. Reisenberger, E. M. M.
Carlsen, Z. Khan, N. O. Hansen, F. Puhm, L. Søndergaard, J. Niemiec, M.
Heninger, G. R. Ren, and C. J. P. Grimmelikhuijzen. 2013. Two types of
muscarinic acetylcholine receptors in Drosophila and other arthropods. Cell. Mol.
Life Sci. 70: 3231–3242.
196. Sullivan, K. M. C., K. Scott, C. S. Zuker, and G. M. Rubin. 2000. The
ryanodine receptor is essential for larval development in Drosophila
melanogaster. Proc. Natl. Acad. Sci. U. S. A. 97: 5942–5947.
197. Gao, S., D. J. Sandstrom, H. E. Smith, B. High, J. W. Marsh, and H. A.
Nash. 2013. Drosophila ryanodine receptors mediate general anesthesia by

161

halothane. Anesthesiology 118: 587–601.
198. Krieger, C., and M. R. Duchen. 2002. Mitochondria, Ca2+ and
neurodegenerative disease. Eur. J. Pharmacol. 447: 177–88.
199. Garrity, A. G., W. Wang, C. M. D. Collier, S. A. Levey, Q. Gao, and H. Xu.
2016. The endoplasmic reticulum, not the pH gradient, drives calcium refilling of
lysosomes. Elife 5.
200. Atakpa, P., N. B. Thillaiappan, S. Mataragka, D. L. Prole, and C. W. Taylor.
2018. IP3 Receptors Preferentially Associate with ER-Lysosome Contact Sites
and Selectively Deliver Ca2+ to Lysosomes. Cell Rep. 25: 3180-3193.e7.
201. Wong, C. O., S. Gregory, H. Hu, Y. Chao, V. E. Sepúlveda, Y. He, D. LiKroeger, W. E. Goldman, H. J. Bellen, and K. Venkatachalam. 2017. Lysosomal
Degradation Is Required for Sustained Phagocytosis of Bacteria by
Macrophages. Cell Host Microbe 21: 719-730.e6.
202. Berg, T. O., P. E. Stromhaug, T. Lovdal, P. O. Seglen, and T. Berg. 1994.
Use of glycyl-L-phenylalanine 2-naphthylamide, a lysosome-disrupting cathepsin
G substrate, to distinguish between lysosomes and prelysosomal endocytic
vacuoles. Biochem. J. 300: 229–236.
203. Atakpa, P., L. M. Van Marrewijk, M. Apta-Smith, S. Chakraborty, and C. W.
Taylor. 2019. GPN does not release lysosomal Ca 2+ but evokes Ca 2+ release
from the ER by increasing the cytosolic pH independently of cathepsin C. J. Cell
Sci. 132.
204. Wong, C. O., R. Li, C. Montell, and K. Venkatachalam. 2012. Drosophila
TRPML is required for TORC1 activation. Curr. Biol. 22: 1616–1621.

162

205. Venkatachalam, K., A. A. Long, R. Elsaesser, D. Nikolaeva, K. Broadie, and
C. Montell. 2008. Motor Deficit in a Drosophila Model of Mucolipidosis Type IV
due to Defective Clearance of Apoptotic Cells. Cell 135: 838–851.
206. Kadir, L. A., M. Stacey, and R. Barrett-Jolley. 2018. Emerging roles of the
membrane potential: Action beyond the action potential. Front. Physiol. 9.
207. Plowman, S. J., C. Muncke, R. G. Parton, and J. F. Hancock. 2005. H-ras,
K-ras, and inner plasma membrane raft proteins operate in nanoclusters with
differential dependence on the actin cytoskleton. Proc. Natl. Acad. Sci. U. S. A.
102: 15500–15505.
208. James, S. R., A. Paterson, T. K. Harden, and C. P. Downes. 1995. Kinetic
analysis of phospholipase C beta isoforms using phospholipid-detergent mixed
micelles. Evidence for interfacial catalysis involving distinct micelle binding and
catalytic steps. J. Biol. Chem. 270: 11872–81.
209. Goldstein, S. A., D. Bockenhauer, I. O’Kelly, and N. Zilberberg. 2001.
Potassium leak channels and the KCNK family of two-P-domain subunits. Nat.
Rev. Neurosci. 2: 175–84.
210. Johnson, B., A. N. Leek, L. Solé, E. E. Maverick, T. P. Levine, and M. M.
Tamkun. 2018. Kv2 potassium channels form endoplasmic reticulum/plasma
membrane junctions via interaction with VAPA and VAPB. Proc. Natl. Acad. Sci.
U. S. A. 115: E7331–E7340.
211. Kirmiz, M., N. C. Vierra, S. Palacio, and J. S. Trimmer. 2018. Identification
of VAPA and VAPB as Kv2 channel-interacting proteins defining endoplasmic
reticulum–plasma membrane junctions in mammalian brain neurons. J. Neurosci.

163

38: 7562–7584.
212. Li, X. C., Y. Hu, Z. H. Wang, Y. Luo, Y. Zhang, X. P. Liu, Q. Feng, Q. Wang,
K. Ye, G. P. Liu, and J. Z. Wang. 2016. Human wild-type full-length tau
accumulation disrupts mitochondrial dynamics and the functions via increasing
mitofusins. Sci. Rep. 6: 24756.
213. Medina, D. L., S. Di Paola, I. Peluso, A. Armani, D. De Stefani, R. Venditti,
S. Montefusco, A. Scotto-Rosato, C. Prezioso, A. Forrester, C. Settembre, W.
Wang, Q. Gao, H. Xu, M. Sandri, R. Rizzuto, M. A. De Matteis, and A. Ballabio.
2015. Lysosomal calcium signalling regulates autophagy through calcineurin and
TFEB. Nat. Cell Biol. 17: 288–299.
214. Lee, J. H., M. K. McBrayer, D. M. Wolfe, L. J. Haslett, A. Kumar, Y. Sato, P.
P. Y. Lie, P. Mohan, E. E. Coffey, U. Kompella, C. H. Mitchell, E. Lloyd-Evans,
and R. A. Nixon. 2015. Presenilin 1 Maintains Lysosomal Ca2+ Homeostasis via
TRPML1 by Regulating vATPase-Mediated Lysosome Acidification. Cell Rep. 12:
1430–1444.
215. Zhang, X., K. Garbett, K. Veeraraghavalu, B. Wilburn, R. Gilmore, K.
Mirnics, and S. S. Sisodia. 2012. A role for presenilins in autophagy revisited:
Normal acidification of lysosomes in cells lacking PSEN1 and PSEN2. J.
Neurosci. 32: 8633–8648.
216. Divakaruni, A. S., A. Paradyse, D. A. Ferrick, A. N. Murphy, and J. Martin.
2014. Analysis and interpretation of microplate-based oxygen consumption and
pH data. In Methods in Enzymology A. N. Murphy, and D. C. Chan, eds. 309–
354.

164

217. Hodge, J. J. L. 2009. Ion channels to inactivate neurons in Drosophila.
Front. Mol. Neurosci. 2.
218. Misonou, H., D. P. Mohapatra, and J. S. Trimmer. 2005. Kv2.1: A voltagegated K+ channel critical to dynamic control of neuronal excitability. In
NeuroToxicology vol. 26. 743–752.
219. Jędrychowska, J., and V. Korzh. 2019. Kv2.1 voltage-gated potassium
channels in developmental perspective. Dev. Dyn. 248: 1180–1194.
220. Islas, L. D., and F. J. Sigworth. 1999. Voltage sensitivity and gating charge
in Shaker and Shab family potassium channels. J. Gen. Physiol. 114: 723–741.
221. Ping, Y., E. T. Hahm, G. Waro, Q. Song, D. A. Vo-Ba, A. Licursi, H. Bao, L.
Ganoe, K. Finch, and S. Tsunoda. 2015. Linking Aβ42-Induced Hyperexcitability
to Neurodegeneration, Learning and Motor Deficits, and a Shorter Lifespan in an
Alzheimer’s Model. PLoS Genet. 11.
222. Cowan, C. M., T. Bossing, A. Page, D. Shepherd, and A. Mudher. 2010.
Soluble hyper-phosphorylated tau causes microtubule breakdown and
functionally compromises normal tau in vivo. Acta Neuropathol. 120: 593–604.
223. Patergnani, S., J. M. Suski, C. Agnoletto, A. Bononi, M. Bonora, E. De
Marchi, C. Giorgi, S. Marchi, S. Missiroli, F. Poletti, A. Rimessi, J. Duszynski, M.
R. Wieckowski, and P. Pinton. 2011. Calcium signaling around Mitochondria
Associated Membranes (MAMs). Cell Commun. Signal. 9: 19.
224. Bouché, V., A. P. Espinosa, L. Leone, M. Sardiello, A. Ballabio, and J.
Botas. 2016. Drosophila Mitf regulates the V-ATPase and the lysosomalautophagic pathway. Autophagy 12: 484–498.

165

225. Kilpatrick, B. S., E. R. Eden, L. N. Hockey, E. Yates, C. E. Futter, and S.
Patel. 2017. An Endosomal NAADP-Sensitive Two-Pore Ca2+ Channel
Regulates ER-Endosome Membrane Contact Sites to Control Growth Factor
Signaling. Cell Rep. 18: 1636–1645.
226. Wang, X., X. Zhang, X. P. Dong, M. Samie, X. Li, X. Cheng, A. Goschka, D.
Shen, Y. Zhou, J. Harlow, M. X. Zhu, D. E. Clapham, D. Ren, and H. Xu. 2012.
TPC proteins are phosphoinositide- Activated sodium-selective ion channels in
endosomes and lysosomes. Cell 151: 372–383.
227. Dong, R., Y. Saheki, S. Swarup, L. Lucast, J. W. Harper, and P. De Camilli.
2016. Endosome-ER Contacts Control Actin Nucleation and Retromer Function
through VAP-Dependent Regulation of PI4P. Cell 166: 408–423.
228. Phillips, M. J., and G. K. Voeltz. 2016. Structure and function of ER
membrane contact sites with other organelles. Nat. Rev. Mol. Cell Biol. 17: 69–
82.
229. Morgan, A. J., L. C. Davis, S. K. T. Y. Wagner, A. M. Lewis, J. Parrington,
G. C. Churchill, and A. Galione. 2013. Bidirectional Ca2+ signaling occurs
between the endoplasmic reticulum and acidic organelles. J. Cell Biol. 200: 789–
805.
230. Kilpatrick, B. S., E. Yates, C. Grimm, A. H. Schapira, and S. Patel. 2016.
Endo-lysosomal TRP mucolipin-1 channels trigger global ER Ca2+ release and
Ca2+ influx. J. Cell Sci. 129: 3859–3867.
231. Han, X. 2016. Lipidomics for studying metabolism. Nat. Rev. Endocrinol. 12:
668–679.

166

232. Lin, X., V. Nair, Y. Zhou, and A. A. Gorfe. 2018. Membrane potential and
dynamics in a ternary lipid mixture: insights from molecular dynamics
simulations. Phys. Chem. Chem. Phys. 20: 15841–15851.
233. Engl, E., and D. Attwell. 2015. Non-signalling energy use in the brain. J.
Physiol. 593: 3417–3429.
234. Baeza-Lehnert, F., A. S. Saab, R. Gutiérrez, V. Larenas, E. Díaz, M. Horn,
M. Vargas, L. Hösli, J. Stobart, J. Hirrlinger, B. Weber, and L. F. Barros. 2019.
Non-Canonical Control of Neuronal Energy Status by the Na + Pump. Cell
Metab. 29: 668-680.e4.

167

Vita
Nicholas Emanuel Karagas was born in Corpus Christi, Texas on November 28th,
1990, the son of Karen Karagas and Michael Karagas. After completing his work
at Calallen High School, Corpus Christi, Texas in 2009, he entered Trinity
University in San Antonio, Texas. He received the degree of Bachelor of Science
with a major in biochemistry and molecular biology and a minor in religion from
Trinity in May 2013. In August of 2013, he entered McGovern Medical School
and subsequently transferred into the MD/PhD dual degree program during his
second year. After completing three years of medical training, he began his PhD
in the lab of Dr. Kartik Venkatachalam during 2016.

168

